id	sid	tid	token	lemma	pos
njb-66	1	1	nepal	nepal	ADJ
njb-66	1	2	journal	journal	NOUN
njb-66	1	3	of	of	ADP
njb-66	1	4	biotechnology	biotechnology	NOUN
njb-66	1	5	.	.	PUNCT
njb-66	2	1	d	d	X
njb-66	2	2	e	e	PROPN
njb-66	2	3	c	c	PROPN
njb-66	2	4	.	.	PUNCT
njb-66	3	1	2	2	NUM
njb-66	3	2	0	0	NUM
njb-66	3	3	1	1	NUM
njb-66	3	4	9	9	NUM
njb-66	3	5	vol	vol	NOUN
njb-66	3	6	.	.	PUNCT
njb-66	4	1	7	7	NUM
njb-66	4	2	,	,	PUNCT
njb-66	4	3	no	no	NOUN
njb-66	4	4	.	.	NOUN
njb-66	4	5	1	1	NUM
njb-66	4	6	:	:	SYM
njb-66	4	7	82	82	NUM
njb-66	4	8	-	-	SYM
njb-66	4	9	89	89	NUM
njb-66	4	10	doi	doi	NOUN
njb-66	4	11	:	:	PUNCT
njb-66	4	12	https://doi.org/10.3126/njb.v7i1.26957	https://doi.org/10.3126/njb.v7i1.26957	PROPN
njb-66	5	1	©	©	PROPN
njb-66	5	2	njb	njb	PROPN
njb-66	5	3	,	,	PUNCT
njb-66	5	4	biotechnology	biotechnology	NOUN
njb-66	5	5	society	society	NOUN
njb-66	5	6	of	of	ADP
njb-66	5	7	nepal	nepal	ADJ
njb-66	5	8	82	82	NUM
njb-66	5	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-66	5	10	.	.	PUNCT
njb-66	6	1	original	original	ADJ
njb-66	6	2	research	research	NOUN
njb-66	6	3	article	article	NOUN
njb-66	6	4	screening	screen	VERB
njb-66	6	5	of	of	ADP
njb-66	6	6	methicillin	methicillin	NOUN
njb-66	6	7	resistant	resistant	ADJ
njb-66	6	8	staphylococcus	staphylococcus	NOUN
njb-66	6	9	aureus	aureus	NOUN
njb-66	6	10	(	(	PUNCT
njb-66	6	11	mrsa	mrsa	PROPN
njb-66	6	12	)	)	PUNCT
njb-66	6	13	from	from	ADP
njb-66	6	14	wounds	wound	NOUN
njb-66	6	15	in	in	ADP
njb-66	6	16	pediatric	pediatric	ADJ
njb-66	6	17	patients	patient	NOUN
njb-66	6	18	visiting	visit	VERB
njb-66	6	19	tertiary	tertiary	ADJ
njb-66	6	20	care	care	NOUN
njb-66	6	21	in	in	ADP
njb-66	6	22	hospital	hospital	PROPN
njb-66	6	23	ganesh	ganesh	PROPN
njb-66	6	24	bhandari1	bhandari1	PROPN
njb-66	6	25	,	,	PUNCT
njb-66	6	26	basant	basant	ADJ
njb-66	6	27	pokhrel1	pokhrel1	PROPN
njb-66	6	28	,	,	PUNCT
njb-66	6	29	yogesh	yogesh	PROPN
njb-66	6	30	oli2	oli2	PROPN
njb-66	6	31	,	,	PUNCT
njb-66	6	32	archana	archana	PROPN
njb-66	6	33	katuwal2	katuwal2	PROPN
njb-66	6	34	,	,	PUNCT
njb-66	6	35	netra	netra	PROPN
njb-66	6	36	lal	lal	PROPN
njb-66	6	37	bhandari1	bhandari1	PROPN
njb-66	6	38	*	*	PROPN
njb-66	6	39	1department	1department	NUM
njb-66	6	40	of	of	ADP
njb-66	6	41	chemistry	chemistry	NOUN
njb-66	6	42	,	,	PUNCT
njb-66	6	43	tri	tri	ADJ
njb-66	6	44	-	-	ADJ
njb-66	6	45	chandra	chandra	ADJ
njb-66	6	46	multiple	multiple	ADJ
njb-66	6	47	campus	campus	NOUN
njb-66	6	48	,	,	PUNCT
njb-66	6	49	tribhuvan	tribhuvan	PROPN
njb-66	6	50	university	university	PROPN
njb-66	6	51	,	,	PUNCT
njb-66	6	52	kathmandu	kathmandu	NOUN
njb-66	6	53	,	,	PUNCT
njb-66	6	54	nepal	nepal	ADJ
njb-66	6	55	2department	2department	NUM
njb-66	6	56	of	of	ADP
njb-66	6	57	microbiology	microbiology	NOUN
njb-66	6	58	,	,	PUNCT
njb-66	6	59	tri	tri	ADJ
njb-66	6	60	-	-	ADJ
njb-66	6	61	chandra	chandra	ADJ
njb-66	6	62	multiple	multiple	ADJ
njb-66	6	63	campus	campus	NOUN
njb-66	6	64	,	,	PUNCT
njb-66	6	65	tribhuvan	tribhuvan	PROPN
njb-66	6	66	university	university	PROPN
njb-66	6	67	,	,	PUNCT
njb-66	6	68	kathmandu	kathmandu	PROPN
njb-66	6	69	,	,	PUNCT
njb-66	6	70	nepal	nepal	ADJ
njb-66	6	71	abstract	abstract	ADJ
njb-66	6	72	the	the	DET
njb-66	6	73	extent	extent	NOUN
njb-66	6	74	of	of	ADP
njb-66	6	75	methicillin	methicillin	NOUN
njb-66	6	76	-	-	PUNCT
njb-66	6	77	resistant	resistant	ADJ
njb-66	6	78	staphylococcus	staphylococcus	NOUN
njb-66	6	79	aureus	aureus	NOUN
njb-66	6	80	(	(	PUNCT
njb-66	6	81	mrsa	mrsa	PROPN
njb-66	6	82	)	)	PUNCT
njb-66	6	83	in	in	ADP
njb-66	6	84	children	child	NOUN
njb-66	6	85	is	be	AUX
njb-66	6	86	still	still	ADV
njb-66	6	87	unknown	unknown	ADJ
njb-66	6	88	.	.	PUNCT
njb-66	7	1	the	the	DET
njb-66	7	2	collected	collected	ADJ
njb-66	7	3	wound	wound	NOUN
njb-66	7	4	pus	pus	NOUN
njb-66	7	5	samples	sample	NOUN
njb-66	7	6	were	be	AUX
njb-66	7	7	processed	process	VERB
njb-66	7	8	.	.	PUNCT
njb-66	8	1	identification	identification	NOUN
njb-66	8	2	of	of	ADP
njb-66	8	3	s.	s.	PROPN
njb-66	8	4	aureus	aureus	PROPN
njb-66	8	5	was	be	AUX
njb-66	8	6	done	do	VERB
njb-66	8	7	according	accord	VERB
njb-66	8	8	to	to	ADP
njb-66	8	9	standard	standard	ADJ
njb-66	8	10	microbiological	microbiological	ADJ
njb-66	8	11	procedures	procedure	NOUN
njb-66	8	12	as	as	ADP
njb-66	8	13	per	per	ADP
njb-66	8	14	the	the	DET
njb-66	8	15	clinical	clinical	ADJ
njb-66	8	16	laboratory	laboratory	PROPN
njb-66	8	17	standards	standards	PROPN
njb-66	8	18	institute	institute	PROPN
njb-66	8	19	(	(	PUNCT
njb-66	8	20	clsi	clsi	PROPN
njb-66	8	21	)	)	PUNCT
njb-66	8	22	guidelines	guideline	NOUN
njb-66	8	23	(	(	PUNCT
njb-66	8	24	2016	2016	NUM
njb-66	8	25	)	)	PUNCT
njb-66	8	26	.	.	PUNCT
njb-66	9	1	the	the	DET
njb-66	9	2	antibiogram	antibiogram	PROPN
njb-66	9	3	of	of	ADP
njb-66	9	4	the	the	DET
njb-66	9	5	isolates	isolate	NOUN
njb-66	9	6	was	be	AUX
njb-66	9	7	carried	carry	VERB
njb-66	9	8	out	out	ADP
njb-66	9	9	by	by	ADP
njb-66	9	10	the	the	DET
njb-66	9	11	kirby	kirby	PROPN
njb-66	9	12	-	-	PUNCT
njb-66	9	13	bauer	bauer	NOUN
njb-66	9	14	disc	disc	NOUN
njb-66	9	15	diffusion	diffusion	NOUN
njb-66	9	16	technique	technique	NOUN
njb-66	9	17	.	.	PUNCT
njb-66	10	1	mrsa	mrsa	PROPN
njb-66	10	2	was	be	AUX
njb-66	10	3	determined	determine	VERB
njb-66	10	4	by	by	ADP
njb-66	10	5	measuring	measure	VERB
njb-66	10	6	the	the	DET
njb-66	10	7	zone	zone	NOUN
njb-66	10	8	of	of	ADP
njb-66	10	9	inhibition	inhibition	NOUN
njb-66	10	10	(	(	PUNCT
njb-66	10	11	zoi	zoi	NOUN
njb-66	10	12	)	)	PUNCT
njb-66	10	13	surrounding	surround	VERB
njb-66	10	14	to	to	ADP
njb-66	10	15	cefoxitin	cefoxitin	NOUN
njb-66	10	16	disc	disc	NOUN
njb-66	10	17	,	,	PUNCT
njb-66	10	18	with	with	ADP
njb-66	10	19	resistance	resistance	NOUN
njb-66	10	20	defined	define	VERB
njb-66	10	21	as	as	ADP
njb-66	10	22	zoi	zoi	NOUN
njb-66	10	23	of	of	ADP
njb-66	10	24	≤	≤	PROPN
njb-66	10	25	21	21	NUM
njb-66	10	26	mm	mm	PROPN
njb-66	10	27	.	.	PUNCT
njb-66	11	1	out	out	ADP
njb-66	11	2	of	of	ADP
njb-66	11	3	357	357	NUM
njb-66	11	4	bacterial	bacterial	ADJ
njb-66	11	5	culture	culture	NOUN
njb-66	11	6	-	-	PUNCT
njb-66	11	7	positive	positive	ADJ
njb-66	11	8	samples	sample	NOUN
njb-66	11	9	,	,	PUNCT
njb-66	11	10	278	278	NUM
njb-66	11	11	(	(	PUNCT
njb-66	11	12	77.87	77.87	NUM
njb-66	11	13	%	%	NOUN
njb-66	11	14	)	)	PUNCT
njb-66	11	15	were	be	AUX
njb-66	11	16	s.	s.	PROPN
njb-66	11	17	aureus	aureus	PROPN
njb-66	11	18	isolates	isolate	NOUN
njb-66	11	19	,	,	PUNCT
njb-66	11	20	among	among	ADP
njb-66	11	21	them	they	PRON
njb-66	11	22	102	102	NUM
njb-66	11	23	(	(	PUNCT
njb-66	11	24	36.69	36.69	NUM
njb-66	11	25	%	%	NOUN
njb-66	11	26	)	)	PUNCT
njb-66	11	27	were	be	AUX
njb-66	11	28	found	find	VERB
njb-66	11	29	to	to	PART
njb-66	11	30	be	be	AUX
njb-66	11	31	mrsa	mrsa	PROPN
njb-66	11	32	.	.	PUNCT
njb-66	12	1	the	the	DET
njb-66	12	2	percentage	percentage	NOUN
njb-66	12	3	of	of	ADP
njb-66	12	4	mrsa	mrsa	PROPN
njb-66	12	5	isolates	isolate	NOUN
njb-66	12	6	was	be	AUX
njb-66	12	7	found	find	VERB
njb-66	12	8	high	high	ADJ
njb-66	12	9	in	in	ADP
njb-66	12	10	male	male	ADJ
njb-66	12	11	children	child	NOUN
njb-66	12	12	and	and	CCONJ
njb-66	12	13	inpatients	inpatient	NOUN
njb-66	12	14	with	with	ADP
njb-66	12	15	61.76	61.76	NUM
njb-66	12	16	%	%	NOUN
njb-66	12	17	and	and	CCONJ
njb-66	12	18	73.52	73.52	NUM
njb-66	12	19	%	%	NOUN
njb-66	12	20	respectively	respectively	ADV
njb-66	12	21	.	.	PUNCT
njb-66	13	1	all	all	DET
njb-66	13	2	the	the	DET
njb-66	13	3	mrsa	mrsa	PROPN
njb-66	13	4	isolates	isolate	NOUN
njb-66	13	5	were	be	AUX
njb-66	13	6	susceptible	susceptible	ADJ
njb-66	13	7	to	to	ADP
njb-66	13	8	gentamicin	gentamicin	PROPN
njb-66	13	9	(	(	PUNCT
njb-66	13	10	79.41	79.41	NUM
njb-66	13	11	%	%	NOUN
njb-66	13	12	)	)	PUNCT
njb-66	13	13	,	,	PUNCT
njb-66	13	14	whereas	whereas	SCONJ
njb-66	13	15	(	(	PUNCT
njb-66	13	16	91.17	91.17	NUM
njb-66	13	17	%	%	NOUN
njb-66	13	18	)	)	PUNCT
njb-66	13	19	were	be	AUX
njb-66	13	20	resistant	resistant	ADJ
njb-66	13	21	to	to	ADP
njb-66	13	22	penicillin	penicillin	PROPN
njb-66	13	23	.	.	PUNCT
njb-66	14	1	the	the	DET
njb-66	14	2	distribution	distribution	NOUN
njb-66	14	3	of	of	ADP
njb-66	14	4	mrsa	mrsa	PROPN
njb-66	14	5	in	in	ADP
njb-66	14	6	inpatients	inpatient	NOUN
njb-66	14	7	75	75	NUM
njb-66	14	8	(	(	PUNCT
njb-66	14	9	73.52	73.52	NUM
njb-66	14	10	%	%	NOUN
njb-66	14	11	)	)	PUNCT
njb-66	14	12	is	be	AUX
njb-66	14	13	higher	high	ADJ
njb-66	14	14	than	than	ADP
njb-66	14	15	that	that	PRON
njb-66	14	16	of	of	ADP
njb-66	14	17	outpatients	outpatient	NOUN
njb-66	14	18	27	27	NUM
njb-66	14	19	(	(	PUNCT
njb-66	14	20	26.74	26.74	NUM
njb-66	14	21	%	%	NOUN
njb-66	14	22	)	)	PUNCT
njb-66	14	23	.	.	PUNCT
njb-66	15	1	this	this	DET
njb-66	15	2	study	study	NOUN
njb-66	15	3	shows	show	VERB
njb-66	15	4	that	that	SCONJ
njb-66	15	5	the	the	DET
njb-66	15	6	mrsa	mrsa	ADJ
njb-66	15	7	occurrence	occurrence	NOUN
njb-66	15	8	is	be	AUX
njb-66	15	9	prevalent	prevalent	ADJ
njb-66	15	10	in	in	ADP
njb-66	15	11	pediatric	pediatric	ADJ
njb-66	15	12	patients	patient	NOUN
njb-66	15	13	.	.	PUNCT
njb-66	16	1	keywords	keyword	NOUN
njb-66	16	2	:	:	PUNCT
njb-66	16	3	staphylococcus	staphylococcus	NOUN
njb-66	16	4	aureus	aureus	PROPN
njb-66	16	5	,	,	PUNCT
njb-66	16	6	mrsa	mrsa	PROPN
njb-66	16	7	,	,	PUNCT
njb-66	16	8	antibiotic	antibiotic	ADJ
njb-66	16	9	susceptibility	susceptibility	NOUN
njb-66	16	10	test	test	NOUN
njb-66	16	11	,	,	PUNCT
njb-66	16	12	disc	disc	NOUN
njb-66	16	13	-	-	PUNCT
njb-66	16	14	diffusion	diffusion	NOUN
njb-66	16	15	,	,	PUNCT
njb-66	16	16	methicillin	methicillin	NOUN
njb-66	16	17	resistant	resistant	ADJ
njb-66	16	18	*	*	NOUN
njb-66	16	19	corresponding	correspond	VERB
njb-66	16	20	author	author	NOUN
njb-66	16	21	email	email	NOUN
njb-66	16	22	:	:	PUNCT
njb-66	16	23	netra.tu.edu@gmail.com	netra.tu.edu@gmail.com	PROPN
njb-66	16	24	introduction	introduction	NOUN
njb-66	16	25	staphylococcus	staphylococcus	PROPN
njb-66	16	26	aureus	aureus	PROPN
njb-66	16	27	(	(	PUNCT
njb-66	16	28	s.	s.	PROPN
njb-66	16	29	aureus	aureus	PROPN
njb-66	16	30	)	)	PUNCT
njb-66	16	31	is	be	AUX
njb-66	16	32	one	one	NUM
njb-66	16	33	of	of	ADP
njb-66	16	34	the	the	DET
njb-66	16	35	important	important	ADJ
njb-66	16	36	human	human	PROPN
njb-66	16	37	pathogen	pathogen	PROPN
njb-66	16	38	known	know	VERB
njb-66	16	39	over	over	ADP
njb-66	16	40	the	the	DET
njb-66	16	41	past	past	ADJ
njb-66	16	42	several	several	ADJ
njb-66	16	43	decades	decade	NOUN
njb-66	16	44	.	.	PUNCT
njb-66	17	1	it	it	PRON
njb-66	17	2	is	be	AUX
njb-66	17	3	the	the	DET
njb-66	17	4	cause	cause	NOUN
njb-66	17	5	of	of	ADP
njb-66	17	6	hospital	hospital	NOUN
njb-66	17	7	and	and	CCONJ
njb-66	17	8	community	community	NOUN
njb-66	17	9	-	-	PUNCT
njb-66	17	10	acquired	acquire	VERB
njb-66	17	11	infections	infection	NOUN
njb-66	17	12	[	[	X
njb-66	17	13	1	1	NUM
njb-66	17	14	]	]	PUNCT
njb-66	17	15	.	.	PUNCT
njb-66	18	1	it	it	PRON
njb-66	18	2	is	be	AUX
njb-66	18	3	one	one	NUM
njb-66	18	4	of	of	ADP
njb-66	18	5	the	the	DET
njb-66	18	6	versatile	versatile	ADJ
njb-66	18	7	nosocomial	nosocomial	ADJ
njb-66	18	8	pathogens	pathogen	NOUN
njb-66	18	9	worldwide	worldwide	ADV
njb-66	18	10	causing	cause	VERB
njb-66	18	11	skin	skin	NOUN
njb-66	18	12	infections	infection	NOUN
njb-66	18	13	to	to	ADP
njb-66	18	14	life	life	NOUN
njb-66	18	15	-	-	PUNCT
njb-66	18	16	threatening	threaten	VERB
njb-66	18	17	systemic	systemic	ADJ
njb-66	18	18	illnesses	illness	NOUN
njb-66	18	19	including	include	VERB
njb-66	18	20	pneumonia	pneumonia	NOUN
njb-66	18	21	,	,	PUNCT
njb-66	18	22	osteomyelitis	osteomyelitis	NOUN
njb-66	18	23	and	and	CCONJ
njb-66	18	24	endocarditis	endocarditis	NOUN
njb-66	18	25	[	[	PUNCT
njb-66	18	26	2	2	NUM
njb-66	18	27	,	,	PUNCT
njb-66	18	28	3	3	NUM
njb-66	18	29	]	]	PUNCT
njb-66	18	30	.	.	PUNCT
njb-66	19	1	s.	s.	PROPN
njb-66	19	2	aureus	aureus	PROPN
njb-66	19	3	is	be	AUX
njb-66	19	4	one	one	NUM
njb-66	19	5	of	of	ADP
njb-66	19	6	the	the	DET
njb-66	19	7	common	common	ADJ
njb-66	19	8	and	and	CCONJ
njb-66	19	9	important	important	ADJ
njb-66	19	10	gram	gram	NOUN
njb-66	19	11	-	-	PUNCT
njb-66	19	12	positive	positive	ADJ
njb-66	19	13	hospital	hospital	NOUN
njb-66	19	14	-	-	PUNCT
njb-66	19	15	acquired	acquire	VERB
njb-66	19	16	organisms	organism	NOUN
njb-66	19	17	.	.	PUNCT
njb-66	20	1	it	it	PRON
njb-66	20	2	can	can	AUX
njb-66	20	3	cause	cause	VERB
njb-66	20	4	infection	infection	NOUN
njb-66	20	5	;	;	PUNCT
njb-66	20	6	most	most	ADV
njb-66	20	7	commonly	commonly	ADV
njb-66	20	8	at	at	ADP
njb-66	20	9	sites	site	NOUN
njb-66	20	10	of	of	ADP
njb-66	20	11	lowered	lower	VERB
njb-66	20	12	host	host	NOUN
njb-66	20	13	resistance	resistance	NOUN
njb-66	20	14	such	such	ADJ
njb-66	20	15	as	as	ADP
njb-66	20	16	damaged	damage	VERB
njb-66	20	17	skin	skin	NOUN
njb-66	20	18	or	or	CCONJ
njb-66	20	19	mucosal	mucosal	NOUN
njb-66	20	20	membranes	membrane	NOUN
njb-66	20	21	,	,	PUNCT
njb-66	20	22	infections	infection	NOUN
njb-66	20	23	like	like	ADP
njb-66	20	24	pimples	pimple	NOUN
njb-66	20	25	,	,	PUNCT
njb-66	20	26	boils	boil	VERB
njb-66	20	27	and	and	CCONJ
njb-66	20	28	abscesses	abscess	NOUN
njb-66	20	29	to	to	ADP
njb-66	20	30	severe	severe	ADJ
njb-66	20	31	systemic	systemic	ADJ
njb-66	20	32	infections	infection	NOUN
njb-66	20	33	like	like	ADP
njb-66	20	34	bacteremia	bacteremia	NOUN
njb-66	20	35	,	,	PUNCT
njb-66	20	36	endocarditis	endocarditis	NOUN
njb-66	20	37	,	,	PUNCT
njb-66	20	38	pneumonia	pneumonia	NOUN
njb-66	20	39	and	and	CCONJ
njb-66	20	40	toxic	toxic	ADJ
njb-66	20	41	shock	shock	NOUN
njb-66	20	42	syndrome	syndrome	NOUN
njb-66	20	43	[	[	PUNCT
njb-66	20	44	4	4	NUM
njb-66	20	45	,	,	PUNCT
njb-66	20	46	5	5	NUM
njb-66	20	47	]	]	PUNCT
njb-66	20	48	.	.	PUNCT
njb-66	21	1	s.	s.	PROPN
njb-66	21	2	aureus	aureus	PROPN
njb-66	21	3	resistant	resistant	ADJ
njb-66	21	4	to	to	ADP
njb-66	21	5	oxacillin	oxacillin	PROPN
njb-66	21	6	,	,	PUNCT
njb-66	21	7	methicillin	methicillin	PROPN
njb-66	21	8	and	and	CCONJ
njb-66	21	9	a	a	DET
njb-66	21	10	few	few	ADJ
njb-66	21	11	others	other	NOUN
njb-66	21	12	related	related	ADJ
njb-66	21	13	antibiotics	antibiotic	NOUN
njb-66	21	14	are	be	AUX
njb-66	21	15	all	all	PRON
njb-66	21	16	known	know	VERB
njb-66	21	17	under	under	ADP
njb-66	21	18	the	the	DET
njb-66	21	19	generic	generic	ADJ
njb-66	21	20	term	term	NOUN
njb-66	21	21	methicillin	methicillin	NOUN
njb-66	21	22	-	-	PUNCT
njb-66	21	23	resistant	resistant	ADJ
njb-66	21	24	s.	s.	PROPN
njb-66	21	25	aureus	aureus	PROPN
njb-66	21	26	.	.	PUNCT
njb-66	22	1	the	the	DET
njb-66	22	2	penicillin	penicillin	NOUN
njb-66	22	3	-	-	PUNCT
njb-66	22	4	resistance	resistance	PROPN
njb-66	22	5	s.	s.	PROPN
njb-66	22	6	aureus	aureus	PROPN
njb-66	22	7	(	(	PUNCT
njb-66	22	8	prsa	prsa	NOUN
njb-66	22	9	)	)	PUNCT
njb-66	22	10	is	be	AUX
njb-66	22	11	typically	typically	ADV
njb-66	22	12	coincides	coincide	VERB
njb-66	22	13	with	with	ADP
njb-66	22	14	the	the	DET
njb-66	22	15	emergence	emergence	NOUN
njb-66	22	16	of	of	ADP
njb-66	22	17	mrsa	mrsa	PROPN
njb-66	22	18	[	[	PUNCT
njb-66	22	19	6	6	NUM
njb-66	22	20	]	]	PUNCT
njb-66	22	21	.	.	PUNCT
njb-66	23	1	mrsa	mrsa	PROPN
njb-66	23	2	is	be	AUX
njb-66	23	3	a	a	DET
njb-66	23	4	global	global	ADJ
njb-66	23	5	public	public	ADJ
njb-66	23	6	health	health	NOUN
njb-66	23	7	problem	problem	NOUN
njb-66	23	8	,	,	PUNCT
njb-66	23	9	associated	associate	VERB
njb-66	23	10	with	with	ADP
njb-66	23	11	considerable	considerable	ADJ
njb-66	23	12	morbidity	morbidity	NOUN
njb-66	23	13	and	and	CCONJ
njb-66	23	14	mortality	mortality	NOUN
njb-66	23	15	,	,	PUNCT
njb-66	23	16	causing	cause	VERB
njb-66	23	17	both	both	PRON
njb-66	23	18	hospital	hospital	NOUN
njb-66	23	19	and	and	CCONJ
njb-66	23	20	communityacquired	communityacquire	VERB
njb-66	23	21	infections	infection	NOUN
njb-66	23	22	[	[	PUNCT
njb-66	23	23	7	7	NUM
njb-66	23	24	]	]	PUNCT
njb-66	23	25	.	.	PUNCT
njb-66	24	1	among	among	ADP
njb-66	24	2	the	the	DET
njb-66	24	3	many	many	ADJ
njb-66	24	4	species	specie	NOUN
njb-66	24	5	of	of	ADP
njb-66	24	6	antibiotic	antibiotic	ADJ
njb-66	24	7	-	-	PUNCT
njb-66	24	8	resistant	resistant	ADJ
njb-66	24	9	bacteria	bacteria	NOUN
njb-66	24	10	,	,	PUNCT
njb-66	24	11	mrsa	mrsa	PROPN
njb-66	24	12	is	be	AUX
njb-66	24	13	one	one	NUM
njb-66	24	14	of	of	ADP
njb-66	24	15	the	the	DET
njb-66	24	16	most	most	ADV
njb-66	24	17	important	important	ADJ
njb-66	24	18	causes	cause	NOUN
njb-66	24	19	of	of	ADP
njb-66	24	20	antibiotic	antibiotic	ADJ
njb-66	24	21	treatment	treatment	NOUN
njb-66	24	22	failure	failure	NOUN
njb-66	24	23	,	,	PUNCT
njb-66	24	24	increased	increase	VERB
njb-66	24	25	morbidity	morbidity	NOUN
njb-66	24	26	and	and	CCONJ
njb-66	24	27	mortality	mortality	NOUN
njb-66	24	28	.	.	PUNCT
njb-66	25	1	s.	s.	PROPN
njb-66	25	2	aureus	aureus	PROPN
njb-66	25	3	has	have	VERB
njb-66	25	4	a	a	DET
njb-66	25	5	remarkable	remarkable	ADJ
njb-66	25	6	ability	ability	NOUN
njb-66	25	7	to	to	PART
njb-66	25	8	colonize	colonize	VERB
njb-66	25	9	the	the	DET
njb-66	25	10	skin	skin	NOUN
njb-66	25	11	and	and	CCONJ
njb-66	25	12	mucous	mucous	ADJ
njb-66	25	13	membranes	membrane	NOUN
njb-66	25	14	.	.	PUNCT
njb-66	26	1	hospitalized	hospitalize	VERB
njb-66	26	2	patients	patient	NOUN
njb-66	26	3	and	and	CCONJ
njb-66	26	4	health	health	NOUN
njb-66	26	5	-	-	PUNCT
njb-66	26	6	care	care	NOUN
njb-66	26	7	workers	worker	NOUN
njb-66	26	8	have	have	VERB
njb-66	26	9	higher	high	ADJ
njb-66	26	10	colonization	colonization	NOUN
njb-66	26	11	rates	rate	NOUN
njb-66	26	12	than	than	ADP
njb-66	26	13	the	the	DET
njb-66	26	14	general	general	ADJ
njb-66	26	15	population	population	NOUN
njb-66	26	16	[	[	PUNCT
njb-66	26	17	8	8	NUM
njb-66	26	18	]	]	PUNCT
njb-66	26	19	.	.	PUNCT
njb-66	27	1	studies	study	NOUN
njb-66	27	2	revealed	reveal	VERB
njb-66	27	3	that	that	SCONJ
njb-66	27	4	nearly	nearly	ADV
njb-66	27	5	6	6	NUM
njb-66	27	6	%	%	NOUN
njb-66	27	7	hospital	hospital	NOUN
njb-66	27	8	personnel	personnel	NOUN
njb-66	27	9	and	and	CCONJ
njb-66	27	10	nearly	nearly	ADV
njb-66	27	11	3	3	NUM
njb-66	27	12	%	%	NOUN
njb-66	27	13	outpatients	outpatient	NOUN
njb-66	27	14	carry	carry	VERB
njb-66	27	15	mrsa	mrsa	PROPN
njb-66	28	1	[	[	PUNCT
njb-66	28	2	9	9	NUM
njb-66	28	3	-	-	SYM
njb-66	28	4	12	12	NUM
njb-66	28	5	]	]	PUNCT
njb-66	28	6	.	.	PUNCT
njb-66	29	1	the	the	DET
njb-66	29	2	prevalence	prevalence	NOUN
njb-66	29	3	of	of	ADP
njb-66	29	4	mrsa	mrsa	PROPN
njb-66	29	5	has	have	AUX
njb-66	29	6	varied	vary	VERB
njb-66	29	7	from	from	ADP
njb-66	29	8	hospital	hospital	NOUN
njb-66	29	9	to	to	ADP
njb-66	29	10	hospital	hospital	NOUN
njb-66	29	11	in	in	ADP
njb-66	29	12	various	various	ADJ
njb-66	29	13	countries	country	NOUN
njb-66	29	14	.	.	PUNCT
njb-66	30	1	several	several	ADJ
njb-66	30	2	types	type	NOUN
njb-66	30	3	of	of	ADP
njb-66	30	4	research	research	NOUN
njb-66	30	5	and	and	CCONJ
njb-66	30	6	studies	study	NOUN
njb-66	30	7	conducted	conduct	VERB
njb-66	30	8	in	in	ADP
njb-66	30	9	nepal	nepal	ADJ
njb-66	30	10	about	about	ADP
njb-66	30	11	s.	s.	PROPN
njb-66	30	12	aureus	aureus	PROPN
njb-66	30	13	and	and	CCONJ
njb-66	30	14	their	their	PRON
njb-66	30	15	antibiotic	antibiotic	ADJ
njb-66	30	16	susceptibility	susceptibility	NOUN
njb-66	30	17	pattern	pattern	NOUN
njb-66	30	18	suggest	suggest	VERB
njb-66	30	19	the	the	DET
njb-66	30	20	gradual	gradual	ADJ
njb-66	30	21	emergence	emergence	NOUN
njb-66	30	22	of	of	ADP
njb-66	30	23	mrsa	mrsa	PROPN
njb-66	30	24	in	in	ADP
njb-66	30	25	hospitals	hospital	NOUN
njb-66	30	26	.	.	PUNCT
njb-66	31	1	however	however	ADV
njb-66	31	2	,	,	PUNCT
njb-66	31	3	only	only	ADV
njb-66	31	4	a	a	DET
njb-66	31	5	few	few	ADJ
njb-66	31	6	reports	report	NOUN
njb-66	31	7	related	relate	VERB
njb-66	31	8	to	to	ADP
njb-66	31	9	mrsa	mrsa	PROPN
njb-66	31	10	are	be	AUX
njb-66	31	11	available	available	ADJ
njb-66	31	12	in	in	ADP
njb-66	31	13	nepal	nepal	NOUN
njb-66	31	14	which	which	PRON
njb-66	31	15	is	be	AUX
njb-66	31	16	carried	carry	VERB
njb-66	31	17	out	out	ADP
njb-66	31	18	in	in	ADP
njb-66	31	19	different	different	ADJ
njb-66	31	20	hospitals	hospital	NOUN
njb-66	31	21	at	at	ADP
njb-66	31	22	different	different	ADJ
njb-66	31	23	periods	period	NOUN
njb-66	31	24	.	.	PUNCT
njb-66	32	1	in	in	ADP
njb-66	32	2	a	a	DET
njb-66	32	3	bacteriological	bacteriological	ADJ
njb-66	32	4	study	study	NOUN
njb-66	32	5	carried	carry	VERB
njb-66	32	6	out	out	ADP
njb-66	32	7	at	at	ADP
njb-66	32	8	tribhuvan	tribhuvan	PROPN
njb-66	32	9	university	university	PROPN
njb-66	32	10	teaching	teaching	NOUN
njb-66	32	11	hospital	hospital	NOUN
njb-66	32	12	(	(	PUNCT
njb-66	32	13	tuth	tuth	PROPN
njb-66	32	14	)	)	PUNCT
njb-66	32	15	,	,	PUNCT
njb-66	32	16	the	the	DET
njb-66	32	17	prevalence	prevalence	NOUN
njb-66	32	18	of	of	ADP
njb-66	32	19	mrsa	mrsa	PROPN
njb-66	32	20	was	be	AUX
njb-66	32	21	found	find	VERB
njb-66	32	22	to	to	PART
njb-66	32	23	be	be	AUX
njb-66	32	24	23.5	23.5	NUM
njb-66	32	25	%	%	NOUN
njb-66	32	26	[	[	PUNCT
njb-66	32	27	13	13	NUM
njb-66	32	28	]	]	PUNCT
njb-66	32	29	.	.	PUNCT
njb-66	33	1	a	a	DET
njb-66	33	2	similar	similar	ADJ
njb-66	33	3	study	study	NOUN
njb-66	33	4	carried	carry	VERB
njb-66	33	5	out	out	ADP
njb-66	33	6	at	at	ADP
njb-66	33	7	kanti	kanti	PROPN
njb-66	33	8	children	children	PROPN
njb-66	33	9	’s	’s	PART
njb-66	33	10	nepal	nepal	ADJ
njb-66	33	11	journal	journal	NOUN
njb-66	33	12	of	of	ADP
njb-66	33	13	biotechnology	biotechnology	NOUN
njb-66	33	14	.	.	PUNCT
njb-66	34	1	d	d	X
njb-66	34	2	e	e	PROPN
njb-66	34	3	c	c	PROPN
njb-66	34	4	.	.	PUNCT
njb-66	35	1	2	2	NUM
njb-66	35	2	0	0	NUM
njb-66	35	3	1	1	NUM
njb-66	35	4	9	9	NUM
njb-66	35	5	vol	vol	NOUN
njb-66	35	6	.	.	PUNCT
njb-66	36	1	7	7	NUM
njb-66	36	2	,	,	PUNCT
njb-66	36	3	no	no	NOUN
njb-66	36	4	.	.	NOUN
njb-66	36	5	1	1	NUM
njb-66	36	6	:	:	SYM
njb-66	36	7	82	82	NUM
njb-66	36	8	-	-	SYM
njb-66	36	9	89	89	NUM
njb-66	36	10	bhandari	bhandari	PROPN
njb-66	36	11	et	et	PROPN
njb-66	36	12	al	al	PROPN
njb-66	36	13	.	.	PROPN
njb-66	36	14	2019	2019	NUM
njb-66	37	1	©	©	ADP
njb-66	37	2	njb	njb	PROPN
njb-66	37	3	,	,	PUNCT
njb-66	37	4	biotechnology	biotechnology	NOUN
njb-66	37	5	society	society	NOUN
njb-66	37	6	of	of	ADP
njb-66	37	7	nepal	nepal	ADJ
njb-66	37	8	83	83	NUM
njb-66	37	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-66	37	10	.	.	PUNCT
njb-66	38	1	hospital	hospital	NOUN
njb-66	38	2	showed	show	VERB
njb-66	38	3	31.4	31.4	NUM
njb-66	38	4	%	%	NOUN
njb-66	38	5	of	of	ADP
njb-66	38	6	mrsa	mrsa	PROPN
njb-66	38	7	isolates	isolate	NOUN
njb-66	38	8	and	and	CCONJ
njb-66	38	9	11.7	11.7	NUM
njb-66	38	10	%	%	NOUN
njb-66	38	11	from	from	ADP
njb-66	38	12	tuth	tuth	PROPN
njb-66	38	13	[	[	PUNCT
njb-66	38	14	14	14	NUM
njb-66	38	15	]	]	PUNCT
njb-66	38	16	.	.	PUNCT
njb-66	39	1	rajbhandari	rajbhandari	PROPN
njb-66	39	2	et	et	PROPN
njb-66	39	3	al	al	PROPN
njb-66	39	4	.	.	PUNCT
njb-66	40	1	(	(	PUNCT
njb-66	40	2	2002	2002	NUM
njb-66	40	3	)	)	PUNCT
njb-66	41	1	reported	report	VERB
njb-66	41	2	54.9	54.9	NUM
njb-66	41	3	%	%	NOUN
njb-66	41	4	strains	strain	NOUN
njb-66	41	5	of	of	ADP
njb-66	41	6	mrsa	mrsa	PROPN
njb-66	42	1	[	[	X
njb-66	42	2	15	15	NUM
njb-66	42	3	]	]	PUNCT
njb-66	42	4	.	.	PUNCT
njb-66	43	1	similarly	similarly	ADV
njb-66	43	2	,	,	PUNCT
njb-66	43	3	kumari	kumari	PROPN
njb-66	43	4	et	et	X
njb-66	43	5	al	al	PROPN
njb-66	43	6	.	.	PUNCT
njb-66	43	7	(	(	PUNCT
njb-66	43	8	2008	2008	NUM
njb-66	43	9	)	)	PUNCT
njb-66	43	10	reported	report	VERB
njb-66	43	11	26.14	26.14	NUM
njb-66	43	12	%	%	NOUN
njb-66	43	13	mrsa	mrsa	NOUN
njb-66	43	14	strains	strain	VERB
njb-66	43	15	in	in	ADP
njb-66	43	16	a	a	DET
njb-66	43	17	study	study	NOUN
njb-66	43	18	carried	carry	VERB
njb-66	43	19	out	out	ADP
njb-66	43	20	in	in	ADP
njb-66	43	21	a	a	DET
njb-66	43	22	tertiarycare	tertiarycare	NOUN
njb-66	43	23	hospital	hospital	NOUN
njb-66	43	24	in	in	ADP
njb-66	43	25	eastern	eastern	ADJ
njb-66	43	26	nepal	nepal	PROPN
njb-66	43	27	[	[	PUNCT
njb-66	43	28	16	16	NUM
njb-66	43	29	]	]	PUNCT
njb-66	43	30	.	.	PUNCT
njb-66	44	1	sanjana	sanjana	PROPN
njb-66	44	2	et	et	PROPN
njb-66	44	3	al	al	PROPN
njb-66	44	4	.	.	PUNCT
njb-66	44	5	(	(	PUNCT
njb-66	44	6	2010	2010	NUM
njb-66	44	7	)	)	PUNCT
njb-66	44	8	also	also	ADV
njb-66	44	9	reported	report	VERB
njb-66	44	10	39.6	39.6	NUM
njb-66	44	11	%	%	NOUN
njb-66	44	12	methicillin	methicillin	NOUN
njb-66	44	13	-	-	PUNCT
njb-66	44	14	resistant	resistant	ADJ
njb-66	44	15	s.	s.	PROPN
njb-66	44	16	aureus	aureus	PROPN
njb-66	44	17	isolates	isolate	VERB
njb-66	44	18	at	at	ADP
njb-66	44	19	the	the	DET
njb-66	44	20	college	college	NOUN
njb-66	44	21	of	of	ADP
njb-66	44	22	medical	medical	ADJ
njb-66	44	23	sciencesteaching	sciencesteaching	NOUN
njb-66	44	24	hospital	hospital	NOUN
njb-66	44	25	,	,	PUNCT
njb-66	44	26	chitwan	chitwan	PROPN
njb-66	44	27	.	.	PUNCT
njb-66	44	28	tiwari	tiwari	PROPN
njb-66	44	29	et	et	PROPN
njb-66	44	30	al	al	PROPN
njb-66	44	31	.	.	PUNCT
njb-66	44	32	(	(	PUNCT
njb-66	44	33	2009	2009	NUM
njb-66	44	34	)	)	PUNCT
njb-66	44	35	reported	report	VERB
njb-66	44	36	mrsa	mrsa	PROPN
njb-66	44	37	isolates	isolate	NOUN
njb-66	44	38	were	be	AUX
njb-66	44	39	resistant	resistant	ADJ
njb-66	44	40	to	to	PART
njb-66	44	41	co	co	VERB
njb-66	44	42	trimoxazole	trimoxazole	PROPN
njb-66	44	43	was	be	AUX
njb-66	44	44	77	77	NUM
njb-66	44	45	%	%	NOUN
njb-66	44	46	and	and	CCONJ
njb-66	44	47	81.7	81.7	NUM
njb-66	44	48	%	%	NOUN
njb-66	44	49	(	(	PUNCT
njb-66	44	50	ansari	ansari	PROPN
njb-66	44	51	et	et	X
njb-66	44	52	al	al	PROPN
njb-66	44	53	.	.	PROPN
njb-66	44	54	2014	2014	NUM
njb-66	44	55	)	)	PUNCT
njb-66	44	56	.	.	PUNCT
njb-66	45	1	pant	pant	NOUN
njb-66	45	2	et	et	PROPN
njb-66	45	3	al	al	PROPN
njb-66	45	4	.	.	PUNCT
njb-66	45	5	(	(	PUNCT
njb-66	45	6	2018	2018	NUM
njb-66	45	7	)	)	PUNCT
njb-66	45	8	reported	report	VERB
njb-66	45	9	82.6	82.6	NUM
njb-66	45	10	%	%	NOUN
njb-66	45	11	mrsa	mrsa	NOUN
njb-66	45	12	resistance	resistance	NOUN
njb-66	45	13	to	to	ADP
njb-66	45	14	chloramphenicol	chloramphenicol	NOUN
njb-66	46	1	[	[	PUNCT
njb-66	46	2	17	17	NUM
njb-66	46	3	-	-	SYM
njb-66	46	4	20	20	NUM
njb-66	46	5	]	]	PUNCT
njb-66	46	6	.	.	PUNCT
njb-66	47	1	the	the	DET
njb-66	47	2	prime	prime	ADJ
njb-66	47	3	focus	focus	NOUN
njb-66	47	4	of	of	ADP
njb-66	47	5	the	the	DET
njb-66	47	6	study	study	NOUN
njb-66	47	7	is	be	AUX
njb-66	47	8	the	the	DET
njb-66	47	9	distribution	distribution	NOUN
njb-66	47	10	and	and	CCONJ
njb-66	47	11	prevalence	prevalence	NOUN
njb-66	47	12	of	of	ADP
njb-66	47	13	s.	s.	PROPN
njb-66	47	14	aureus	aureus	PROPN
njb-66	47	15	and	and	CCONJ
njb-66	47	16	mrsa	mrsa	PROPN
njb-66	47	17	in	in	ADP
njb-66	47	18	wound	wound	ADJ
njb-66	47	19	samples	sample	NOUN
njb-66	47	20	collected	collect	VERB
njb-66	47	21	in	in	ADP
njb-66	47	22	the	the	DET
njb-66	47	23	microbiology	microbiology	NOUN
njb-66	47	24	laboratory	laboratory	NOUN
njb-66	47	25	of	of	ADP
njb-66	47	26	international	international	ADJ
njb-66	47	27	friendship	friendship	NOUN
njb-66	47	28	children	child	NOUN
njb-66	47	29	’s	’s	PART
njb-66	47	30	hospital	hospital	NOUN
njb-66	47	31	as	as	ADV
njb-66	47	32	well	well	ADV
njb-66	47	33	as	as	ADP
njb-66	47	34	on	on	ADP
njb-66	47	35	its	its	PRON
njb-66	47	36	antibiotic	antibiotic	ADJ
njb-66	47	37	sensitivity	sensitivity	NOUN
njb-66	47	38	pattern	pattern	NOUN
njb-66	47	39	.	.	PUNCT
njb-66	48	1	the	the	DET
njb-66	48	2	study	study	NOUN
njb-66	48	3	will	will	AUX
njb-66	48	4	also	also	ADV
njb-66	48	5	demonstrate	demonstrate	VERB
njb-66	48	6	the	the	DET
njb-66	48	7	present	present	ADJ
njb-66	48	8	scenario	scenario	NOUN
njb-66	48	9	of	of	ADP
njb-66	48	10	mrsa	mrsa	PROPN
njb-66	48	11	in	in	ADP
njb-66	48	12	children	child	NOUN
njb-66	48	13	and	and	CCONJ
njb-66	48	14	the	the	DET
njb-66	48	15	sensitivity	sensitivity	NOUN
njb-66	48	16	pattern	pattern	NOUN
njb-66	48	17	of	of	ADP
njb-66	48	18	different	different	ADJ
njb-66	48	19	antibiotics	antibiotic	NOUN
njb-66	48	20	used	use	VERB
njb-66	48	21	against	against	ADP
njb-66	48	22	it	it	PRON
njb-66	48	23	.	.	PUNCT
njb-66	49	1	this	this	PRON
njb-66	49	2	is	be	AUX
njb-66	49	3	useful	useful	ADJ
njb-66	49	4	for	for	ADP
njb-66	49	5	future	future	ADJ
njb-66	49	6	planning	planning	NOUN
njb-66	49	7	and	and	CCONJ
njb-66	49	8	policy	policy	NOUN
njb-66	49	9	making	making	NOUN
njb-66	49	10	in	in	ADP
njb-66	49	11	health	health	NOUN
njb-66	49	12	care	care	NOUN
njb-66	49	13	centers	center	NOUN
njb-66	49	14	and	and	CCONJ
njb-66	49	15	hospitals	hospital	NOUN
njb-66	49	16	in	in	ADP
njb-66	49	17	order	order	NOUN
njb-66	49	18	to	to	PART
njb-66	49	19	combat	combat	VERB
njb-66	49	20	the	the	DET
njb-66	49	21	spreading	spreading	NOUN
njb-66	49	22	of	of	ADP
njb-66	49	23	infectious	infectious	ADJ
njb-66	49	24	diseases	disease	NOUN
njb-66	49	25	.	.	PUNCT
njb-66	50	1	materials	material	NOUN
njb-66	50	2	and	and	CCONJ
njb-66	50	3	methods	method	NOUN
njb-66	50	4	sample	sample	VERB
njb-66	50	5	collection	collection	NOUN
njb-66	50	6	and	and	CCONJ
njb-66	50	7	transportation	transportation	NOUN
njb-66	50	8	clinical	clinical	ADJ
njb-66	50	9	specimens	specimen	NOUN
njb-66	50	10	were	be	AUX
njb-66	50	11	collected	collect	VERB
njb-66	50	12	,	,	PUNCT
njb-66	50	13	stored	store	VERB
njb-66	50	14	,	,	PUNCT
njb-66	50	15	transported	transport	VERB
njb-66	50	16	and	and	CCONJ
njb-66	50	17	processed	process	VERB
njb-66	50	18	in	in	ADP
njb-66	50	19	the	the	DET
njb-66	50	20	laboratory	laboratory	NOUN
njb-66	50	21	immediately	immediately	ADV
njb-66	50	22	after	after	ADP
njb-66	50	23	collection	collection	NOUN
njb-66	50	24	by	by	ADP
njb-66	50	25	following	follow	VERB
njb-66	50	26	standard	standard	ADJ
njb-66	50	27	microbiology	microbiology	NOUN
njb-66	50	28	guidelines	guideline	NOUN
njb-66	50	29	[	[	X
njb-66	50	30	21	21	NUM
njb-66	50	31	]	]	PUNCT
njb-66	50	32	.	.	PUNCT
njb-66	51	1	the	the	DET
njb-66	51	2	sterile	sterile	ADJ
njb-66	51	3	swab	swab	NOUN
njb-66	51	4	was	be	AUX
njb-66	51	5	moved	move	VERB
njb-66	51	6	across	across	ADP
njb-66	51	7	the	the	DET
njb-66	51	8	surface	surface	NOUN
njb-66	51	9	of	of	ADP
njb-66	51	10	wounds	wound	NOUN
njb-66	51	11	in	in	ADP
njb-66	51	12	a	a	DET
njb-66	51	13	zigzag	zigzag	PROPN
njb-66	51	14	motion	motion	NOUN
njb-66	51	15	and	and	CCONJ
njb-66	51	16	pus	pus	NOUN
njb-66	51	17	aspirates	aspirate	NOUN
njb-66	51	18	were	be	AUX
njb-66	51	19	collected	collect	VERB
njb-66	51	20	aseptically	aseptically	ADV
njb-66	51	21	by	by	ADP
njb-66	51	22	puncturing	puncture	VERB
njb-66	51	23	the	the	DET
njb-66	51	24	wound	wound	NOUN
njb-66	51	25	using	use	VERB
njb-66	51	26	a	a	DET
njb-66	51	27	sterile	sterile	ADJ
njb-66	51	28	syringe	syringe	NOUN
njb-66	51	29	.	.	PUNCT
njb-66	52	1	the	the	DET
njb-66	52	2	accurate	accurate	ADJ
njb-66	52	3	,	,	PUNCT
njb-66	52	4	rapid	rapid	ADJ
njb-66	52	5	microbiological	microbiological	ADJ
njb-66	52	6	diagnosis	diagnosis	NOUN
njb-66	52	7	of	of	ADP
njb-66	52	8	mrsa	mrsa	PROPN
njb-66	52	9	and	and	CCONJ
njb-66	52	10	s.	s.	PROPN
njb-66	52	11	aureus	aureus	PROPN
njb-66	52	12	infections	infection	NOUN
njb-66	52	13	begins	begin	VERB
njb-66	52	14	with	with	ADP
njb-66	52	15	proper	proper	ADJ
njb-66	52	16	specimen	speciman	NOUN
njb-66	52	17	collection	collection	NOUN
njb-66	52	18	and	and	CCONJ
njb-66	52	19	rapid	rapid	ADJ
njb-66	52	20	transportation	transportation	NOUN
njb-66	52	21	to	to	ADP
njb-66	52	22	the	the	DET
njb-66	52	23	laboratory	laboratory	NOUN
njb-66	52	24	.	.	PUNCT
njb-66	53	1	to	to	PART
njb-66	53	2	make	make	VERB
njb-66	53	3	sure	sure	ADJ
njb-66	53	4	the	the	DET
njb-66	53	5	collection	collection	NOUN
njb-66	53	6	of	of	ADP
njb-66	53	7	the	the	DET
njb-66	53	8	best	good	ADJ
njb-66	53	9	possible	possible	ADJ
njb-66	53	10	specimen	speciman	NOUN
njb-66	53	11	,	,	PUNCT
njb-66	53	12	the	the	DET
njb-66	53	13	health	health	NOUN
njb-66	53	14	care	care	NOUN
njb-66	53	15	workers	worker	NOUN
njb-66	53	16	(	(	PUNCT
njb-66	53	17	hcws	hcws	PROPN
njb-66	53	18	)	)	PUNCT
njb-66	53	19	must	must	AUX
njb-66	53	20	be	be	AUX
njb-66	53	21	properly	properly	ADV
njb-66	53	22	trained	train	VERB
njb-66	53	23	,	,	PUNCT
njb-66	53	24	and	and	CCONJ
njb-66	53	25	the	the	DET
njb-66	53	26	patient	patient	NOUN
njb-66	53	27	must	must	AUX
njb-66	53	28	be	be	AUX
njb-66	53	29	provided	provide	VERB
njb-66	53	30	with	with	ADP
njb-66	53	31	clearly	clearly	ADV
njb-66	53	32	presented	present	VERB
njb-66	53	33	and	and	CCONJ
njb-66	53	34	fully	fully	ADV
njb-66	53	35	understood	understand	VERB
njb-66	53	36	instruction	instruction	NOUN
njb-66	53	37	for	for	ADP
njb-66	53	38	sample	sample	NOUN
njb-66	53	39	collection	collection	NOUN
njb-66	53	40	.	.	PUNCT
njb-66	54	1	specimen	speciman	NOUN
njb-66	54	2	processing	process	VERB
njb-66	54	3	pus	pus	NOUN
njb-66	54	4	samples	sample	NOUN
njb-66	54	5	received	receive	VERB
njb-66	54	6	in	in	ADP
njb-66	54	7	the	the	DET
njb-66	54	8	microbiology	microbiology	NOUN
njb-66	54	9	laboratory	laboratory	NOUN
njb-66	54	10	were	be	AUX
njb-66	54	11	processed	process	VERB
njb-66	54	12	as	as	ADP
njb-66	54	13	per	per	ADP
njb-66	54	14	routine	routine	ADJ
njb-66	54	15	standard	standard	ADJ
njb-66	54	16	microbiological	microbiological	ADJ
njb-66	54	17	procedures	procedure	NOUN
njb-66	54	18	described	describe	VERB
njb-66	54	19	by	by	ADP
njb-66	54	20	the	the	DET
njb-66	54	21	established	establish	VERB
njb-66	54	22	guideline	guideline	NOUN
njb-66	54	23	for	for	ADP
njb-66	54	24	the	the	DET
njb-66	54	25	isolation	isolation	NOUN
njb-66	54	26	and	and	CCONJ
njb-66	54	27	identification	identification	NOUN
njb-66	54	28	of	of	ADP
njb-66	54	29	s.	s.	PROPN
njb-66	54	30	aureus	aureus	PROPN
njb-66	55	1	[	[	PUNCT
njb-66	55	2	22	22	NUM
njb-66	55	3	]	]	PUNCT
njb-66	55	4	.	.	PUNCT
njb-66	56	1	culture	culture	NOUN
njb-66	56	2	of	of	ADP
njb-66	56	3	specimen	speciman	NOUN
njb-66	56	4	all	all	DET
njb-66	56	5	the	the	DET
njb-66	56	6	pus	pus	NOUN
njb-66	56	7	samples	sample	NOUN
njb-66	56	8	were	be	AUX
njb-66	56	9	inoculated	inoculate	VERB
njb-66	56	10	on	on	ADP
njb-66	56	11	blood	blood	NOUN
njb-66	56	12	agar	agar	NOUN
njb-66	56	13	(	(	PUNCT
njb-66	56	14	ba	ba	NOUN
njb-66	56	15	)	)	PUNCT
njb-66	56	16	and	and	CCONJ
njb-66	56	17	mac	mac	ADJ
njb-66	56	18	-	-	PUNCT
njb-66	56	19	conkey	conkey	NOUN
njb-66	56	20	agar	agar	NOUN
njb-66	56	21	(	(	PUNCT
njb-66	56	22	ma	ma	PROPN
njb-66	56	23	)	)	PUNCT
njb-66	56	24	plates	plate	NOUN
njb-66	56	25	and	and	CCONJ
njb-66	56	26	incubated	incubate	VERB
njb-66	56	27	aerobically	aerobically	ADV
njb-66	56	28	at	at	ADP
njb-66	56	29	37	37	NUM
njb-66	56	30	̊	̊	PROPN
njb-66	56	31	c	c	NOUN
njb-66	56	32	for	for	ADP
njb-66	56	33	24	24	NUM
njb-66	56	34	to	to	PART
njb-66	56	35	48	48	NUM
njb-66	56	36	hours	hour	NOUN
njb-66	56	37	in	in	ADP
njb-66	56	38	the	the	DET
njb-66	56	39	incubator	incubator	NOUN
njb-66	56	40	.	.	PUNCT
njb-66	57	1	if	if	SCONJ
njb-66	57	2	no	no	DET
njb-66	57	3	growth	growth	NOUN
njb-66	57	4	was	be	AUX
njb-66	57	5	observed	observe	VERB
njb-66	57	6	,	,	PUNCT
njb-66	57	7	it	it	PRON
njb-66	57	8	was	be	AUX
njb-66	57	9	reported	report	VERB
njb-66	57	10	as	as	ADP
njb-66	57	11	growth	growth	NOUN
njb-66	57	12	negative	negative	ADJ
njb-66	57	13	.	.	PUNCT
njb-66	58	1	the	the	DET
njb-66	58	2	suspected	suspect	VERB
njb-66	58	3	s.	s.	PROPN
njb-66	58	4	aureus	aureus	PROPN
njb-66	58	5	isolates	isolate	VERB
njb-66	58	6	(	(	PUNCT
njb-66	58	7	on	on	ADP
njb-66	58	8	the	the	DET
njb-66	58	9	basis	basis	NOUN
njb-66	58	10	of	of	ADP
njb-66	58	11	haemolysis	haemolysis	NOUN
njb-66	58	12	produced	produce	VERB
njb-66	58	13	on	on	ADP
njb-66	58	14	ba	ba	PROPN
njb-66	58	15	)	)	PUNCT
njb-66	58	16	were	be	AUX
njb-66	58	17	inoculated	inoculate	VERB
njb-66	58	18	in	in	ADP
njb-66	58	19	to	to	ADP
njb-66	58	20	mannitol	mannitol	ADJ
njb-66	58	21	salt	salt	NOUN
njb-66	58	22	agar	agar	NOUN
njb-66	58	23	(	(	PUNCT
njb-66	58	24	msa	msa	PROPN
njb-66	58	25	)	)	PUNCT
njb-66	58	26	to	to	PART
njb-66	58	27	check	check	VERB
njb-66	58	28	if	if	SCONJ
njb-66	58	29	the	the	DET
njb-66	58	30	isolates	isolate	VERB
njb-66	58	31	ferment	ferment	NOUN
njb-66	58	32	mannitol	mannitol	NOUN
njb-66	58	33	or	or	CCONJ
njb-66	58	34	not	not	PART
njb-66	58	35	.	.	PUNCT
njb-66	59	1	photograph	photograph	NOUN
njb-66	59	2	of	of	ADP
njb-66	59	3	s.	s.	PROPN
njb-66	59	4	aureus	aureus	PROPN
njb-66	59	5	culture	culture	NOUN
njb-66	59	6	on	on	ADP
njb-66	59	7	blood	blood	NOUN
njb-66	59	8	agar	agar	NOUN
njb-66	59	9	and	and	CCONJ
njb-66	59	10	msa	msa	NOUN
njb-66	59	11	is	be	AUX
njb-66	59	12	pictured	picture	VERB
njb-66	59	13	in	in	ADP
njb-66	59	14	figure	figure	NOUN
njb-66	59	15	1	1	NUM
njb-66	59	16	.	.	PUNCT
njb-66	60	1	figure	figure	VERB
njb-66	60	2	1	1	NUM
njb-66	60	3	.	.	PUNCT
njb-66	61	1	photograph	photograph	NOUN
njb-66	61	2	of	of	ADP
njb-66	61	3	s.	s.	PROPN
njb-66	61	4	aureus	aureus	PROPN
njb-66	61	5	culture	culture	PROPN
njb-66	61	6	on	on	ADP
njb-66	61	7	(	(	PUNCT
njb-66	61	8	a	a	X
njb-66	61	9	)	)	PUNCT
njb-66	61	10	blood	blood	NOUN
njb-66	61	11	agar	agar	NOUN
njb-66	61	12	(	(	PUNCT
njb-66	61	13	b	b	PROPN
njb-66	61	14	)	)	PUNCT
njb-66	61	15	mannitol	mannitol	ADJ
njb-66	61	16	salt	salt	NOUN
njb-66	61	17	agar	agar	NOUN
njb-66	61	18	(	(	PUNCT
njb-66	61	19	msa	msa	PROPN
njb-66	61	20	)	)	PUNCT
njb-66	61	21	figure	figure	NOUN
njb-66	61	22	2	2	NUM
njb-66	61	23	.	.	X
njb-66	62	1	photograph	photograph	NOUN
njb-66	62	2	of	of	ADP
njb-66	62	3	antibiotic	antibiotic	ADJ
njb-66	62	4	sensitivity	sensitivity	NOUN
njb-66	62	5	test	test	NOUN
njb-66	62	6	of	of	ADP
njb-66	62	7	s.	s.	PROPN
njb-66	62	8	aureus	aureus	PROPN
njb-66	62	9	on	on	ADP
njb-66	62	10	mha	mha	PROPN
njb-66	62	11	.	.	PUNCT
njb-66	63	1	a	a	PRON
njb-66	63	2	:	:	PUNCT
njb-66	63	3	gentamicin	gentamicin	PROPN
njb-66	63	4	(	(	PUNCT
njb-66	63	5	30mcg	30mcg	NUM
njb-66	63	6	)	)	PUNCT
njb-66	63	7	,	,	PUNCT
njb-66	63	8	b	b	X
njb-66	63	9	:	:	PUNCT
njb-66	63	10	chloramphenicol	chloramphenicol	NOUN
njb-66	63	11	(	(	PUNCT
njb-66	63	12	30mcg	30mcg	NUM
njb-66	63	13	)	)	PUNCT
njb-66	63	14	,	,	PUNCT
njb-66	63	15	c	c	X
njb-66	63	16	:	:	PUNCT
njb-66	63	17	cefoxitin	cefoxitin	NOUN
njb-66	63	18	(	(	PUNCT
njb-66	63	19	30mcg	30mcg	NUM
njb-66	63	20	)	)	PUNCT
njb-66	63	21	,	,	PUNCT
njb-66	63	22	d	d	NOUN
njb-66	63	23	:	:	PUNCT
njb-66	63	24	ciprofloxacin	ciprofloxacin	NOUN
njb-66	63	25	(	(	PUNCT
njb-66	63	26	5mcg	5mcg	NUM
njb-66	63	27	)	)	PUNCT
njb-66	63	28	,	,	PUNCT
njb-66	63	29	e	e	NOUN
njb-66	63	30	:	:	PUNCT
njb-66	63	31	penicillin	penicillin	PROPN
njb-66	63	32	(	(	PUNCT
njb-66	63	33	10mcg	10mcg	PROPN
njb-66	63	34	)	)	PUNCT
njb-66	63	35	b	b	PROPN
njb-66	63	36	a	a	DET
njb-66	63	37	nepal	nepal	ADJ
njb-66	63	38	journal	journal	NOUN
njb-66	63	39	of	of	ADP
njb-66	63	40	biotechnology	biotechnology	NOUN
njb-66	63	41	.	.	PUNCT
njb-66	64	1	d	d	X
njb-66	64	2	e	e	PROPN
njb-66	64	3	c	c	PROPN
njb-66	64	4	.	.	PUNCT
njb-66	65	1	2	2	NUM
njb-66	65	2	0	0	NUM
njb-66	65	3	1	1	NUM
njb-66	65	4	9	9	NUM
njb-66	65	5	vol	vol	NOUN
njb-66	65	6	.	.	PUNCT
njb-66	66	1	7	7	NUM
njb-66	66	2	,	,	PUNCT
njb-66	66	3	no	no	NOUN
njb-66	66	4	.	.	NOUN
njb-66	66	5	1	1	NUM
njb-66	66	6	:	:	SYM
njb-66	66	7	82	82	NUM
njb-66	66	8	-	-	SYM
njb-66	66	9	89	89	NUM
njb-66	66	10	bhandari	bhandari	PROPN
njb-66	66	11	et	et	PROPN
njb-66	66	12	al	al	PROPN
njb-66	66	13	.	.	PROPN
njb-66	66	14	2019	2019	NUM
njb-66	67	1	©	©	ADP
njb-66	67	2	njb	njb	PROPN
njb-66	67	3	,	,	PUNCT
njb-66	67	4	biotechnology	biotechnology	NOUN
njb-66	67	5	society	society	NOUN
njb-66	67	6	of	of	ADP
njb-66	67	7	nepal	nepal	ADJ
njb-66	67	8	84	84	NUM
njb-66	67	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-66	67	10	.	.	PUNCT
njb-66	67	11	figure	figure	NOUN
njb-66	67	12	3	3	NUM
njb-66	67	13	.	.	PUNCT
njb-66	68	1	flow	flow	NOUN
njb-66	68	2	chart	chart	NOUN
njb-66	68	3	representing	represent	VERB
njb-66	68	4	isolation	isolation	NOUN
njb-66	68	5	and	and	CCONJ
njb-66	68	6	identification	identification	NOUN
njb-66	68	7	of	of	ADP
njb-66	68	8	mrsa	mrsa	PROPN
njb-66	68	9	from	from	ADP
njb-66	68	10	pus	pus	NOUN
njb-66	68	11	samples	sample	NOUN
njb-66	68	12	identification	identification	NOUN
njb-66	68	13	of	of	ADP
njb-66	68	14	the	the	DET
njb-66	68	15	isolates	isolate	NOUN
njb-66	68	16	the	the	DET
njb-66	68	17	growth	growth	NOUN
njb-66	68	18	was	be	AUX
njb-66	68	19	identified	identify	VERB
njb-66	68	20	as	as	ADP
njb-66	68	21	s.	s.	PROPN
njb-66	68	22	aureus	aureus	PROPN
njb-66	68	23	by	by	ADP
njb-66	68	24	using	use	VERB
njb-66	68	25	conventional	conventional	ADJ
njb-66	68	26	biochemical	biochemical	ADJ
njb-66	68	27	methods	method	NOUN
njb-66	68	28	as	as	ADP
njb-66	68	29	per	per	ADP
njb-66	68	30	standard	standard	ADJ
njb-66	68	31	microbiological	microbiological	ADJ
njb-66	68	32	techniques	technique	NOUN
njb-66	68	33	described	describe	VERB
njb-66	68	34	in	in	ADP
njb-66	68	35	bergey	bergey	PROPN
njb-66	68	36	's	's	PART
njb-66	68	37	manual	manual	NOUN
njb-66	68	38	of	of	ADP
njb-66	68	39	determinative	determinative	ADJ
njb-66	68	40	bacteriology	bacteriology	NOUN
njb-66	68	41	[	[	PUNCT
njb-66	68	42	23	23	NUM
njb-66	68	43	]	]	PUNCT
njb-66	68	44	.	.	PUNCT
njb-66	69	1	it	it	PRON
njb-66	69	2	comprises	comprise	VERB
njb-66	69	3	colonial	colonial	ADJ
njb-66	69	4	morphology	morphology	NOUN
njb-66	69	5	,	,	PUNCT
njb-66	69	6	staining	stain	VERB
njb-66	69	7	reactions	reaction	NOUN
njb-66	69	8	and	and	CCONJ
njb-66	69	9	various	various	ADJ
njb-66	69	10	biochemical	biochemical	ADJ
njb-66	69	11	properties	property	NOUN
njb-66	69	12	such	such	ADJ
njb-66	69	13	as	as	ADP
njb-66	69	14	catalase	catalase	NOUN
njb-66	69	15	-	-	PUNCT
njb-66	69	16	positive	positive	ADJ
njb-66	69	17	,	,	PUNCT
njb-66	69	18	coxidase	coxidase	NOUN
njb-66	69	19	negative	negative	ADJ
njb-66	69	20	,	,	PUNCT
njb-66	69	21	fermentative	fermentative	ADJ
njb-66	69	22	,	,	PUNCT
njb-66	69	23	voges	voge	NOUN
njb-66	69	24	-	-	PUNCT
njb-66	69	25	proskauer	proskauer	PROPN
njb-66	69	26	positive	positive	PROPN
njb-66	69	27	,	,	PUNCT
njb-66	69	28	etc	etc	X
njb-66	69	29	.	.	NOUN
njb-66	69	30	preservation	preservation	NOUN
njb-66	69	31	of	of	ADP
njb-66	69	32	isolates	isolate	NOUN
njb-66	69	33	isolates	isolate	NOUN
njb-66	69	34	in	in	ADP
njb-66	69	35	pure	pure	ADJ
njb-66	69	36	culture	culture	NOUN
njb-66	69	37	were	be	AUX
njb-66	69	38	preserved	preserve	VERB
njb-66	69	39	in	in	ADP
njb-66	69	40	glycerol	glycerol	NOUN
njb-66	69	41	20	20	NUM
njb-66	69	42	%	%	NOUN
njb-66	69	43	(	(	PUNCT
njb-66	69	44	v	v	NOUN
njb-66	69	45	/	/	SYM
njb-66	69	46	v	v	NOUN
njb-66	69	47	)	)	PUNCT
njb-66	69	48	in	in	ADP
njb-66	69	49	brain	brain	NOUN
njb-66	69	50	heart	heart	NOUN
njb-66	69	51	infusion	infusion	NOUN
njb-66	69	52	broth	broth	NOUN
njb-66	69	53	(	(	PUNCT
njb-66	69	54	bhi	bhi	PROPN
njb-66	69	55	)	)	PUNCT
njb-66	69	56	at	at	ADP
njb-66	69	57	–	–	PUNCT
njb-66	69	58	20	20	NUM
njb-66	70	1	̊	̊	NOUN
njb-66	70	2	c	c	NOUN
njb-66	70	3	to	to	ADP
njb-66	70	4	-70	-70	PUNCT
njb-66	70	5	̊	̊	PROPN
njb-66	70	6	c	c	X
njb-66	70	7	and	and	CCONJ
njb-66	70	8	recovered	recover	VERB
njb-66	70	9	by	by	ADP
njb-66	70	10	sub	sub	NOUN
njb-66	70	11	culturing	culture	VERB
njb-66	70	12	in	in	ADP
njb-66	70	13	brain	brain	NOUN
njb-66	70	14	heart	heart	NOUN
njb-66	70	15	infusion	infusion	NOUN
njb-66	70	16	broth	broth	NOUN
njb-66	70	17	at	at	ADP
njb-66	70	18	37	37	NUM
njb-66	70	19	̊	̊	PROPN
njb-66	70	20	c	c	X
njb-66	70	21	for	for	ADP
njb-66	70	22	24	24	NUM
njb-66	70	23	hrs	hr	NOUN
njb-66	70	24	followed	follow	VERB
njb-66	70	25	by	by	ADP
njb-66	70	26	further	further	ADJ
njb-66	70	27	subculture	subculture	NOUN
njb-66	70	28	on	on	ADP
njb-66	70	29	nutrient	nutrient	ADJ
njb-66	70	30	agar	agar	NOUN
njb-66	70	31	.	.	PUNCT
njb-66	71	1	antimicrobial	antimicrobial	ADJ
njb-66	71	2	susceptibility	susceptibility	NOUN
njb-66	71	3	testing	testing	NOUN
njb-66	71	4	of	of	ADP
njb-66	71	5	s.	s.	PROPN
njb-66	71	6	aureus	aureus	PROPN
njb-66	71	7	antibiotic	antibiotic	ADJ
njb-66	71	8	susceptibility	susceptibility	NOUN
njb-66	71	9	testing	testing	NOUN
njb-66	71	10	of	of	ADP
njb-66	71	11	isolates	isolate	NOUN
njb-66	71	12	was	be	AUX
njb-66	71	13	assessed	assess	VERB
njb-66	71	14	by	by	ADP
njb-66	71	15	the	the	DET
njb-66	71	16	modified	modify	VERB
njb-66	71	17	kirby	kirby	PROPN
njb-66	71	18	-	-	PUNCT
njb-66	71	19	bauer	bauer	NOUN
njb-66	71	20	disk	disk	NOUN
njb-66	71	21	diffusion	diffusion	NOUN
njb-66	71	22	method	method	NOUN
njb-66	71	23	as	as	SCONJ
njb-66	71	24	recommended	recommend	VERB
njb-66	71	25	by	by	ADP
njb-66	71	26	the	the	DET
njb-66	71	27	clinical	clinical	ADJ
njb-66	71	28	and	and	CCONJ
njb-66	71	29	laboratory	laboratory	PROPN
njb-66	71	30	standard	standard	PROPN
njb-66	71	31	institute	institute	PROPN
njb-66	71	32	using	use	VERB
njb-66	71	33	mueller	mueller	PROPN
njb-66	71	34	hinton	hinton	PROPN
njb-66	71	35	agar	agar	PROPN
njb-66	71	36	(	(	PUNCT
njb-66	71	37	mha	mha	NOUN
njb-66	71	38	)	)	PUNCT
njb-66	71	39	[	[	PUNCT
njb-66	71	40	22	22	NUM
njb-66	71	41	]	]	PUNCT
njb-66	71	42	.	.	PUNCT
njb-66	72	1	using	use	VERB
njb-66	72	2	a	a	DET
njb-66	72	3	sterile	sterile	ADJ
njb-66	72	4	wire	wire	NOUN
njb-66	72	5	loop	loop	NOUN
njb-66	72	6	,	,	PUNCT
njb-66	72	7	a	a	DET
njb-66	72	8	single	single	ADJ
njb-66	72	9	isolated	isolated	ADJ
njb-66	72	10	colony	colony	NOUN
njb-66	72	11	of	of	ADP
njb-66	72	12	which	which	PRON
njb-66	72	13	the	the	DET
njb-66	72	14	sensitivity	sensitivity	NOUN
njb-66	72	15	pattern	pattern	NOUN
njb-66	72	16	is	be	AUX
njb-66	72	17	to	to	PART
njb-66	72	18	be	be	AUX
njb-66	72	19	determined	determine	VERB
njb-66	72	20	was	be	AUX
njb-66	72	21	touched	touch	VERB
njb-66	72	22	and	and	CCONJ
njb-66	72	23	inoculated	inoculate	VERB
njb-66	72	24	into	into	ADP
njb-66	72	25	a	a	DET
njb-66	72	26	nutrient	nutrient	ADJ
njb-66	72	27	broth	broth	NOUN
njb-66	72	28	(	(	PUNCT
njb-66	72	29	nb	nb	NOUN
njb-66	72	30	)	)	PUNCT
njb-66	72	31	tube	tube	NOUN
njb-66	72	32	and	and	CCONJ
njb-66	72	33	was	be	AUX
njb-66	72	34	incubated	incubate	VERB
njb-66	72	35	for	for	ADP
njb-66	72	36	2	2	NUM
njb-66	72	37	-	-	SYM
njb-66	72	38	4	4	NUM
njb-66	72	39	hours	hour	NOUN
njb-66	72	40	.	.	PUNCT
njb-66	73	1	after	after	ADP
njb-66	73	2	incubation	incubation	NOUN
njb-66	73	3	in	in	ADP
njb-66	73	4	a	a	DET
njb-66	73	5	good	good	ADJ
njb-66	73	6	light	light	ADJ
njb-66	73	7	source	source	NOUN
njb-66	73	8	,	,	PUNCT
njb-66	73	9	the	the	DET
njb-66	73	10	turbidity	turbidity	NOUN
njb-66	73	11	of	of	ADP
njb-66	73	12	the	the	DET
njb-66	73	13	suspension	suspension	NOUN
njb-66	73	14	was	be	AUX
njb-66	73	15	matched	match	VERB
njb-66	73	16	with	with	ADP
njb-66	73	17	the	the	DET
njb-66	73	18	turbidity	turbidity	NOUN
njb-66	73	19	of	of	ADP
njb-66	73	20	the	the	DET
njb-66	73	21	standard	standard	NOUN
njb-66	73	22	of	of	ADP
njb-66	73	23	mac	mac	PROPN
njb-66	73	24	farland	farland	PROPN
njb-66	73	25	0.5	0.5	NUM
njb-66	73	26	(	(	PUNCT
njb-66	73	27	prepared	prepare	VERB
njb-66	73	28	by	by	ADP
njb-66	73	29	adding	add	VERB
njb-66	73	30	0.6ml	0.6ml	NUM
njb-66	73	31	of	of	ADP
njb-66	73	32	1	1	NUM
njb-66	73	33	%	%	NOUN
njb-66	73	34	w	w	NOUN
njb-66	73	35	/	/	SYM
njb-66	73	36	v	v	NOUN
njb-66	73	37	barium	barium	NOUN
njb-66	73	38	chloride	chloride	PROPN
njb-66	73	39	solution	solution	NOUN
njb-66	73	40	to	to	ADP
njb-66	73	41	99.4ml	99.4ml	NUM
njb-66	73	42	of	of	ADP
njb-66	73	43	1	1	NUM
njb-66	73	44	%	%	NOUN
njb-66	73	45	v	v	NOUN
njb-66	73	46	/	/	SYM
njb-66	73	47	v	v	NOUN
njb-66	73	48	solution	solution	NOUN
njb-66	73	49	of	of	ADP
njb-66	73	50	sulphuric	sulphuric	ADJ
njb-66	73	51	acid	acid	NOUN
njb-66	73	52	)	)	PUNCT
njb-66	74	1	[	[	X
njb-66	74	2	24	24	NUM
njb-66	74	3	]	]	PUNCT
njb-66	74	4	.	.	PUNCT
njb-66	75	1	using	use	VERB
njb-66	75	2	a	a	DET
njb-66	75	3	sterile	sterile	ADJ
njb-66	75	4	swab	swab	NOUN
njb-66	75	5	,	,	PUNCT
njb-66	75	6	a	a	DET
njb-66	75	7	plate	plate	NOUN
njb-66	75	8	of	of	ADP
njb-66	75	9	mueller	mueller	PROPN
njb-66	75	10	hinton	hinton	PROPN
njb-66	75	11	agar	agar	PROPN
njb-66	75	12	was	be	AUX
njb-66	75	13	inoculated	inoculate	VERB
njb-66	75	14	with	with	ADP
njb-66	75	15	bacterial	bacterial	ADJ
njb-66	75	16	suspension	suspension	NOUN
njb-66	75	17	using	use	VERB
njb-66	75	18	carpet	carpet	NOUN
njb-66	75	19	culture	culture	NOUN
njb-66	75	20	technique	technique	NOUN
njb-66	75	21	and	and	CCONJ
njb-66	75	22	plates	plate	NOUN
njb-66	75	23	were	be	AUX
njb-66	75	24	taken	take	VERB
njb-66	75	25	for	for	ADP
njb-66	75	26	incubation	incubation	NOUN
njb-66	75	27	at	at	ADP
njb-66	75	28	37	37	NUM
njb-66	75	29	̊	̊	PROPN
njb-66	75	30	c	c	NOUN
njb-66	75	31	for	for	ADP
njb-66	75	32	18	18	NUM
njb-66	75	33	-	-	SYM
njb-66	75	34	24	24	NUM
njb-66	75	35	hours	hour	NOUN
njb-66	75	36	.	.	PUNCT
njb-66	76	1	the	the	DET
njb-66	76	2	result	result	NOUN
njb-66	76	3	was	be	AUX
njb-66	76	4	interpreted	interpret	VERB
njb-66	76	5	as	as	ADP
njb-66	76	6	whether	whether	SCONJ
njb-66	76	7	the	the	DET
njb-66	76	8	organism	organism	NOUN
njb-66	76	9	was	be	AUX
njb-66	76	10	sensitive	sensitive	ADJ
njb-66	76	11	or	or	CCONJ
njb-66	76	12	resistant	resistant	ADJ
njb-66	76	13	to	to	ADP
njb-66	76	14	the	the	DET
njb-66	76	15	tested	tested	ADJ
njb-66	76	16	antimicrobial	antimicrobial	ADJ
njb-66	76	17	agents	agent	NOUN
njb-66	76	18	.	.	PUNCT
njb-66	77	1	photograph	photograph	NOUN
njb-66	77	2	of	of	ADP
njb-66	77	3	antibiotic	antibiotic	ADJ
njb-66	77	4	sensitivity	sensitivity	NOUN
njb-66	77	5	test	test	NOUN
njb-66	77	6	of	of	ADP
njb-66	77	7	s.	s.	PROPN
njb-66	77	8	aureus	aureus	PROPN
njb-66	77	9	on	on	ADP
njb-66	77	10	mha	mha	NOUN
njb-66	77	11	is	be	AUX
njb-66	77	12	shown	show	VERB
njb-66	77	13	in	in	ADP
njb-66	77	14	figure	figure	NOUN
njb-66	77	15	2	2	NUM
njb-66	77	16	.	.	PUNCT
njb-66	77	17	detection	detection	NOUN
njb-66	77	18	of	of	ADP
njb-66	77	19	mrsa	mrsa	PROPN
njb-66	77	20	mrsa	mrsa	PROPN
njb-66	77	21	detection	detection	PROPN
njb-66	77	22	was	be	AUX
njb-66	77	23	done	do	VERB
njb-66	77	24	by	by	ADP
njb-66	77	25	the	the	DET
njb-66	77	26	cefoxitin	cefoxitin	NOUN
njb-66	77	27	disc	disc	NOUN
njb-66	77	28	(	(	PUNCT
njb-66	77	29	30	30	NUM
njb-66	77	30	µg	µg	NOUN
njb-66	77	31	)	)	PUNCT
njb-66	77	32	diffusion	diffusion	NOUN
njb-66	77	33	test	test	NOUN
njb-66	77	34	.	.	PUNCT
njb-66	78	1	as	as	ADP
njb-66	78	2	per	per	ADP
njb-66	78	3	clsi	clsi	PROPN
njb-66	78	4	(	(	PUNCT
njb-66	78	5	2015	2015	NUM
njb-66	78	6	)	)	PUNCT
njb-66	78	7	guideline	guideline	NOUN
njb-66	78	8	,	,	PUNCT
njb-66	78	9	a	a	DET
njb-66	78	10	lawn	lawn	NOUN
njb-66	78	11	culture	culture	NOUN
njb-66	78	12	was	be	AUX
njb-66	78	13	made	make	VERB
njb-66	78	14	on	on	ADP
njb-66	78	15	mueller	mueller	PROPN
njb-66	78	16	hinton	hinton	PROPN
njb-66	78	17	agar	agar	PROPN
njb-66	78	18	(	(	PUNCT
njb-66	78	19	mha	mha	PROPN
njb-66	78	20	)	)	PUNCT
njb-66	78	21	supplemented	supplement	VERB
njb-66	78	22	with	with	ADP
njb-66	78	23	4	4	NUM
njb-66	78	24	%	%	NOUN
njb-66	78	25	nacl	nacl	PROPN
njb-66	78	26	and	and	CCONJ
njb-66	78	27	cefoxitin	cefoxitin	NOUN
njb-66	78	28	disc	disc	NOUN
njb-66	78	29	from	from	ADP
njb-66	78	30	the	the	DET
njb-66	78	31	suspension	suspension	NOUN
njb-66	78	32	of	of	ADP
njb-66	78	33	turbidity	turbidity	NOUN
njb-66	78	34	equivalent	equivalent	ADJ
njb-66	78	35	to	to	ADP
njb-66	78	36	0.5	0.5	NUM
njb-66	78	37	mc	mc	PROPN
njb-66	78	38	farland	farland	NOUN
njb-66	78	39	standards	standard	NOUN
njb-66	78	40	from	from	ADP
njb-66	78	41	overnight	overnight	ADJ
njb-66	78	42	growth	growth	NOUN
njb-66	78	43	in	in	ADP
njb-66	78	44	nutrient	nutrient	ADJ
njb-66	78	45	agar	agar	NOUN
njb-66	78	46	and	and	CCONJ
njb-66	78	47	incubated	incubate	VERB
njb-66	78	48	for	for	ADP
njb-66	78	49	24	24	NUM
njb-66	78	50	hours	hour	NOUN
njb-66	78	51	aerobically	aerobically	ADV
njb-66	78	52	at	at	ADP
njb-66	78	53	35	35	NUM
njb-66	78	54	̊	̊	PROPN
njb-66	78	55	c.	c.	PROPN
njb-66	78	56	after	after	ADP
njb-66	78	57	incubation	incubation	NOUN
njb-66	78	58	,	,	PUNCT
njb-66	78	59	the	the	DET
njb-66	78	60	plates	plate	NOUN
njb-66	78	61	were	be	AUX
njb-66	78	62	examined	examine	VERB
njb-66	78	63	for	for	ADP
njb-66	78	64	zone	zone	NOUN
njb-66	78	65	of	of	ADP
njb-66	78	66	inhibition	inhibition	NOUN
njb-66	78	67	.	.	PUNCT
njb-66	79	1	isolates	isolate	NOUN
njb-66	79	2	exhibiting	exhibit	VERB
njb-66	79	3	zone	zone	NOUN
njb-66	79	4	of	of	ADP
njb-66	79	5	inhibition	inhibition	NOUN
njb-66	79	6	≥	≥	NOUN
njb-66	79	7	22	22	NUM
njb-66	79	8	mm	mm	NOUN
njb-66	79	9	were	be	AUX
njb-66	79	10	considered	consider	VERB
njb-66	79	11	as	as	ADP
njb-66	79	12	sensitive	sensitive	ADJ
njb-66	79	13	,	,	PUNCT
njb-66	79	14	whereas	whereas	SCONJ
njb-66	79	15	those	those	DET
njb-66	79	16	showing	show	VERB
njb-66	79	17	zone	zone	NOUN
njb-66	79	18	of	of	ADP
njb-66	79	19	inhibition	inhibition	NOUN
njb-66	79	20	≤	≤	PROPN
njb-66	79	21	21	21	NUM
njb-66	79	22	mm	mm	NOUN
njb-66	79	23	were	be	AUX
njb-66	79	24	considered	consider	VERB
njb-66	79	25	as	as	ADP
njb-66	79	26	resistant	resistant	ADJ
njb-66	79	27	and	and	CCONJ
njb-66	79	28	were	be	AUX
njb-66	79	29	reported	report	VERB
njb-66	79	30	as	as	ADP
njb-66	79	31	mrsa	mrsa	PROPN
njb-66	79	32	.	.	PUNCT
njb-66	80	1	purity	purity	NOUN
njb-66	80	2	plate	plate	NOUN
njb-66	80	3	the	the	DET
njb-66	80	4	purity	purity	NOUN
njb-66	80	5	was	be	AUX
njb-66	80	6	used	use	VERB
njb-66	80	7	to	to	PART
njb-66	80	8	ensure	ensure	VERB
njb-66	80	9	that	that	SCONJ
njb-66	80	10	the	the	DET
njb-66	80	11	inoculation	inoculation	NOUN
njb-66	80	12	used	use	VERB
njb-66	80	13	for	for	ADP
njb-66	80	14	the	the	DET
njb-66	80	15	biochemical	biochemical	ADJ
njb-66	80	16	tests	test	NOUN
njb-66	80	17	was	be	AUX
njb-66	80	18	.	.	PUNCT
njb-66	81	1	nepal	nepal	ADJ
njb-66	81	2	journal	journal	PROPN
njb-66	81	3	of	of	ADP
njb-66	81	4	biotechnology	biotechnology	NOUN
njb-66	81	5	.	.	PUNCT
njb-66	82	1	d	d	X
njb-66	82	2	e	e	PROPN
njb-66	82	3	c	c	PROPN
njb-66	82	4	.	.	PUNCT
njb-66	83	1	2	2	NUM
njb-66	83	2	0	0	NUM
njb-66	83	3	1	1	NUM
njb-66	83	4	9	9	NUM
njb-66	83	5	vol	vol	NOUN
njb-66	83	6	.	.	PUNCT
njb-66	84	1	7	7	NUM
njb-66	84	2	,	,	PUNCT
njb-66	84	3	no	no	NOUN
njb-66	84	4	.	.	NOUN
njb-66	84	5	1	1	NUM
njb-66	84	6	:	:	SYM
njb-66	84	7	82	82	NUM
njb-66	84	8	-	-	SYM
njb-66	84	9	89	89	NUM
njb-66	84	10	bhandari	bhandari	PROPN
njb-66	84	11	et	et	PROPN
njb-66	84	12	al	al	PROPN
njb-66	84	13	.	.	PROPN
njb-66	84	14	2019	2019	NUM
njb-66	85	1	©	©	ADP
njb-66	85	2	njb	njb	PROPN
njb-66	85	3	,	,	PUNCT
njb-66	85	4	biotechnology	biotechnology	NOUN
njb-66	85	5	society	society	NOUN
njb-66	85	6	of	of	ADP
njb-66	85	7	nepal	nepal	ADJ
njb-66	85	8	85	85	NUM
njb-66	85	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-66	85	10	.	.	PUNCT
njb-66	85	11	table	table	NOUN
njb-66	85	12	2	2	NUM
njb-66	85	13	.	.	PUNCT
njb-66	86	1	gender	gender	NOUN
njb-66	86	2	wise	wise	ADJ
njb-66	86	3	distribution	distribution	NOUN
njb-66	86	4	of	of	ADP
njb-66	86	5	patients	patient	NOUN
njb-66	86	6	(	(	PUNCT
njb-66	86	7	p	p	X
njb-66	86	8	>	>	X
njb-66	86	9	0.05	0.05	NUM
njb-66	86	10	)	)	PUNCT
njb-66	86	11	male	male	ADJ
njb-66	86	12	female	female	ADJ
njb-66	86	13	total	total	ADJ
njb-66	86	14	culture	culture	NOUN
njb-66	86	15	positive	positive	ADJ
njb-66	86	16	196(54.9	196(54.9	NUM
njb-66	86	17	)	)	PUNCT
njb-66	86	18	161(45.09	161(45.09	NUM
njb-66	86	19	)	)	PUNCT
njb-66	86	20	357(54.9	357(54.9	NUM
njb-66	86	21	)	)	PUNCT
njb-66	86	22	culture	culture	NOUN
njb-66	86	23	negative	negative	ADJ
njb-66	86	24	162	162	NUM
njb-66	86	25	(	(	PUNCT
njb-66	86	26	45.2	45.2	NUM
njb-66	86	27	)	)	PUNCT
njb-66	86	28	131	131	NUM
njb-66	86	29	(	(	PUNCT
njb-66	86	30	44.8	44.8	NUM
njb-66	86	31	)	)	PUNCT
njb-66	86	32	293(45.1	293(45.1	NUM
njb-66	86	33	)	)	PUNCT
njb-66	86	34	total	total	NOUN
njb-66	86	35	358	358	NUM
njb-66	86	36	(	(	PUNCT
njb-66	86	37	55.1	55.1	NUM
njb-66	86	38	)	)	PUNCT
njb-66	86	39	292	292	NUM
njb-66	86	40	(	(	PUNCT
njb-66	86	41	44.9	44.9	NUM
njb-66	86	42	)	)	PUNCT
njb-66	86	43	650	650	NUM
njb-66	86	44	(	(	PUNCT
njb-66	86	45	100	100	NUM
njb-66	86	46	)	)	PUNCT
njb-66	86	47	pure	pure	ADJ
njb-66	86	48	culture	culture	NOUN
njb-66	86	49	and	and	CCONJ
njb-66	86	50	also	also	ADV
njb-66	86	51	to	to	PART
njb-66	86	52	see	see	VERB
njb-66	86	53	whether	whether	SCONJ
njb-66	86	54	the	the	DET
njb-66	86	55	biochemical	biochemical	ADJ
njb-66	86	56	tests	test	NOUN
njb-66	86	57	were	be	AUX
njb-66	86	58	performed	perform	VERB
njb-66	86	59	in	in	ADP
njb-66	86	60	aseptic	aseptic	ADJ
njb-66	86	61	condition	condition	NOUN
njb-66	86	62	or	or	CCONJ
njb-66	86	63	not	not	PART
njb-66	86	64	.	.	PUNCT
njb-66	87	1	thus	thus	ADV
njb-66	87	2	,	,	PUNCT
njb-66	87	3	while	while	SCONJ
njb-66	87	4	performing	perform	VERB
njb-66	87	5	biochemical	biochemical	ADJ
njb-66	87	6	tests	test	NOUN
njb-66	87	7	,	,	PUNCT
njb-66	87	8	in	in	ADP
njb-66	87	9	biochemical	biochemical	ADJ
njb-66	87	10	media	medium	NOUN
njb-66	87	11	,	,	PUNCT
njb-66	87	12	the	the	DET
njb-66	87	13	same	same	ADJ
njb-66	87	14	inoculum	inoculum	NOUN
njb-66	87	15	was	be	AUX
njb-66	87	16	sub	sub	ADJ
njb-66	87	17	-	-	ADJ
njb-66	87	18	cultured	cultured	ADJ
njb-66	87	19	on	on	ADP
njb-66	87	20	one	one	NUM
njb-66	87	21	half	half	NOUN
njb-66	87	22	of	of	ADP
njb-66	87	23	nutrient	nutrient	ADJ
njb-66	87	24	agar	agar	NOUN
njb-66	87	25	(	(	PUNCT
njb-66	87	26	na	na	ADP
njb-66	87	27	)	)	PUNCT
njb-66	87	28	medium	medium	NOUN
njb-66	87	29	before	before	ADV
njb-66	87	30	(	(	PUNCT
njb-66	87	31	pre	pre	X
njb-66	87	32	purity	purity	NOUN
njb-66	87	33	)	)	PUNCT
njb-66	87	34	inoculation	inoculation	NOUN
njb-66	87	35	and	and	CCONJ
njb-66	87	36	another	another	DET
njb-66	87	37	half	half	NOUN
njb-66	87	38	after	after	ADP
njb-66	87	39	(	(	PUNCT
njb-66	87	40	post	post	NOUN
njb-66	87	41	purity	purity	NOUN
njb-66	87	42	)	)	PUNCT
njb-66	87	43	inoculation	inoculation	NOUN
njb-66	87	44	.	.	PUNCT
njb-66	88	1	the	the	DET
njb-66	88	2	maintenance	maintenance	NOUN
njb-66	88	3	of	of	ADP
njb-66	88	4	aseptic	aseptic	ADJ
njb-66	88	5	condition	condition	NOUN
njb-66	88	6	is	be	AUX
njb-66	88	7	indicated	indicate	VERB
njb-66	88	8	by	by	ADP
njb-66	88	9	the	the	DET
njb-66	88	10	growth	growth	NOUN
njb-66	88	11	of	of	ADP
njb-66	88	12	the	the	DET
njb-66	88	13	same	same	ADJ
njb-66	88	14	organism	organism	NOUN
njb-66	88	15	in	in	ADP
njb-66	88	16	pure	pure	ADJ
njb-66	88	17	form	form	NOUN
njb-66	88	18	in	in	ADP
njb-66	88	19	both	both	PRON
njb-66	88	20	pre	pre	ADJ
njb-66	88	21	and	and	CCONJ
njb-66	88	22	post	post	NOUN
njb-66	88	23	halves	half	NOUN
njb-66	88	24	of	of	ADP
njb-66	88	25	the	the	DET
njb-66	88	26	medium	medium	NOUN
njb-66	88	27	.	.	PUNCT
njb-66	89	1	the	the	DET
njb-66	89	2	chart	chart	NOUN
njb-66	89	3	below	below	ADV
njb-66	89	4	represents	represent	VERB
njb-66	89	5	the	the	DET
njb-66	89	6	isolation	isolation	NOUN
njb-66	89	7	and	and	CCONJ
njb-66	89	8	identification	identification	NOUN
njb-66	89	9	of	of	ADP
njb-66	89	10	mrsa	mrsa	PROPN
njb-66	89	11	from	from	ADP
njb-66	89	12	pus	pus	NOUN
njb-66	89	13	samples	sample	NOUN
njb-66	89	14	.	.	PUNCT
njb-66	90	1	all	all	DET
njb-66	90	2	the	the	DET
njb-66	90	3	raw	raw	ADJ
njb-66	90	4	data	datum	NOUN
njb-66	90	5	collected	collect	VERB
njb-66	90	6	in	in	ADP
njb-66	90	7	the	the	DET
njb-66	90	8	microbiology	microbiology	NOUN
njb-66	90	9	laboratory	laboratory	NOUN
njb-66	90	10	were	be	AUX
njb-66	90	11	statistically	statistically	ADV
njb-66	90	12	analyzed	analyze	VERB
njb-66	90	13	by	by	ADP
njb-66	90	14	using	use	VERB
njb-66	90	15	computer	computer	NOUN
njb-66	90	16	-	-	PUNCT
njb-66	90	17	based	base	VERB
njb-66	90	18	software	software	NOUN
njb-66	90	19	program	program	NOUN
njb-66	90	20	spss	spss	PROPN
njb-66	90	21	version	version	PROPN
njb-66	90	22	20	20	NUM
njb-66	90	23	.	.	PUNCT
njb-66	91	1	the	the	DET
njb-66	91	2	flow	flow	NOUN
njb-66	91	3	chart	chart	NOUN
njb-66	91	4	representing	represent	VERB
njb-66	91	5	isolation	isolation	NOUN
njb-66	91	6	and	and	CCONJ
njb-66	91	7	identification	identification	NOUN
njb-66	91	8	of	of	ADP
njb-66	91	9	mrsa	mrsa	PROPN
njb-66	91	10	from	from	ADP
njb-66	91	11	pus	pus	NOUN
njb-66	91	12	samples	sample	NOUN
njb-66	91	13	is	be	AUX
njb-66	91	14	shown	show	VERB
njb-66	91	15	in	in	ADP
njb-66	91	16	figure	figure	NOUN
njb-66	91	17	3	3	NUM
njb-66	91	18	.	.	PUNCT
njb-66	91	19	results	result	NOUN
njb-66	91	20	and	and	CCONJ
njb-66	91	21	discussion	discussion	VERB
njb-66	91	22	bacterial	bacterial	ADJ
njb-66	91	23	growth	growth	NOUN
njb-66	91	24	in	in	ADP
njb-66	91	25	different	different	ADJ
njb-66	91	26	pus	pus	NOUN
njb-66	91	27	samples	sample	NOUN
njb-66	91	28	and	and	CCONJ
njb-66	91	29	gender	gender	NOUN
njb-66	91	30	wise	wise	ADJ
njb-66	91	31	distribution	distribution	NOUN
njb-66	91	32	of	of	ADP
njb-66	91	33	patients	patient	NOUN
njb-66	91	34	out	out	ADP
njb-66	91	35	of	of	ADP
njb-66	91	36	650	650	NUM
njb-66	91	37	total	total	ADJ
njb-66	91	38	samples	sample	NOUN
njb-66	91	39	,	,	PUNCT
njb-66	91	40	550	550	NUM
njb-66	91	41	samples	sample	NOUN
njb-66	91	42	were	be	AUX
njb-66	91	43	pus	pus	NOUN
njb-66	91	44	swab	swab	NOUN
njb-66	91	45	and	and	CCONJ
njb-66	91	46	100	100	NUM
njb-66	91	47	samples	sample	NOUN
njb-66	91	48	were	be	AUX
njb-66	91	49	pus	pus	NOUN
njb-66	91	50	aspirate	aspirate	ADJ
njb-66	91	51	.	.	PUNCT
njb-66	92	1	among	among	ADP
njb-66	92	2	total	total	ADJ
njb-66	92	3	pus	pus	NOUN
njb-66	92	4	swabs	swab	NOUN
njb-66	92	5	303	303	NUM
njb-66	92	6	(	(	PUNCT
njb-66	92	7	55.09	55.09	NUM
njb-66	92	8	%	%	NOUN
njb-66	92	9	)	)	PUNCT
njb-66	92	10	were	be	AUX
njb-66	92	11	culture	culture	NOUN
njb-66	92	12	positive	positive	ADJ
njb-66	92	13	and	and	CCONJ
njb-66	92	14	247	247	NUM
njb-66	92	15	(	(	PUNCT
njb-66	92	16	44.91	44.91	NUM
njb-66	92	17	%	%	NOUN
njb-66	92	18	)	)	PUNCT
njb-66	92	19	showed	show	VERB
njb-66	92	20	no	no	DET
njb-66	92	21	growth	growth	NOUN
njb-66	92	22	.	.	PUNCT
njb-66	93	1	moreover	moreover	ADV
njb-66	93	2	,	,	PUNCT
njb-66	93	3	among	among	ADP
njb-66	93	4	total	total	ADJ
njb-66	93	5	pus	pus	NOUN
njb-66	93	6	aspirates	aspirate	NOUN
njb-66	93	7	,	,	PUNCT
njb-66	93	8	54	54	NUM
njb-66	93	9	(	(	PUNCT
njb-66	93	10	54	54	NUM
njb-66	93	11	%	%	NOUN
njb-66	93	12	)	)	PUNCT
njb-66	93	13	were	be	AUX
njb-66	93	14	culture	culture	NOUN
njb-66	93	15	positive	positive	ADJ
njb-66	93	16	and	and	CCONJ
njb-66	93	17	the	the	DET
njb-66	93	18	remaining	remain	VERB
njb-66	93	19	46	46	NUM
njb-66	93	20	(	(	PUNCT
njb-66	93	21	46	46	NUM
njb-66	93	22	%	%	NOUN
njb-66	93	23	)	)	PUNCT
njb-66	93	24	showed	show	VERB
njb-66	93	25	no	no	DET
njb-66	93	26	growth	growth	NOUN
njb-66	93	27	as	as	SCONJ
njb-66	93	28	shown	show	VERB
njb-66	93	29	in	in	ADP
njb-66	93	30	table	table	NOUN
njb-66	93	31	1	1	NUM
njb-66	93	32	.	.	PUNCT
njb-66	94	1	out	out	ADP
njb-66	94	2	of	of	ADP
njb-66	94	3	total	total	ADJ
njb-66	94	4	cases	case	NOUN
njb-66	94	5	,	,	PUNCT
njb-66	94	6	358	358	NUM
njb-66	94	7	(	(	PUNCT
njb-66	94	8	55.07	55.07	NUM
njb-66	94	9	%	%	NOUN
njb-66	94	10	)	)	PUNCT
njb-66	94	11	were	be	AUX
njb-66	94	12	male	male	ADJ
njb-66	94	13	patients	patient	NOUN
njb-66	94	14	and	and	CCONJ
njb-66	94	15	292	292	NUM
njb-66	94	16	(	(	PUNCT
njb-66	94	17	44.92	44.92	NUM
njb-66	94	18	%	%	NOUN
njb-66	94	19	)	)	PUNCT
njb-66	94	20	were	be	AUX
njb-66	94	21	female	female	ADJ
njb-66	94	22	patients	patient	NOUN
njb-66	94	23	.	.	PUNCT
njb-66	95	1	the	the	DET
njb-66	95	2	growth	growth	NOUN
njb-66	95	3	was	be	AUX
njb-66	95	4	found	find	VERB
njb-66	95	5	to	to	PART
njb-66	95	6	be	be	AUX
njb-66	95	7	higher	high	ADJ
njb-66	95	8	in	in	ADP
njb-66	95	9	male	male	ADJ
njb-66	95	10	patients	patient	NOUN
njb-66	95	11	196	196	NUM
njb-66	95	12	(	(	PUNCT
njb-66	95	13	54.9	54.9	NUM
njb-66	95	14	%	%	NOUN
njb-66	95	15	)	)	PUNCT
njb-66	95	16	than	than	ADP
njb-66	95	17	in	in	ADP
njb-66	95	18	female	female	ADJ
njb-66	95	19	patients161	patients161	ADJ
njb-66	95	20	(	(	PUNCT
njb-66	95	21	45.09	45.09	NUM
njb-66	95	22	%	%	NOUN
njb-66	95	23	)	)	PUNCT
njb-66	95	24	.	.	PUNCT
njb-66	96	1	the	the	DET
njb-66	96	2	association	association	NOUN
njb-66	96	3	between	between	ADP
njb-66	96	4	gender	gender	NOUN
njb-66	96	5	and	and	CCONJ
njb-66	96	6	growth	growth	NOUN
njb-66	96	7	of	of	ADP
njb-66	96	8	bacteria	bacteria	NOUN
njb-66	96	9	was	be	AUX
njb-66	96	10	not	not	PART
njb-66	96	11	statistically	statistically	ADV
njb-66	96	12	significant	significant	ADJ
njb-66	96	13	(	(	PUNCT
njb-66	96	14	p	p	NOUN
njb-66	96	15	-	-	PUNCT
njb-66	96	16	value	value	NOUN
njb-66	96	17	>	>	SYM
njb-66	96	18	0.05	0.05	NUM
njb-66	96	19	)	)	PUNCT
njb-66	96	20	is	be	AUX
njb-66	96	21	presented	present	VERB
njb-66	96	22	in	in	ADP
njb-66	96	23	table	table	NOUN
njb-66	96	24	2	2	NUM
njb-66	96	25	.	.	PUNCT
njb-66	97	1	among	among	ADP
njb-66	97	2	650	650	NUM
njb-66	97	3	pus	pus	NOUN
njb-66	97	4	samples	sample	NOUN
njb-66	97	5	,	,	PUNCT
njb-66	97	6	the	the	DET
njb-66	97	7	majority	majority	NOUN
njb-66	97	8	i.e.	i.e.	X
njb-66	97	9	352	352	NUM
njb-66	97	10	(	(	PUNCT
njb-66	97	11	54.15	54.15	NUM
njb-66	97	12	%	%	NOUN
njb-66	97	13	)	)	PUNCT
njb-66	97	14	were	be	AUX
njb-66	97	15	in	in	ADP
njb-66	97	16	-	-	PUNCT
njb-66	97	17	patients	patient	NOUN
njb-66	97	18	who	who	PRON
njb-66	97	19	were	be	AUX
njb-66	97	20	admitted	admit	VERB
njb-66	97	21	to	to	ADP
njb-66	97	22	the	the	DET
njb-66	97	23	different	different	ADJ
njb-66	97	24	departments	department	NOUN
njb-66	97	25	in	in	ADP
njb-66	97	26	the	the	DET
njb-66	97	27	hospital	hospital	NOUN
njb-66	97	28	and	and	CCONJ
njb-66	97	29	298	298	NUM
njb-66	97	30	(	(	PUNCT
njb-66	97	31	45.23	45.23	NUM
njb-66	97	32	%	%	NOUN
njb-66	97	33	)	)	PUNCT
njb-66	97	34	were	be	AUX
njb-66	97	35	from	from	ADP
njb-66	97	36	opd	opd	PROPN
njb-66	97	37	.	.	PUNCT
njb-66	98	1	a	a	DET
njb-66	98	2	total	total	ADJ
njb-66	98	3	221	221	NUM
njb-66	98	4	(	(	PUNCT
njb-66	98	5	62.78	62.78	NUM
njb-66	98	6	%	%	NOUN
njb-66	98	7	)	)	PUNCT
njb-66	98	8	of	of	ADP
njb-66	98	9	inpatient	inpatient	PROPN
njb-66	98	10	department	department	PROPN
njb-66	98	11	(	(	PUNCT
njb-66	98	12	ipd	ipd	PROPN
njb-66	98	13	)	)	PUNCT
njb-66	98	14	and	and	CCONJ
njb-66	98	15	136	136	NUM
njb-66	98	16	(	(	PUNCT
njb-66	98	17	45.36	45.36	NUM
njb-66	98	18	%	%	NOUN
njb-66	98	19	)	)	PUNCT
njb-66	98	20	of	of	ADP
njb-66	98	21	out	out	ADP
njb-66	98	22	patient	patient	PROPN
njb-66	98	23	department	department	NOUN
njb-66	98	24	(	(	PUNCT
njb-66	98	25	opd	opd	PROPN
njb-66	98	26	)	)	PUNCT
njb-66	98	27	showed	show	VERB
njb-66	98	28	growth	growth	NOUN
njb-66	98	29	.	.	PUNCT
njb-66	99	1	such	such	ADJ
njb-66	99	2	distribution	distribution	NOUN
njb-66	99	3	pattern	pattern	NOUN
njb-66	99	4	of	of	ADP
njb-66	99	5	growth	growth	NOUN
njb-66	99	6	on	on	ADP
njb-66	99	7	the	the	DET
njb-66	99	8	basis	basis	NOUN
njb-66	99	9	of	of	ADP
njb-66	99	10	the	the	DET
njb-66	99	11	department	department	NOUN
njb-66	99	12	was	be	AUX
njb-66	99	13	statistically	statistically	ADV
njb-66	99	14	significant	significant	ADJ
njb-66	99	15	(	(	PUNCT
njb-66	99	16	pvalue	pvalue	NOUN
njb-66	99	17	<	<	X
njb-66	99	18	0.05	0.05	NUM
njb-66	99	19	)	)	PUNCT
njb-66	99	20	is	be	AUX
njb-66	99	21	as	as	ADP
njb-66	99	22	in	in	ADP
njb-66	99	23	table	table	NOUN
njb-66	99	24	3	3	NUM
njb-66	99	25	.	.	PUNCT
njb-66	100	1	distribution	distribution	NOUN
njb-66	100	2	of	of	ADP
njb-66	100	3	s.	s.	PROPN
njb-66	100	4	aureus	aureus	PROPN
njb-66	100	5	in	in	ADP
njb-66	100	6	pus	pus	PROPN
njb-66	100	7	sample	sample	NOUN
njb-66	100	8	among	among	ADP
njb-66	100	9	the	the	DET
njb-66	100	10	culture	culture	NOUN
njb-66	100	11	-	-	PUNCT
njb-66	100	12	positive	positive	ADJ
njb-66	100	13	specimens	specimen	NOUN
njb-66	100	14	,	,	PUNCT
njb-66	100	15	278	278	NUM
njb-66	100	16	(	(	PUNCT
njb-66	100	17	77.87	77.87	NUM
njb-66	100	18	%	%	NOUN
njb-66	100	19	)	)	PUNCT
njb-66	100	20	s.	s.	PROPN
njb-66	100	21	aureus	aureus	PROPN
njb-66	100	22	isolates	isolate	NOUN
njb-66	100	23	were	be	AUX
njb-66	100	24	obtained	obtain	VERB
njb-66	100	25	while	while	SCONJ
njb-66	100	26	remaining	remain	VERB
njb-66	100	27	79	79	NUM
njb-66	100	28	(	(	PUNCT
njb-66	100	29	22.12	22.12	NUM
njb-66	100	30	%	%	NOUN
njb-66	100	31	)	)	PUNCT
njb-66	100	32	were	be	AUX
njb-66	100	33	other	other	ADJ
njb-66	100	34	bacterial	bacterial	ADJ
njb-66	100	35	isolates	isolate	NOUN
njb-66	100	36	which	which	PRON
njb-66	100	37	include	include	VERB
njb-66	100	38	both	both	DET
njb-66	100	39	gram	gram	ADJ
njb-66	100	40	-	-	PUNCT
njb-66	100	41	positive	positive	ADJ
njb-66	100	42	coagulase	coagulase	NOUN
njb-66	100	43	negative	negative	ADJ
njb-66	100	44	staphylococcus	staphylococcus	NOUN
njb-66	100	45	species	specie	NOUN
njb-66	100	46	(	(	PUNCT
njb-66	100	47	cons	con	NOUN
njb-66	100	48	)	)	PUNCT
njb-66	100	49	and	and	CCONJ
njb-66	100	50	gram	gram	NOUN
njb-66	100	51	-	-	PUNCT
njb-66	100	52	negative	negative	ADJ
njb-66	100	53	bacteria	bacteria	NOUN
njb-66	100	54	(	(	PUNCT
njb-66	100	55	e.	e.	PROPN
njb-66	100	56	coli	coli	PROPN
njb-66	100	57	,	,	PUNCT
njb-66	100	58	pseudomonas	pseudomonas	PROPN
njb-66	100	59	aeruginosa	aeruginosa	PROPN
njb-66	100	60	,	,	PUNCT
njb-66	100	61	klebsiella	klebsiella	PROPN
njb-66	100	62	pneumonia	pneumonia	PROPN
njb-66	100	63	and	and	CCONJ
njb-66	100	64	enterobacter	enterobacter	NOUN
njb-66	100	65	aerogens	aerogen	NOUN
njb-66	100	66	)	)	PUNCT
njb-66	100	67	as	as	SCONJ
njb-66	100	68	shown	show	VERB
njb-66	100	69	in	in	ADP
njb-66	100	70	pie	pie	NOUN
njb-66	100	71	chart	chart	NOUN
njb-66	100	72	in	in	ADP
njb-66	100	73	figure	figure	NOUN
njb-66	100	74	4	4	NUM
njb-66	100	75	.	.	PUNCT
njb-66	101	1	distribution	distribution	NOUN
njb-66	101	2	of	of	ADP
njb-66	101	3	clinical	clinical	ADJ
njb-66	101	4	isolates	isolate	NOUN
njb-66	101	5	of	of	ADP
njb-66	101	6	s.	s.	PROPN
njb-66	101	7	aureus	aureus	PROPN
njb-66	101	8	according	accord	VERB
njb-66	101	9	to	to	ADP
njb-66	101	10	age	age	NOUN
njb-66	101	11	and	and	CCONJ
njb-66	101	12	gender	gender	NOUN
njb-66	101	13	of	of	ADP
njb-66	101	14	the	the	DET
njb-66	101	15	patient	patient	NOUN
njb-66	101	16	among	among	ADP
njb-66	101	17	278	278	NUM
njb-66	101	18	s.	s.	PROPN
njb-66	101	19	aureus	aureus	PROPN
njb-66	101	20	isolates	isolate	NOUN
njb-66	101	21	,	,	PUNCT
njb-66	101	22	a	a	DET
njb-66	101	23	higher	high	ADJ
njb-66	101	24	number	number	NOUN
njb-66	101	25	of	of	ADP
njb-66	101	26	isolation	isolation	NOUN
njb-66	101	27	was	be	AUX
njb-66	101	28	found	find	VERB
njb-66	101	29	in	in	ADP
njb-66	101	30	male	male	NOUN
njb-66	101	31	169	169	NUM
njb-66	101	32	(	(	PUNCT
njb-66	101	33	60.79	60.79	NUM
njb-66	101	34	%	%	NOUN
njb-66	101	35	)	)	PUNCT
njb-66	101	36	as	as	SCONJ
njb-66	101	37	compared	compare	VERB
njb-66	101	38	to	to	ADP
njb-66	101	39	female	female	ADJ
njb-66	101	40	109	109	NUM
njb-66	101	41	(	(	PUNCT
njb-66	101	42	39.20	39.20	NUM
njb-66	101	43	%	%	NOUN
njb-66	101	44	)	)	PUNCT
njb-66	101	45	patients	patient	NOUN
njb-66	101	46	.	.	PUNCT
njb-66	102	1	in	in	ADP
njb-66	102	2	the	the	DET
njb-66	102	3	male	male	NOUN
njb-66	102	4	,	,	PUNCT
njb-66	102	5	the	the	DET
njb-66	102	6	maximum	maximum	ADJ
njb-66	102	7	number	number	NOUN
njb-66	102	8	of	of	ADP
njb-66	102	9	s.	s.	PROPN
njb-66	102	10	aureus	aureus	PROPN
njb-66	102	11	isolates	isolate	NOUN
njb-66	102	12	(	(	PUNCT
njb-66	102	13	n=87	n=87	PROPN
njb-66	102	14	,	,	PUNCT
njb-66	102	15	51.47	51.47	NUM
njb-66	102	16	%	%	NOUN
njb-66	102	17	)	)	PUNCT
njb-66	102	18	was	be	AUX
njb-66	102	19	observed	observe	VERB
njb-66	102	20	in	in	ADP
njb-66	102	21	the	the	DET
njb-66	102	22	patient	patient	NOUN
njb-66	102	23	with	with	ADP
njb-66	102	24	an	an	DET
njb-66	102	25	age	age	NOUN
njb-66	102	26	group	group	NOUN
njb-66	102	27	of	of	ADP
njb-66	102	28	1	1	NUM
njb-66	102	29	-	-	SYM
njb-66	102	30	5	5	NUM
njb-66	102	31	and	and	CCONJ
njb-66	102	32	in	in	ADP
njb-66	102	33	females	female	NOUN
njb-66	102	34	,	,	PUNCT
njb-66	102	35	the	the	DET
njb-66	102	36	maximum	maximum	ADJ
njb-66	102	37	table	table	NOUN
njb-66	102	38	1	1	NUM
njb-66	102	39	.	.	PUNCT
njb-66	103	1	bacterial	bacterial	ADJ
njb-66	103	2	growth	growth	NOUN
njb-66	103	3	in	in	ADP
njb-66	103	4	different	different	ADJ
njb-66	103	5	pus	pus	NOUN
njb-66	103	6	samples	sample	NOUN
njb-66	103	7	types	type	NOUN
njb-66	103	8	of	of	ADP
njb-66	103	9	sample	sample	NOUN
njb-66	103	10	growth	growth	NOUN
njb-66	103	11	(	(	PUNCT
njb-66	103	12	no	no	INTJ
njb-66	103	13	.	.	PUNCT
njb-66	104	1	%	%	INTJ
njb-66	104	2	)	)	PUNCT
njb-66	105	1	no	no	DET
njb-66	105	2	growth	growth	NOUN
njb-66	105	3	(	(	PUNCT
njb-66	105	4	no	no	INTJ
njb-66	105	5	.	.	PUNCT
njb-66	105	6	%	%	INTJ
njb-66	105	7	)	)	PUNCT
njb-66	105	8	total	total	ADJ
njb-66	105	9	pus	pus	NOUN
njb-66	105	10	swab	swab	NOUN
njb-66	105	11	303(55.09	303(55.09	NUM
njb-66	105	12	%	%	NOUN
njb-66	105	13	)	)	PUNCT
njb-66	105	14	247(44.91	247(44.91	NUM
njb-66	105	15	%	%	NOUN
njb-66	105	16	)	)	PUNCT
njb-66	105	17	550	550	NUM
njb-66	105	18	pus	pus	NOUN
njb-66	105	19	aspirate	aspirate	VERB
njb-66	105	20	54	54	NUM
njb-66	105	21	(	(	PUNCT
njb-66	105	22	54	54	NUM
njb-66	105	23	%	%	NOUN
njb-66	105	24	)	)	PUNCT
njb-66	105	25	46	46	NUM
njb-66	105	26	(	(	PUNCT
njb-66	105	27	46	46	NUM
njb-66	105	28	%	%	NOUN
njb-66	105	29	)	)	PUNCT
njb-66	105	30	100	100	NUM
njb-66	105	31	total	total	ADJ
njb-66	105	32	357	357	NUM
njb-66	105	33	(	(	PUNCT
njb-66	105	34	54.92	54.92	NUM
njb-66	105	35	)	)	PUNCT
njb-66	105	36	293	293	NUM
njb-66	105	37	(	(	PUNCT
njb-66	105	38	45.08	45.08	NUM
njb-66	105	39	)	)	PUNCT
njb-66	105	40	650(100	650(100	NUM
njb-66	105	41	)	)	PUNCT
njb-66	105	42	table	table	NOUN
njb-66	105	43	3	3	NUM
njb-66	105	44	.	.	PUNCT
njb-66	106	1	distribution	distribution	NOUN
njb-66	106	2	of	of	ADP
njb-66	106	3	bacterial	bacterial	ADJ
njb-66	106	4	growth	growth	NOUN
njb-66	106	5	on	on	ADP
njb-66	106	6	the	the	DET
njb-66	106	7	basis	basis	NOUN
njb-66	106	8	of	of	ADP
njb-66	106	9	hospital	hospital	NOUN
njb-66	106	10	department	department	NOUN
njb-66	106	11	organism	organism	NOUN
njb-66	106	12	ipd	ipd	PROPN
njb-66	106	13	{	{	PUNCT
njb-66	106	14	n	n	ADP
njb-66	106	15	(	(	PUNCT
njb-66	106	16	%	%	INTJ
njb-66	106	17	)	)	PUNCT
njb-66	106	18	}	}	PUNCT
njb-66	106	19	opd	opd	NOUN
njb-66	106	20	{	{	PUNCT
njb-66	106	21	n	n	ADV
njb-66	106	22	(	(	PUNCT
njb-66	106	23	%	%	INTJ
njb-66	106	24	)	)	PUNCT
njb-66	106	25	}	}	PUNCT
njb-66	106	26	total	total	NOUN
njb-66	106	27	{	{	PUNCT
njb-66	106	28	n	n	ADV
njb-66	106	29	(	(	PUNCT
njb-66	106	30	%	%	INTJ
njb-66	106	31	)	)	PUNCT
njb-66	106	32	}	}	PUNCT
njb-66	106	33	p	p	NOUN
njb-66	106	34	-	-	PUNCT
njb-66	106	35	value	value	NOUN
njb-66	106	36	culture	culture	NOUN
njb-66	106	37	positive	positive	ADJ
njb-66	106	38	221	221	NUM
njb-66	106	39	(	(	PUNCT
njb-66	106	40	62.78	62.78	NUM
njb-66	106	41	)	)	PUNCT
njb-66	106	42	136	136	NUM
njb-66	106	43	(	(	PUNCT
njb-66	106	44	45.36	45.36	NUM
njb-66	106	45	)	)	PUNCT
njb-66	106	46	357	357	NUM
njb-66	106	47	(	(	PUNCT
njb-66	106	48	54.92	54.92	NUM
njb-66	106	49	)	)	PUNCT
njb-66	106	50	culture	culture	NOUN
njb-66	106	51	negative	negative	ADJ
njb-66	106	52	131	131	NUM
njb-66	106	53	(	(	PUNCT
njb-66	106	54	37.21	37.21	NUM
njb-66	106	55	)	)	PUNCT
njb-66	106	56	162	162	NUM
njb-66	106	57	(	(	PUNCT
njb-66	106	58	54.36	54.36	NUM
njb-66	106	59	)	)	PUNCT
njb-66	106	60	293	293	NUM
njb-66	106	61	(	(	PUNCT
njb-66	106	62	45.07	45.07	NUM
njb-66	106	63	)	)	PUNCT
njb-66	106	64	p	p	X
njb-66	106	65	<	<	X
njb-66	106	66	0.05	0.05	NUM
njb-66	106	67	total	total	NOUN
njb-66	106	68	352	352	NUM
njb-66	106	69	(	(	PUNCT
njb-66	106	70	54.15	54.15	NUM
njb-66	106	71	)	)	PUNCT
njb-66	106	72	298	298	NUM
njb-66	106	73	(	(	PUNCT
njb-66	106	74	45.84	45.84	NUM
njb-66	106	75	)	)	PUNCT
njb-66	106	76	650	650	NUM
njb-66	106	77	(	(	PUNCT
njb-66	106	78	100	100	NUM
njb-66	106	79	)	)	PUNCT
njb-66	106	80	nepal	nepal	ADJ
njb-66	106	81	journal	journal	NOUN
njb-66	106	82	of	of	ADP
njb-66	106	83	biotechnology	biotechnology	NOUN
njb-66	106	84	.	.	PUNCT
njb-66	107	1	d	d	X
njb-66	107	2	e	e	PROPN
njb-66	107	3	c	c	PROPN
njb-66	107	4	.	.	PUNCT
njb-66	108	1	2	2	NUM
njb-66	108	2	0	0	NUM
njb-66	108	3	1	1	NUM
njb-66	108	4	9	9	NUM
njb-66	108	5	vol	vol	NOUN
njb-66	108	6	.	.	PUNCT
njb-66	109	1	7	7	NUM
njb-66	109	2	,	,	PUNCT
njb-66	109	3	no	no	NOUN
njb-66	109	4	.	.	NOUN
njb-66	109	5	1	1	NUM
njb-66	109	6	:	:	SYM
njb-66	109	7	82	82	NUM
njb-66	109	8	-	-	SYM
njb-66	109	9	89	89	NUM
njb-66	109	10	bhandari	bhandari	PROPN
njb-66	109	11	et	et	PROPN
njb-66	109	12	al	al	PROPN
njb-66	109	13	.	.	PROPN
njb-66	109	14	2019	2019	NUM
njb-66	110	1	©	©	ADP
njb-66	110	2	njb	njb	PROPN
njb-66	110	3	,	,	PUNCT
njb-66	110	4	biotechnology	biotechnology	NOUN
njb-66	110	5	society	society	NOUN
njb-66	110	6	of	of	ADP
njb-66	110	7	nepal	nepal	ADJ
njb-66	110	8	86	86	NUM
njb-66	110	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-66	110	10	.	.	PUNCT
njb-66	110	11	figure	figure	NOUN
njb-66	110	12	4	4	NUM
njb-66	110	13	.	.	PUNCT
njb-66	111	1	distribution	distribution	NOUN
njb-66	111	2	of	of	ADP
njb-66	111	3	s.	s.	PROPN
njb-66	111	4	aureus	aureus	PROPN
njb-66	111	5	in	in	ADP
njb-66	111	6	pus	pus	PROPN
njb-66	111	7	sample	sample	NOUN
njb-66	111	8	.	.	PUNCT
njb-66	112	1	number	number	NOUN
njb-66	112	2	of	of	ADP
njb-66	112	3	s.	s.	PROPN
njb-66	112	4	aureus	aureus	PROPN
njb-66	112	5	isolates	isolate	NOUN
njb-66	112	6	(	(	PUNCT
njb-66	112	7	n=55	n=55	PROPN
njb-66	112	8	,	,	PUNCT
njb-66	112	9	50.45	50.45	NUM
njb-66	112	10	%	%	NOUN
njb-66	112	11	)	)	PUNCT
njb-66	112	12	was	be	AUX
njb-66	112	13	observed	observe	VERB
njb-66	112	14	in	in	ADP
njb-66	112	15	the	the	DET
njb-66	112	16	same	same	ADJ
njb-66	112	17	1	1	NUM
njb-66	112	18	-	-	SYM
njb-66	112	19	5	5	NUM
njb-66	112	20	age	age	NOUN
njb-66	112	21	group	group	NOUN
njb-66	112	22	patients	patient	NOUN
njb-66	112	23	.	.	PUNCT
njb-66	113	1	likewise	likewise	ADV
njb-66	113	2	,	,	PUNCT
njb-66	113	3	the	the	DET
njb-66	113	4	least	least	ADJ
njb-66	113	5	number	number	NOUN
njb-66	113	6	of	of	ADP
njb-66	113	7	s.	s.	PROPN
njb-66	113	8	aureus	aureus	PROPN
njb-66	113	9	isolates	isolate	NOUN
njb-66	113	10	(	(	PUNCT
njb-66	113	11	n=12	n=12	NOUN
njb-66	113	12	,	,	PUNCT
njb-66	113	13	7.10	7.10	NUM
njb-66	113	14	%	%	NOUN
njb-66	113	15	)	)	PUNCT
njb-66	113	16	was	be	AUX
njb-66	113	17	observed	observe	VERB
njb-66	113	18	in	in	ADP
njb-66	113	19	11	11	NUM
njb-66	113	20	-	-	SYM
njb-66	113	21	15	15	NUM
njb-66	113	22	age	age	NOUN
njb-66	113	23	group	group	NOUN
njb-66	113	24	patient	patient	NOUN
njb-66	113	25	in	in	ADP
njb-66	113	26	male	male	ADJ
njb-66	113	27	and	and	CCONJ
njb-66	113	28	female	female	ADJ
njb-66	113	29	least	least	ADJ
njb-66	113	30	number	number	NOUN
njb-66	113	31	of	of	ADP
njb-66	113	32	s.	s.	PROPN
njb-66	113	33	aureus	aureus	PROPN
njb-66	113	34	isolates	isolate	NOUN
njb-66	113	35	(	(	PUNCT
njb-66	113	36	n=9	n=9	NOUN
njb-66	113	37	,	,	PUNCT
njb-66	113	38	8.25	8.25	NUM
njb-66	113	39	%	%	NOUN
njb-66	113	40	)	)	PUNCT
njb-66	113	41	was	be	AUX
njb-66	113	42	observed	observe	VERB
njb-66	113	43	in	in	ADP
njb-66	113	44	the	the	DET
njb-66	113	45	same	same	ADJ
njb-66	113	46	11	11	NUM
njb-66	113	47	-	-	SYM
njb-66	113	48	15	15	NUM
njb-66	113	49	age	age	NOUN
njb-66	113	50	group	group	NOUN
njb-66	113	51	patients	patient	NOUN
njb-66	113	52	is	be	AUX
njb-66	113	53	shown	show	VERB
njb-66	113	54	in	in	ADP
njb-66	113	55	table	table	NOUN
njb-66	113	56	4	4	NUM
njb-66	113	57	.	.	PUNCT
njb-66	113	58	table	table	NOUN
njb-66	113	59	4	4	NUM
njb-66	113	60	.	.	PUNCT
njb-66	114	1	distribution	distribution	NOUN
njb-66	114	2	of	of	ADP
njb-66	114	3	clinical	clinical	ADJ
njb-66	114	4	isolates	isolate	NOUN
njb-66	114	5	of	of	ADP
njb-66	114	6	s.	s.	PROPN
njb-66	114	7	aureus	aureus	PROPN
njb-66	114	8	according	accord	VERB
njb-66	114	9	to	to	ADP
njb-66	114	10	age	age	NOUN
njb-66	114	11	and	and	CCONJ
njb-66	114	12	gender	gender	NOUN
njb-66	114	13	of	of	ADP
njb-66	114	14	the	the	DET
njb-66	114	15	patient	patient	ADJ
njb-66	114	16	age	age	NOUN
njb-66	114	17	group(in	group(in	ADJ
njb-66	114	18	years	year	NOUN
njb-66	114	19	)	)	PUNCT
njb-66	115	1	gender	gender	NOUN
njb-66	115	2	total	total	ADJ
njb-66	115	3	male	male	ADJ
njb-66	115	4	female	female	NOUN
njb-66	115	5	no	no	INTJ
njb-66	115	6	.	.	PUNCT
njb-66	116	1	%	%	NOUN
njb-66	116	2	below	below	ADP
njb-66	116	3	1	1	NUM
njb-66	116	4	1	1	NUM
njb-66	116	5	-	-	SYM
njb-66	116	6	5	5	NUM
njb-66	116	7	6	6	NUM
njb-66	116	8	-	-	SYM
njb-66	116	9	10	10	NUM
njb-66	116	10	11	11	NUM
njb-66	116	11	-	-	SYM
njb-66	116	12	15	15	NUM
njb-66	116	13	32	32	NUM
njb-66	116	14	87	87	NUM
njb-66	116	15	38	38	NUM
njb-66	116	16	12	12	NUM
njb-66	116	17	18	18	NUM
njb-66	116	18	55	55	NUM
njb-66	116	19	27	27	NUM
njb-66	116	20	9	9	NUM
njb-66	116	21	50	50	NUM
njb-66	116	22	142	142	NUM
njb-66	116	23	65	65	NUM
njb-66	116	24	21	21	NUM
njb-66	116	25	17.98	17.98	NUM
njb-66	116	26	51.07	51.07	NUM
njb-66	116	27	23.38	23.38	NUM
njb-66	116	28	7.55	7.55	NUM
njb-66	116	29	total	total	ADJ
njb-66	116	30	169(60.79	169(60.79	NUM
njb-66	116	31	%	%	NOUN
njb-66	116	32	)	)	PUNCT
njb-66	116	33	109(39.2	109(39.2	NUM
njb-66	116	34	%	%	NOUN
njb-66	116	35	)	)	PUNCT
njb-66	117	1	278	278	NUM
njb-66	117	2	100.0	100.0	NUM
njb-66	117	3	comparison	comparison	NOUN
njb-66	117	4	of	of	ADP
njb-66	117	5	clinical	clinical	ADJ
njb-66	117	6	isolates	isolate	NOUN
njb-66	117	7	of	of	ADP
njb-66	117	8	s.	s.	PROPN
njb-66	117	9	aureus	aureus	PROPN
njb-66	117	10	in	in	ADP
njb-66	117	11	inpatients	inpatient	NOUN
njb-66	117	12	and	and	CCONJ
njb-66	117	13	outpatients	outpatient	NOUN
njb-66	117	14	among	among	ADP
njb-66	117	15	278	278	NUM
njb-66	117	16	s.	s.	PROPN
njb-66	117	17	aureus	aureus	PROPN
njb-66	117	18	isolates	isolate	NOUN
njb-66	117	19	,	,	PUNCT
njb-66	117	20	177	177	NUM
njb-66	117	21	(	(	PUNCT
njb-66	117	22	63.66	63.66	NUM
njb-66	117	23	%	%	NOUN
njb-66	117	24	)	)	PUNCT
njb-66	117	25	isolates	isolate	NOUN
njb-66	117	26	of	of	ADP
njb-66	117	27	s.	s.	PROPN
njb-66	117	28	aureus	aureus	PROPN
njb-66	117	29	were	be	AUX
njb-66	117	30	from	from	ADP
njb-66	117	31	inpatients	inpatient	NOUN
njb-66	117	32	whereas	whereas	SCONJ
njb-66	117	33	101	101	NUM
njb-66	117	34	(	(	PUNCT
njb-66	117	35	36.33	36.33	NUM
njb-66	117	36	%	%	NOUN
njb-66	117	37	)	)	PUNCT
njb-66	117	38	s.	s.	PROPN
njb-66	117	39	aureus	aureus	PROPN
njb-66	117	40	were	be	AUX
njb-66	117	41	from	from	ADP
njb-66	117	42	outpatients	outpatient	NOUN
njb-66	117	43	.	.	PUNCT
njb-66	118	1	similarly	similarly	ADV
njb-66	118	2	,	,	PUNCT
njb-66	118	3	among	among	ADP
njb-66	118	4	79	79	NUM
njb-66	118	5	growths	growth	NOUN
njb-66	118	6	other	other	ADJ
njb-66	118	7	than	than	ADP
njb-66	118	8	s.	s.	PROPN
njb-66	118	9	aureus	aureus	PROPN
njb-66	118	10	isolates	isolate	NOUN
njb-66	118	11	,	,	PUNCT
njb-66	118	12	47	47	NUM
njb-66	118	13	(	(	PUNCT
njb-66	118	14	59.49	59.49	NUM
njb-66	118	15	%	%	NOUN
njb-66	118	16	)	)	PUNCT
njb-66	118	17	and	and	CCONJ
njb-66	118	18	32	32	NUM
njb-66	118	19	(	(	PUNCT
njb-66	118	20	40.50	40.50	NUM
njb-66	118	21	%	%	NOUN
njb-66	118	22	)	)	PUNCT
njb-66	118	23	cases	case	NOUN
njb-66	118	24	of	of	ADP
njb-66	118	25	cultures	culture	NOUN
njb-66	118	26	other	other	ADJ
njb-66	118	27	than	than	ADP
njb-66	118	28	s.	s.	PROPN
njb-66	118	29	aureus	aureus	PROPN
njb-66	118	30	were	be	AUX
njb-66	118	31	found	find	VERB
njb-66	118	32	from	from	ADP
njb-66	118	33	inpatients	inpatient	NOUN
njb-66	118	34	and	and	CCONJ
njb-66	118	35	outpatients	outpatient	NOUN
njb-66	118	36	respectively	respectively	ADV
njb-66	118	37	.	.	PUNCT
njb-66	119	1	a	a	DET
njb-66	119	2	comparison	comparison	NOUN
njb-66	119	3	of	of	ADP
njb-66	119	4	clinical	clinical	ADJ
njb-66	119	5	isolates	isolate	NOUN
njb-66	119	6	of	of	ADP
njb-66	119	7	s.	s.	PROPN
njb-66	119	8	aureus	aureus	PROPN
njb-66	119	9	in	in	ADP
njb-66	119	10	inpatients	inpatient	NOUN
njb-66	119	11	and	and	CCONJ
njb-66	119	12	outpatients	outpatient	NOUN
njb-66	119	13	is	be	AUX
njb-66	119	14	pictured	picture	VERB
njb-66	119	15	in	in	ADP
njb-66	119	16	figure	figure	NOUN
njb-66	119	17	5	5	NUM
njb-66	119	18	.	.	PUNCT
njb-66	120	1	distribution	distribution	NOUN
njb-66	120	2	of	of	ADP
njb-66	120	3	mrsa	mrsa	PROPN
njb-66	120	4	among	among	ADP
njb-66	120	5	s.	s.	PROPN
njb-66	120	6	aureus	aureus	PROPN
njb-66	120	7	and	and	CCONJ
njb-66	120	8	in	in	ADP
njb-66	120	9	different	different	ADJ
njb-66	120	10	age	age	NOUN
njb-66	120	11	groups	group	NOUN
njb-66	120	12	out	out	ADP
njb-66	120	13	of	of	ADP
njb-66	120	14	357	357	NUM
njb-66	120	15	culture	culture	NOUN
njb-66	120	16	-	-	PUNCT
njb-66	120	17	positive	positive	ADJ
njb-66	120	18	isolates	isolate	NOUN
njb-66	120	19	,	,	PUNCT
njb-66	120	20	278	278	NUM
njb-66	120	21	(	(	PUNCT
njb-66	120	22	77.87	77.87	NUM
njb-66	120	23	%	%	NOUN
njb-66	120	24	)	)	PUNCT
njb-66	120	25	were	be	AUX
njb-66	120	26	s.	s.	PROPN
njb-66	120	27	aureus	aureus	PROPN
njb-66	120	28	.	.	PUNCT
njb-66	121	1	out	out	ADP
njb-66	121	2	of	of	ADP
njb-66	121	3	total	total	ADJ
njb-66	121	4	s.	s.	PROPN
njb-66	121	5	aureus	aureus	PROPN
njb-66	121	6	;	;	PUNCT
njb-66	121	7	102	102	NUM
njb-66	121	8	(	(	PUNCT
njb-66	121	9	36.69	36.69	NUM
njb-66	121	10	%	%	NOUN
njb-66	121	11	)	)	PUNCT
njb-66	121	12	were	be	AUX
njb-66	121	13	mrsa	mrsa	PROPN
njb-66	121	14	and	and	CCONJ
njb-66	121	15	176	176	NUM
njb-66	121	16	(	(	PUNCT
njb-66	121	17	63.30	63.30	NUM
njb-66	121	18	%	%	NOUN
njb-66	121	19	)	)	PUNCT
njb-66	121	20	were	be	AUX
njb-66	121	21	mssa	mssa	ADJ
njb-66	121	22	(	(	PUNCT
njb-66	121	23	methicillin	methicillin	NOUN
njb-66	121	24	-	-	PUNCT
njb-66	121	25	sensitive	sensitive	ADJ
njb-66	121	26	staphylococcus	staphylococcus	NOUN
njb-66	121	27	aureus	aureus	NOUN
njb-66	121	28	)	)	PUNCT
njb-66	121	29	.	.	PUNCT
njb-66	122	1	out	out	ADP
njb-66	122	2	of	of	ADP
njb-66	122	3	169	169	NUM
njb-66	122	4	(	(	PUNCT
njb-66	122	5	60.79	60.79	NUM
njb-66	122	6	%	%	NOUN
njb-66	122	7	)	)	PUNCT
njb-66	122	8	s.	s.	PROPN
njb-66	122	9	aureus	aureus	PROPN
njb-66	122	10	isolates	isolate	VERB
njb-66	122	11	among	among	ADP
njb-66	122	12	male	male	ADJ
njb-66	122	13	patients	patient	NOUN
njb-66	122	14	,	,	PUNCT
njb-66	122	15	63	63	NUM
njb-66	122	16	(	(	PUNCT
njb-66	122	17	61.76	61.76	NUM
njb-66	122	18	%	%	NOUN
njb-66	122	19	)	)	PUNCT
njb-66	122	20	were	be	AUX
njb-66	122	21	found	find	VERB
njb-66	122	22	to	to	PART
njb-66	122	23	be	be	AUX
njb-66	122	24	mrsa	mrsa	PROPN
njb-66	122	25	.	.	PUNCT
njb-66	123	1	likewise	likewise	ADV
njb-66	123	2	,	,	PUNCT
njb-66	123	3	among	among	ADP
njb-66	123	4	109	109	NUM
njb-66	123	5	(	(	PUNCT
njb-66	123	6	39.20	39.20	NUM
njb-66	123	7	%	%	NOUN
njb-66	123	8	)	)	PUNCT
njb-66	123	9	s.	s.	PROPN
njb-66	123	10	aureus	aureus	PROPN
njb-66	123	11	isolates	isolate	VERB
njb-66	123	12	among	among	ADP
njb-66	123	13	female	female	ADJ
njb-66	123	14	patients	patient	NOUN
njb-66	123	15	,	,	PUNCT
njb-66	123	16	39	39	NUM
njb-66	123	17	(	(	PUNCT
njb-66	123	18	38.23	38.23	NUM
njb-66	123	19	%	%	NOUN
njb-66	123	20	)	)	PUNCT
njb-66	123	21	were	be	AUX
njb-66	123	22	found	find	VERB
njb-66	123	23	to	to	PART
njb-66	123	24	be	be	AUX
njb-66	123	25	mrsa	mrsa	PROPN
njb-66	123	26	.	.	PUNCT
njb-66	124	1	such	such	ADJ
njb-66	124	2	distribution	distribution	NOUN
njb-66	124	3	of	of	ADP
njb-66	124	4	mrsa	mrsa	PROPN
njb-66	124	5	based	base	VERB
njb-66	124	6	on	on	ADP
njb-66	124	7	gender	gender	NOUN
njb-66	124	8	was	be	AUX
njb-66	124	9	not	not	PART
njb-66	124	10	statistically	statistically	ADV
njb-66	124	11	significant	significant	ADJ
njb-66	124	12	(	(	PUNCT
njb-66	124	13	p	p	NOUN
njb-66	124	14	-	-	NOUN
njb-66	124	15	value	value	NOUN
njb-66	124	16	;	;	PUNCT
njb-66	124	17	>	>	X
njb-66	124	18	0.05	0.05	NUM
njb-66	124	19	)	)	PUNCT
njb-66	124	20	is	be	AUX
njb-66	124	21	given	give	VERB
njb-66	124	22	in	in	ADP
njb-66	124	23	the	the	DET
njb-66	124	24	pie	pie	NOUN
njb-66	124	25	chart	chart	NOUN
njb-66	124	26	in	in	ADP
njb-66	124	27	figure	figure	NOUN
njb-66	124	28	6	6	NUM
njb-66	124	29	.	.	PUNCT
njb-66	125	1	figure	figure	VERB
njb-66	125	2	5	5	NUM
njb-66	125	3	.	.	PUNCT
njb-66	126	1	comparison	comparison	NOUN
njb-66	126	2	of	of	ADP
njb-66	126	3	clinical	clinical	ADJ
njb-66	126	4	isolates	isolate	NOUN
njb-66	126	5	of	of	ADP
njb-66	126	6	s.	s.	PROPN
njb-66	126	7	aureus	aureus	PROPN
njb-66	126	8	in	in	ADP
njb-66	126	9	inpatients	inpatient	NOUN
njb-66	126	10	and	and	CCONJ
njb-66	126	11	outpatients	outpatient	NOUN
njb-66	126	12	figure	figure	VERB
njb-66	126	13	6	6	NUM
njb-66	126	14	.	.	PUNCT
njb-66	127	1	distribution	distribution	NOUN
njb-66	127	2	of	of	ADP
njb-66	127	3	mrsa	mrsa	PROPN
njb-66	127	4	among	among	ADP
njb-66	127	5	s.	s.	PROPN
njb-66	127	6	aureus	aureus	PROPN
njb-66	127	7	out	out	ADP
njb-66	127	8	of	of	ADP
njb-66	127	9	278	278	NUM
njb-66	127	10	s.	s.	PROPN
njb-66	127	11	aureus	aureus	PROPN
njb-66	127	12	isolates	isolate	NOUN
njb-66	127	13	,	,	PUNCT
njb-66	127	14	altogether	altogether	ADV
njb-66	127	15	102	102	NUM
njb-66	127	16	(	(	PUNCT
njb-66	127	17	36.69	36.69	NUM
njb-66	127	18	%	%	NOUN
njb-66	127	19	)	)	PUNCT
njb-66	127	20	and	and	CCONJ
njb-66	127	21	176	176	NUM
njb-66	127	22	(	(	PUNCT
njb-66	127	23	63.30	63.30	NUM
njb-66	127	24	%	%	NOUN
njb-66	127	25	)	)	PUNCT
njb-66	127	26	were	be	AUX
njb-66	127	27	identified	identify	VERB
njb-66	127	28	as	as	ADP
njb-66	127	29	mrsa	mrsa	PROPN
njb-66	127	30	and	and	CCONJ
njb-66	127	31	mssa	mssa	ADJ
njb-66	127	32	respectively	respectively	ADV
njb-66	127	33	by	by	ADP
njb-66	127	34	cefoxitin	cefoxitin	NOUN
njb-66	127	35	disc	disc	NOUN
njb-66	127	36	diffusion	diffusion	NOUN
njb-66	127	37	test	test	NOUN
njb-66	127	38	which	which	PRON
njb-66	127	39	constituted	constitute	VERB
njb-66	127	40	75	75	NUM
njb-66	127	41	(	(	PUNCT
njb-66	127	42	73.52	73.52	NUM
njb-66	127	43	%	%	NOUN
njb-66	127	44	)	)	PUNCT
njb-66	127	45	mrsa	mrsa	PROPN
njb-66	127	46	and	and	CCONJ
njb-66	127	47	101	101	NUM
njb-66	127	48	(	(	PUNCT
njb-66	127	49	57.38	57.38	NUM
njb-66	127	50	%	%	NOUN
njb-66	127	51	)	)	PUNCT
njb-66	127	52	mssa	mssa	ADJ
njb-66	127	53	in	in	ADP
njb-66	127	54	admitted	admit	VERB
njb-66	127	55	patients	patient	NOUN
njb-66	127	56	.	.	PUNCT
njb-66	128	1	similarly	similarly	ADV
njb-66	128	2	,	,	PUNCT
njb-66	128	3	in	in	ADP
njb-66	128	4	outpatients	outpatient	NOUN
njb-66	128	5	,	,	PUNCT
njb-66	128	6	27(26.47	27(26.47	NUM
njb-66	128	7	%	%	NOUN
njb-66	128	8	)	)	PUNCT
njb-66	128	9	mrsa	mrsa	PROPN
njb-66	128	10	and	and	CCONJ
njb-66	128	11	75(42.61	75(42.61	NUM
njb-66	128	12	%	%	NOUN
njb-66	128	13	)	)	PUNCT
njb-66	128	14	mssa	mssa	PROPN
njb-66	128	15	were	be	AUX
njb-66	128	16	observed	observe	VERB
njb-66	128	17	.	.	PUNCT
njb-66	129	1	the	the	DET
njb-66	129	2	association	association	NOUN
njb-66	129	3	in	in	ADP
njb-66	129	4	the	the	DET
njb-66	129	5	mrsa	mrsa	PROPN
njb-66	129	6	occurrence	occurrence	NOUN
njb-66	129	7	and	and	CCONJ
njb-66	129	8	inpatients	inpatient	NOUN
njb-66	129	9	was	be	AUX
njb-66	129	10	statistically	statistically	ADV
njb-66	129	11	significant	significant	ADJ
njb-66	129	12	(	(	PUNCT
njb-66	129	13	p	p	NOUN
njb-66	129	14	=	=	NOUN
njb-66	129	15	0.024	0.024	NUM
njb-66	129	16	)	)	PUNCT
njb-66	129	17	is	be	AUX
njb-66	129	18	in	in	ADP
njb-66	129	19	table	table	NOUN
njb-66	129	20	5	5	NUM
njb-66	129	21	77.87	77.87	NUM
njb-66	129	22	%	%	NOUN
njb-66	129	23	22.12	22.12	NUM
njb-66	129	24	%	%	NOUN
njb-66	129	25	s.	s.	PROPN
njb-66	129	26	aureus	aureus	PROPN
njb-66	129	27	others	other	NOUN
njb-66	129	28	59.49	59.49	NUM
njb-66	129	29	%	%	NOUN
njb-66	129	30	40.50	40.50	NUM
njb-66	129	31	%	%	NOUN
njb-66	129	32	63.66	63.66	NUM
njb-66	129	33	%	%	NOUN
njb-66	129	34	36.33	36.33	NUM
njb-66	129	35	%	%	NOUN
njb-66	129	36	0	0	NUM
njb-66	129	37	20	20	NUM
njb-66	129	38	40	40	NUM
njb-66	129	39	60	60	NUM
njb-66	129	40	80	80	NUM
njb-66	129	41	100	100	NUM
njb-66	129	42	120	120	NUM
njb-66	129	43	140	140	NUM
njb-66	129	44	inpatient	inpatient	NOUN
njb-66	129	45	outpatient	outpatient	NOUN
njb-66	129	46	others	other	NOUN
njb-66	129	47	s.	s.	PROPN
njb-66	129	48	aureus	aureus	PROPN
njb-66	129	49	63.30	63.30	NUM
njb-66	129	50	%	%	NOUN
njb-66	129	51	36.69	36.69	NUM
njb-66	129	52	%	%	NOUN
njb-66	129	53	mssa	mssa	ADJ
njb-66	129	54	mrsa	mrsa	PROPN
njb-66	129	55	table	table	PROPN
njb-66	129	56	5	5	NUM
njb-66	129	57	.	.	PUNCT
njb-66	130	1	distribution	distribution	NOUN
njb-66	130	2	of	of	ADP
njb-66	130	3	mrsa	mrsa	PROPN
njb-66	130	4	in	in	ADP
njb-66	130	5	outpatients	outpatient	NOUN
njb-66	130	6	and	and	CCONJ
njb-66	130	7	inpatients	inpatient	NOUN
njb-66	130	8	inpatients	inpatient	NOUN
njb-66	130	9	(	(	PUNCT
njb-66	130	10	no	no	INTJ
njb-66	130	11	.	.	PUNCT
njb-66	130	12	%	%	NOUN
njb-66	130	13	)	)	PUNCT
njb-66	130	14	outpatients	outpatient	NOUN
njb-66	130	15	(	(	PUNCT
njb-66	130	16	no	no	INTJ
njb-66	130	17	.	.	PUNCT
njb-66	130	18	%	%	INTJ
njb-66	130	19	)	)	PUNCT
njb-66	130	20	total	total	ADJ
njb-66	130	21	(	(	PUNCT
njb-66	130	22	no	no	INTJ
njb-66	130	23	.	.	PUNCT
njb-66	131	1	%	%	INTJ
njb-66	131	2	)	)	PUNCT
njb-66	132	1	p	p	NOUN
njb-66	132	2	-	-	PUNCT
njb-66	132	3	value	value	NOUN
njb-66	132	4	mrsa	mrsa	PROPN
njb-66	132	5	mssa	mssa	PROPN
njb-66	132	6	75(73.52	75(73.52	NUM
njb-66	132	7	%	%	NOUN
njb-66	132	8	)	)	PUNCT
njb-66	132	9	101	101	NUM
njb-66	132	10	(	(	PUNCT
njb-66	132	11	57.38	57.38	NUM
njb-66	132	12	%	%	NOUN
njb-66	132	13	)	)	PUNCT
njb-66	132	14	27	27	NUM
njb-66	132	15	(	(	PUNCT
njb-66	132	16	26.47	26.47	NUM
njb-66	132	17	%	%	NOUN
njb-66	132	18	)	)	PUNCT
njb-66	132	19	75	75	NUM
njb-66	132	20	(	(	PUNCT
njb-66	132	21	42.61	42.61	NUM
njb-66	132	22	%	%	NOUN
njb-66	132	23	)	)	PUNCT
njb-66	132	24	102	102	NUM
njb-66	132	25	(	(	PUNCT
njb-66	132	26	36.69	36.69	NUM
njb-66	132	27	%	%	NOUN
njb-66	132	28	)	)	PUNCT
njb-66	132	29	176	176	NUM
njb-66	132	30	(	(	PUNCT
njb-66	132	31	63.30	63.30	NUM
njb-66	132	32	%	%	NOUN
njb-66	132	33	)	)	PUNCT
njb-66	133	1	p	p	X
njb-66	133	2	<	<	X
njb-66	133	3	0.05	0.05	NUM
njb-66	133	4	total	total	NOUN
njb-66	133	5	176	176	NUM
njb-66	133	6	102	102	NUM
njb-66	133	7	278	278	NUM
njb-66	133	8	(	(	PUNCT
njb-66	133	9	100.0	100.0	NUM
njb-66	133	10	)	)	PUNCT
njb-66	133	11	nepal	nepal	ADJ
njb-66	133	12	journal	journal	NOUN
njb-66	133	13	of	of	ADP
njb-66	133	14	biotechnology	biotechnology	NOUN
njb-66	133	15	.	.	PUNCT
njb-66	134	1	d	d	X
njb-66	134	2	e	e	PROPN
njb-66	134	3	c	c	PROPN
njb-66	134	4	.	.	PUNCT
njb-66	135	1	2	2	NUM
njb-66	135	2	0	0	NUM
njb-66	135	3	1	1	NUM
njb-66	135	4	9	9	NUM
njb-66	135	5	vol	vol	NOUN
njb-66	135	6	.	.	PUNCT
njb-66	136	1	7	7	NUM
njb-66	136	2	,	,	PUNCT
njb-66	136	3	no	no	NOUN
njb-66	136	4	.	.	NOUN
njb-66	136	5	1	1	NUM
njb-66	136	6	:	:	SYM
njb-66	136	7	82	82	NUM
njb-66	136	8	-	-	SYM
njb-66	136	9	89	89	NUM
njb-66	136	10	bhandari	bhandari	PROPN
njb-66	136	11	et	et	PROPN
njb-66	136	12	al	al	PROPN
njb-66	136	13	.	.	PROPN
njb-66	136	14	2019	2019	NUM
njb-66	137	1	©	©	ADP
njb-66	137	2	njb	njb	PROPN
njb-66	137	3	,	,	PUNCT
njb-66	137	4	biotechnology	biotechnology	NOUN
njb-66	137	5	society	society	NOUN
njb-66	137	6	of	of	ADP
njb-66	137	7	nepal	nepal	ADJ
njb-66	137	8	87	87	NUM
njb-66	137	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-66	137	10	.	.	PUNCT
njb-66	138	1	antibiotic	antibiotic	ADJ
njb-66	138	2	susceptibility	susceptibility	NOUN
njb-66	138	3	pattern	pattern	NOUN
njb-66	138	4	of	of	ADP
njb-66	138	5	s.	s.	PROPN
njb-66	138	6	aureus	aureus	PROPN
njb-66	138	7	isolates	isolate	VERB
njb-66	138	8	the	the	DET
njb-66	138	9	antibiotic	antibiotic	ADJ
njb-66	138	10	susceptibility	susceptibility	NOUN
njb-66	138	11	pattern	pattern	NOUN
njb-66	138	12	showed	show	VERB
njb-66	138	13	that	that	SCONJ
njb-66	138	14	the	the	DET
njb-66	138	15	highest	high	ADJ
njb-66	138	16	number	number	NOUN
njb-66	138	17	of	of	ADP
njb-66	138	18	isolates	isolate	NOUN
njb-66	138	19	were	be	AUX
njb-66	138	20	resistant	resistant	ADJ
njb-66	138	21	to	to	ADP
njb-66	138	22	penicillin	penicillin	PROPN
njb-66	138	23	(	(	PUNCT
njb-66	138	24	n=250	n=250	PROPN
njb-66	138	25	,	,	PUNCT
njb-66	138	26	89.92	89.92	NUM
njb-66	138	27	%	%	NOUN
njb-66	138	28	)	)	PUNCT
njb-66	138	29	,	,	PUNCT
njb-66	138	30	ciprofloxacin	ciprofloxacin	NOUN
njb-66	138	31	(	(	PUNCT
njb-66	138	32	n=178	n=178	NOUN
njb-66	138	33	,	,	PUNCT
njb-66	138	34	64.02	64.02	NUM
njb-66	138	35	%	%	NOUN
njb-66	138	36	)	)	PUNCT
njb-66	138	37	,	,	PUNCT
njb-66	138	38	ofloxacin	ofloxacin	PROPN
njb-66	138	39	(	(	PUNCT
njb-66	138	40	n=162	n=162	PROPN
njb-66	138	41	,	,	PUNCT
njb-66	138	42	58.27	58.27	NUM
njb-66	138	43	%	%	NOUN
njb-66	138	44	)	)	PUNCT
njb-66	138	45	,	,	PUNCT
njb-66	138	46	cotrimoxazole	cotrimoxazole	PROPN
njb-66	138	47	(	(	PUNCT
njb-66	138	48	n=153	n=153	PROPN
njb-66	138	49	,	,	PUNCT
njb-66	138	50	55.04	55.04	NUM
njb-66	138	51	%	%	NOUN
njb-66	138	52	)	)	PUNCT
njb-66	138	53	,	,	PUNCT
njb-66	138	54	erythromycin	erythromycin	PROPN
njb-66	138	55	(	(	PUNCT
njb-66	138	56	n=112	n=112	NOUN
njb-66	138	57	,	,	PUNCT
njb-66	138	58	40.28	40.28	NUM
njb-66	138	59	%	%	NOUN
njb-66	138	60	)	)	PUNCT
njb-66	138	61	,	,	PUNCT
njb-66	138	62	cefoxitin	cefoxitin	NOUN
njb-66	138	63	(	(	PUNCT
njb-66	138	64	n=102	n=102	ADJ
njb-66	138	65	,	,	PUNCT
njb-66	138	66	36.69	36.69	NUM
njb-66	138	67	%	%	NOUN
njb-66	138	68	)	)	PUNCT
njb-66	138	69	and	and	CCONJ
njb-66	138	70	cloxacillin	cloxacillin	NOUN
njb-66	138	71	(	(	PUNCT
njb-66	138	72	n=98	n=98	PROPN
njb-66	138	73	,	,	PUNCT
njb-66	138	74	35.25	35.25	NUM
njb-66	138	75	%	%	NOUN
njb-66	138	76	)	)	PUNCT
njb-66	138	77	.	.	PUNCT
njb-66	139	1	the	the	DET
njb-66	139	2	highest	high	ADJ
njb-66	139	3	number	number	NOUN
njb-66	139	4	of	of	ADP
njb-66	139	5	penicillin	penicillin	PROPN
njb-66	139	6	resistant	resistant	ADJ
njb-66	139	7	s.	s.	PROPN
njb-66	139	8	aureus	aureus	PROPN
njb-66	139	9	developed	develop	VERB
njb-66	139	10	the	the	DET
njb-66	139	11	ability	ability	NOUN
njb-66	139	12	to	to	PART
njb-66	139	13	inactivate	inactivate	VERB
njb-66	139	14	the	the	DET
njb-66	139	15	βlactam	βlactam	NOUN
njb-66	139	16	ring	ring	NOUN
njb-66	139	17	of	of	ADP
njb-66	139	18	penicillin	penicillin	NOUN
njb-66	139	19	by	by	ADP
njb-66	139	20	producing	produce	VERB
njb-66	139	21	plasmid	plasmid	NOUN
njb-66	139	22	encoded	encode	VERB
njb-66	139	23	βlactamase	βlactamase	NOUN
njb-66	139	24	[	[	PUNCT
njb-66	139	25	25	25	NUM
njb-66	139	26	]	]	PUNCT
njb-66	139	27	.	.	PUNCT
njb-66	140	1	similarly	similarly	ADV
njb-66	140	2	,	,	PUNCT
njb-66	140	3	highest	high	ADJ
njb-66	140	4	number	number	NOUN
njb-66	140	5	of	of	ADP
njb-66	140	6	mrsa	mrsa	PROPN
njb-66	140	7	isolates	isolate	NOUN
njb-66	140	8	were	be	AUX
njb-66	140	9	susceptible	susceptible	ADJ
njb-66	140	10	to	to	ADP
njb-66	140	11	gentamicin	gentamicin	PROPN
njb-66	140	12	(	(	PUNCT
njb-66	140	13	n=264	n=264	ADJ
njb-66	140	14	,	,	PUNCT
njb-66	140	15	94.96	94.96	NUM
njb-66	140	16	%	%	NOUN
njb-66	140	17	)	)	PUNCT
njb-66	140	18	is	be	AUX
njb-66	140	19	due	due	ADJ
njb-66	140	20	to	to	ADP
njb-66	140	21	the	the	DET
njb-66	140	22	combination	combination	NOUN
njb-66	140	23	βlactam	βlactam	NOUN
njb-66	140	24	and	and	CCONJ
njb-66	140	25	amino	amino	NOUN
njb-66	140	26	glycosides	glycoside	NOUN
njb-66	140	27	which	which	PRON
njb-66	140	28	increases	increase	VERB
njb-66	140	29	bacterial	bacterial	ADJ
njb-66	140	30	killing	killing	NOUN
njb-66	140	31	invitro	invitro	NOUN
njb-66	140	32	and	and	CCONJ
njb-66	140	33	in	in	ADP
njb-66	140	34	animal	animal	NOUN
njb-66	140	35	model	model	NOUN
njb-66	140	36	of	of	ADP
njb-66	140	37	endocarditis	endocarditis	PROPN
njb-66	140	38	,	,	PUNCT
njb-66	140	39	followed	follow	VERB
njb-66	140	40	by	by	ADP
njb-66	140	41	chloramphenicol	chloramphenicol	NOUN
njb-66	140	42	(	(	PUNCT
njb-66	140	43	n=255	n=255	PROPN
njb-66	140	44	,	,	PUNCT
njb-66	140	45	91.72	91.72	NUM
njb-66	140	46	%	%	NOUN
njb-66	140	47	)	)	PUNCT
njb-66	140	48	,	,	PUNCT
njb-66	140	49	cefotaxime	cefotaxime	PROPN
njb-66	140	50	(	(	PUNCT
njb-66	140	51	n=236	n=236	NOUN
njb-66	140	52	,	,	PUNCT
njb-66	140	53	84.89	84.89	NUM
njb-66	140	54	%	%	NOUN
njb-66	140	55	)	)	PUNCT
njb-66	140	56	and	and	CCONJ
njb-66	140	57	amikacin	amikacin	PROPN
njb-66	140	58	(	(	PUNCT
njb-66	140	59	n=236	n=236	ADJ
njb-66	140	60	,	,	PUNCT
njb-66	140	61	84.89	84.89	NUM
njb-66	140	62	%	%	NOUN
njb-66	140	63	)	)	PUNCT
njb-66	140	64	,	,	PUNCT
njb-66	140	65	cloxacillin	cloxacillin	NOUN
njb-66	140	66	(	(	PUNCT
njb-66	140	67	n=180	n=180	PROPN
njb-66	140	68	,	,	PUNCT
njb-66	140	69	64.74	64.74	NUM
njb-66	140	70	%	%	NOUN
njb-66	140	71	)	)	PUNCT
njb-66	140	72	,	,	PUNCT
njb-66	140	73	cefoxitin	cefoxitin	NOUN
njb-66	140	74	(	(	PUNCT
njb-66	140	75	n=176	n=176	PROPN
njb-66	140	76	,	,	PUNCT
njb-66	140	77	63.30	63.30	NUM
njb-66	140	78	%	%	NOUN
njb-66	140	79	)	)	PUNCT
njb-66	140	80	,	,	PUNCT
njb-66	140	81	erythromycin	erythromycin	PROPN
njb-66	140	82	(	(	PUNCT
njb-66	140	83	n=166	n=166	PROPN
njb-66	140	84	,	,	PUNCT
njb-66	140	85	59.7	59.7	NUM
njb-66	140	86	%	%	NOUN
njb-66	140	87	)	)	PUNCT
njb-66	140	88	is	be	AUX
njb-66	140	89	as	as	SCONJ
njb-66	140	90	shown	show	VERB
njb-66	140	91	in	in	ADP
njb-66	140	92	table	table	NOUN
njb-66	140	93	6	6	NUM
njb-66	140	94	.	.	PUNCT
njb-66	141	1	antibiotic	antibiotic	ADJ
njb-66	141	2	susceptibility	susceptibility	NOUN
njb-66	141	3	pattern	pattern	NOUN
njb-66	141	4	of	of	ADP
njb-66	141	5	mrsa	mrsa	PROPN
njb-66	141	6	and	and	CCONJ
njb-66	141	7	mssa	mssa	ADJ
njb-66	141	8	isolates	isolate	VERB
njb-66	141	9	the	the	DET
njb-66	141	10	isolates	isolate	NOUN
njb-66	141	11	of	of	ADP
njb-66	141	12	s.	s.	PROPN
njb-66	141	13	aureus	aureus	PROPN
njb-66	141	14	were	be	AUX
njb-66	141	15	broadly	broadly	ADV
njb-66	141	16	categorized	categorize	VERB
njb-66	141	17	into	into	ADP
njb-66	141	18	two	two	NUM
njb-66	141	19	groups	group	NOUN
njb-66	141	20	:	:	PUNCT
njb-66	141	21	mrsa	mrsa	PROPN
njb-66	141	22	and	and	CCONJ
njb-66	141	23	mssa	mssa	PROPN
njb-66	141	24	.	.	PUNCT
njb-66	142	1	both	both	DET
njb-66	142	2	the	the	DET
njb-66	142	3	groups	group	NOUN
njb-66	142	4	of	of	ADP
njb-66	142	5	s.	s.	PROPN
njb-66	142	6	aureus	aureus	PROPN
njb-66	142	7	showed	show	VERB
njb-66	142	8	marked	marked	ADJ
njb-66	142	9	variation	variation	NOUN
njb-66	142	10	in	in	ADP
njb-66	142	11	the	the	DET
njb-66	142	12	sensitivity	sensitivity	NOUN
njb-66	142	13	pattern	pattern	NOUN
njb-66	142	14	against	against	ADP
njb-66	142	15	common	common	ADJ
njb-66	142	16	antibiotics	antibiotic	NOUN
njb-66	142	17	.	.	PUNCT
njb-66	143	1	it	it	PRON
njb-66	143	2	was	be	AUX
njb-66	143	3	observed	observe	VERB
njb-66	143	4	that	that	SCONJ
njb-66	143	5	,	,	PUNCT
njb-66	143	6	for	for	ADP
njb-66	143	7	mrsa	mrsa	PROPN
njb-66	143	8	,	,	PUNCT
njb-66	143	9	the	the	DET
njb-66	143	10	most	most	ADV
njb-66	143	11	effective	effective	ADJ
njb-66	143	12	antibiotic	antibiotic	NOUN
njb-66	143	13	was	be	AUX
njb-66	143	14	cefotaxime	cefotaxime	NOUN
njb-66	143	15	(	(	PUNCT
njb-66	143	16	n=83	n=83	PROPN
njb-66	143	17	,	,	PUNCT
njb-66	143	18	81.37	81.37	NUM
njb-66	143	19	%	%	NOUN
njb-66	143	20	)	)	PUNCT
njb-66	143	21	followed	follow	VERB
njb-66	143	22	by	by	ADP
njb-66	143	23	gentamicin	gentamicin	PROPN
njb-66	143	24	(	(	PUNCT
njb-66	143	25	n=81	n=81	PROPN
njb-66	143	26	,	,	PUNCT
njb-66	143	27	79.41	79.41	NUM
njb-66	143	28	%	%	NOUN
njb-66	143	29	)	)	PUNCT
njb-66	143	30	,	,	PUNCT
njb-66	143	31	amikacin	amikacin	PROPN
njb-66	143	32	(	(	PUNCT
njb-66	143	33	n=77	n=77	PROPN
njb-66	143	34	,	,	PUNCT
njb-66	143	35	75.49	75.49	NUM
njb-66	143	36	%	%	NOUN
njb-66	143	37	)	)	PUNCT
njb-66	143	38	,	,	PUNCT
njb-66	143	39	chloramphenicol	chloramphenicol	NOUN
njb-66	143	40	(	(	PUNCT
njb-66	143	41	n=76	n=76	PROPN
njb-66	143	42	,	,	PUNCT
njb-66	143	43	74.50	74.50	NUM
njb-66	143	44	%	%	NOUN
njb-66	143	45	)	)	PUNCT
njb-66	143	46	.	.	PUNCT
njb-66	144	1	similarly	similarly	ADV
njb-66	144	2	,	,	PUNCT
njb-66	144	3	highest	high	ADJ
njb-66	144	4	resistance	resistance	NOUN
njb-66	144	5	of	of	ADP
njb-66	144	6	mrsa	mrsa	PROPN
njb-66	144	7	was	be	AUX
njb-66	144	8	with	with	ADP
njb-66	144	9	penicillin	penicillin	PROPN
njb-66	144	10	(	(	PUNCT
njb-66	144	11	n=93	n=93	PROPN
njb-66	144	12	,	,	PUNCT
njb-66	144	13	91.17	91.17	NUM
njb-66	144	14	%	%	NOUN
njb-66	144	15	)	)	PUNCT
njb-66	144	16	followed	follow	VERB
njb-66	144	17	by	by	ADP
njb-66	144	18	ciprofloxacin	ciprofloxacin	NOUN
njb-66	144	19	(	(	PUNCT
njb-66	144	20	n=85	n=85	PROPN
njb-66	144	21	,	,	PUNCT
njb-66	144	22	83.3	83.3	NUM
njb-66	144	23	%	%	NOUN
njb-66	144	24	)	)	PUNCT
njb-66	144	25	and	and	CCONJ
njb-66	144	26	cotrimoxazole	cotrimoxazole	PROPN
njb-66	144	27	(	(	PUNCT
njb-66	144	28	n=77	n=77	PROPN
njb-66	144	29	,	,	PUNCT
njb-66	144	30	75.49	75.49	NUM
njb-66	144	31	%	%	NOUN
njb-66	144	32	)	)	PUNCT
njb-66	144	33	is	be	AUX
njb-66	144	34	in	in	ADP
njb-66	144	35	table	table	NOUN
njb-66	144	36	7	7	NUM
njb-66	144	37	.	.	PUNCT
njb-66	145	1	conclusion	conclusion	NOUN
njb-66	145	2	mrsa	mrsa	PROPN
njb-66	145	3	has	have	AUX
njb-66	145	4	acquired	acquire	VERB
njb-66	145	5	resistant	resistant	ADJ
njb-66	145	6	to	to	ADP
njb-66	145	7	previously	previously	ADV
njb-66	145	8	effective	effective	ADJ
njb-66	145	9	antimicrobials	antimicrobial	NOUN
njb-66	145	10	including	include	VERB
njb-66	145	11	in	in	ADP
njb-66	145	12	the	the	DET
njb-66	145	13	penicillin	penicillin	NOUN
njb-66	145	14	,	,	PUNCT
njb-66	145	15	methicillin	methicillin	NOUN
njb-66	145	16	in	in	ADP
njb-66	145	17	comparison	comparison	NOUN
njb-66	145	18	over	over	ADP
njb-66	145	19	the	the	DET
njb-66	145	20	past	past	ADJ
njb-66	145	21	50	50	NUM
njb-66	145	22	years	year	NOUN
njb-66	145	23	.	.	PUNCT
njb-66	146	1	in	in	ADP
njb-66	146	2	hospital	hospital	NOUN
njb-66	146	3	infected	infect	VERB
njb-66	146	4	patients	patient	NOUN
njb-66	146	5	and	and	CCONJ
njb-66	146	6	health	health	NOUN
njb-66	146	7	carriers	carrier	NOUN
njb-66	146	8	are	be	AUX
njb-66	146	9	also	also	ADV
njb-66	146	10	important	important	ADJ
njb-66	146	11	source	source	NOUN
njb-66	146	12	of	of	ADP
njb-66	146	13	nosocomial	nosocomial	ADJ
njb-66	146	14	s.	s.	PROPN
njb-66	146	15	aureus	aureus	PROPN
njb-66	147	1	[	[	PUNCT
njb-66	147	2	26	26	NUM
njb-66	147	3	,	,	PUNCT
njb-66	147	4	27	27	NUM
njb-66	147	5	]	]	PUNCT
njb-66	147	6	.	.	PUNCT
njb-66	148	1	out	out	ADP
njb-66	148	2	of	of	ADP
njb-66	148	3	278	278	NUM
njb-66	148	4	s.	s.	PROPN
njb-66	148	5	aureus	aureus	PROPN
njb-66	148	6	isolates	isolate	VERB
njb-66	148	7	isolated	isolate	VERB
njb-66	148	8	from	from	ADP
njb-66	148	9	pus	pus	NOUN
njb-66	148	10	samples	sample	NOUN
njb-66	148	11	,	,	PUNCT
njb-66	148	12	102	102	NUM
njb-66	148	13	(	(	PUNCT
njb-66	148	14	36.69	36.69	NUM
njb-66	148	15	%	%	NOUN
njb-66	148	16	)	)	PUNCT
njb-66	148	17	were	be	AUX
njb-66	148	18	methicillin	methicillin	NOUN
njb-66	148	19	-	-	PUNCT
njb-66	148	20	resistant	resistant	ADJ
njb-66	148	21	(	(	PUNCT
njb-66	148	22	mrsa	mrsa	PROPN
njb-66	148	23	)	)	PUNCT
njb-66	148	24	.	.	PUNCT
njb-66	149	1	from	from	ADP
njb-66	149	2	this	this	DET
njb-66	149	3	study	study	NOUN
njb-66	149	4	it	it	PRON
njb-66	149	5	can	can	AUX
njb-66	149	6	be	be	AUX
njb-66	149	7	concluded	conclude	VERB
njb-66	149	8	that	that	SCONJ
njb-66	149	9	mrsa	mrsa	PROPN
njb-66	149	10	infection	infection	NOUN
njb-66	149	11	in	in	ADP
njb-66	149	12	pediatric	pediatric	ADJ
njb-66	149	13	patients	patient	NOUN
njb-66	149	14	is	be	AUX
njb-66	149	15	still	still	ADV
njb-66	149	16	one	one	NUM
njb-66	149	17	of	of	ADP
njb-66	149	18	the	the	DET
njb-66	149	19	most	most	ADV
njb-66	149	20	threatening	threatening	ADJ
njb-66	149	21	infections	infection	NOUN
njb-66	149	22	in	in	ADP
njb-66	149	23	hospitals	hospital	NOUN
njb-66	149	24	of	of	ADP
njb-66	149	25	nepal	nepal	NOUN
njb-66	149	26	.	.	PUNCT
njb-66	150	1	the	the	DET
njb-66	150	2	rate	rate	NOUN
njb-66	150	3	of	of	ADP
njb-66	150	4	mrsa	mrsa	PROPN
njb-66	150	5	occurrence	occurrence	NOUN
njb-66	150	6	was	be	AUX
njb-66	150	7	found	find	VERB
njb-66	150	8	to	to	PART
njb-66	150	9	be	be	AUX
njb-66	150	10	higher	high	ADJ
njb-66	150	11	in	in	ADP
njb-66	150	12	inpatients	inpatient	NOUN
njb-66	150	13	compared	compare	VERB
njb-66	150	14	to	to	ADP
njb-66	150	15	outpatients	outpatient	NOUN
njb-66	150	16	and	and	CCONJ
njb-66	150	17	the	the	DET
njb-66	150	18	male	male	ADJ
njb-66	150	19	patient	patient	NOUN
njb-66	150	20	than	than	ADP
njb-66	150	21	female	female	ADJ
njb-66	150	22	patients	patient	NOUN
njb-66	150	23	.	.	PUNCT
njb-66	151	1	the	the	DET
njb-66	151	2	highest	high	ADJ
njb-66	151	3	number	number	NOUN
njb-66	151	4	of	of	ADP
njb-66	151	5	mrsa	mrsa	PROPN
njb-66	151	6	isolates	isolate	NOUN
njb-66	151	7	was	be	AUX
njb-66	151	8	found	find	VERB
njb-66	151	9	in	in	ADP
njb-66	151	10	1	1	NUM
njb-66	151	11	-	-	SYM
njb-66	151	12	5	5	NUM
njb-66	151	13	age	age	NOUN
njb-66	151	14	table	table	NOUN
njb-66	151	15	6	6	NUM
njb-66	151	16	.	.	PUNCT
njb-66	152	1	antibiotic	antibiotic	ADJ
njb-66	152	2	susceptibility	susceptibility	NOUN
njb-66	152	3	pattern	pattern	NOUN
njb-66	152	4	of	of	ADP
njb-66	152	5	s.	s.	PROPN
njb-66	152	6	aureus	aureus	PROPN
njb-66	152	7	isolates	isolate	VERB
njb-66	152	8	antibiotics	antibiotic	NOUN
njb-66	152	9	used	use	VERB
njb-66	152	10	total	total	NOUN
njb-66	152	11	no	no	PRON
njb-66	152	12	of	of	ADP
njb-66	152	13	s.	s.	PROPN
njb-66	152	14	aureus	aureus	PROPN
njb-66	152	15	isolates	isolate	VERB
njb-66	152	16	=	=	SYM
njb-66	152	17	278	278	NUM
njb-66	152	18	sensitive	sensitive	ADJ
njb-66	152	19	%	%	NOUN
njb-66	152	20	resistant	resistant	ADJ
njb-66	152	21	%	%	NOUN
njb-66	152	22	amikacin	amikacin	PROPN
njb-66	152	23	ciprofloxacin	ciprofloxacin	NOUN
njb-66	152	24	cotrimoxazole	cotrimoxazole	PROPN
njb-66	152	25	cefoxitin	cefoxitin	PROPN
njb-66	152	26	erythromycin	erythromycin	PROPN
njb-66	152	27	cloxacillin	cloxacillin	PROPN
njb-66	152	28	cefotaxime	cefotaxime	PROPN
njb-66	152	29	penicillin	penicillin	PROPN
njb-66	152	30	ofloxacin	ofloxacin	PROPN
njb-66	152	31	chloramphenicol	chloramphenicol	NOUN
njb-66	152	32	gentamicin	gentamicin	NOUN
njb-66	152	33	236	236	NUM
njb-66	152	34	100	100	NUM
njb-66	152	35	125	125	NUM
njb-66	152	36	176	176	NUM
njb-66	152	37	166	166	NUM
njb-66	152	38	180	180	NUM
njb-66	152	39	236	236	NUM
njb-66	152	40	28	28	NUM
njb-66	152	41	116	116	NUM
njb-66	152	42	255	255	NUM
njb-66	152	43	264	264	NUM
njb-66	152	44	84.89	84.89	NUM
njb-66	152	45	35.97	35.97	NUM
njb-66	152	46	44.96	44.96	NUM
njb-66	152	47	63.30	63.30	NUM
njb-66	152	48	59.7	59.7	NUM
njb-66	152	49	64.74	64.74	NUM
njb-66	152	50	84.89	84.89	NUM
njb-66	152	51	10.08	10.08	NUM
njb-66	152	52	41.72	41.72	NUM
njb-66	152	53	91.72	91.72	NUM
njb-66	152	54	94.96	94.96	NUM
njb-66	152	55	42	42	NUM
njb-66	152	56	178	178	NUM
njb-66	152	57	153	153	NUM
njb-66	152	58	102	102	NUM
njb-66	152	59	112	112	NUM
njb-66	152	60	98	98	NUM
njb-66	152	61	42	42	NUM
njb-66	152	62	250	250	NUM
njb-66	152	63	162	162	NUM
njb-66	152	64	23	23	NUM
njb-66	152	65	14	14	NUM
njb-66	152	66	15.10	15.10	NUM
njb-66	152	67	64.02	64.02	NUM
njb-66	152	68	55.04	55.04	NUM
njb-66	152	69	36.69	36.69	NUM
njb-66	152	70	40.28	40.28	NUM
njb-66	152	71	35.25	35.25	NUM
njb-66	152	72	15.10	15.10	NUM
njb-66	152	73	89.92	89.92	NUM
njb-66	152	74	58.27	58.27	NUM
njb-66	152	75	8.27	8.27	NUM
njb-66	152	76	5.03	5.03	NUM
njb-66	152	77	table	table	NOUN
njb-66	152	78	7	7	NUM
njb-66	152	79	.	.	PUNCT
njb-66	153	1	antibiotic	antibiotic	ADJ
njb-66	153	2	susceptibility	susceptibility	NOUN
njb-66	153	3	pattern	pattern	NOUN
njb-66	153	4	of	of	ADP
njb-66	153	5	mrsa	mrsa	PROPN
njb-66	153	6	and	and	CCONJ
njb-66	153	7	mssa	mssa	ADJ
njb-66	153	8	isolates	isolate	VERB
njb-66	153	9	antibiotics	antibiotic	NOUN
njb-66	153	10	used	use	VERB
njb-66	153	11	mssa(n=176	mssa(n=176	SYM
njb-66	153	12	)	)	PUNCT
njb-66	153	13	mrsa(n=102	mrsa(n=102	ADJ
njb-66	153	14	)	)	PUNCT
njb-66	153	15	sensitive	sensitive	ADJ
njb-66	153	16	%	%	NOUN
njb-66	153	17	resistant	resistant	ADJ
njb-66	153	18	%	%	NOUN
njb-66	153	19	sensitive	sensitive	ADJ
njb-66	153	20	%	%	NOUN
njb-66	153	21	resistant	resistant	ADJ
njb-66	153	22	%	%	NOUN
njb-66	153	23	amikacin	amikacin	PROPN
njb-66	153	24	163	163	NUM
njb-66	153	25	92.61	92.61	NUM
njb-66	153	26	13	13	NUM
njb-66	153	27	7.38	7.38	NUM
njb-66	153	28	77	77	NUM
njb-66	153	29	75.49	75.49	NUM
njb-66	153	30	25	25	NUM
njb-66	153	31	24.50	24.50	NUM
njb-66	153	32	ciprofloxacin	ciprofloxacin	NOUN
njb-66	153	33	91	91	NUM
njb-66	153	34	51.70	51.70	NUM
njb-66	153	35	85	85	NUM
njb-66	153	36	48.29	48.29	NUM
njb-66	153	37	17	17	NUM
njb-66	153	38	16.60	16.60	NUM
njb-66	153	39	85	85	NUM
njb-66	153	40	83.33	83.33	NUM
njb-66	153	41	cotrimoxazole	cotrimoxazole	PROPN
njb-66	153	42	93	93	NUM
njb-66	153	43	52.84	52.84	NUM
njb-66	153	44	83	83	NUM
njb-66	154	1	47.15	47.15	NUM
njb-66	154	2	25	25	NUM
njb-66	154	3	24.5	24.5	NUM
njb-66	154	4	77	77	NUM
njb-66	155	1	75.49	75.49	NUM
njb-66	155	2	cefoxitin	cefoxitin	NOUN
njb-66	155	3	176	176	NUM
njb-66	155	4	100.0	100.0	NUM
njb-66	155	5	0	0	NUM
njb-66	155	6	0.0	0.0	NUM
njb-66	155	7	0	0	NUM
njb-66	155	8	0.0	0.0	NUM
njb-66	155	9	102	102	NUM
njb-66	155	10	100.0	100.0	NUM
njb-66	155	11	erythromycin	erythromycin	PROPN
njb-66	155	12	114	114	NUM
njb-66	155	13	64.77	64.77	NUM
njb-66	155	14	62	62	NUM
njb-66	155	15	35.22	35.22	NUM
njb-66	155	16	59	59	NUM
njb-66	155	17	57.84	57.84	NUM
njb-66	155	18	43	43	NUM
njb-66	155	19	42.15	42.15	NUM
njb-66	155	20	cloxacillin	cloxacillin	NOUN
njb-66	155	21	151	151	NUM
njb-66	155	22	85.79	85.79	NUM
njb-66	155	23	25	25	NUM
njb-66	155	24	14.20	14.20	NUM
njb-66	155	25	76	76	NUM
njb-66	155	26	74.50	74.50	NUM
njb-66	155	27	26	26	NUM
njb-66	155	28	25.49	25.49	NUM
njb-66	155	29	cefotaxime	cefotaxime	NOUN
njb-66	155	30	161	161	NUM
njb-66	155	31	91.47	91.47	NUM
njb-66	155	32	15	15	NUM
njb-66	155	33	8.52	8.52	NUM
njb-66	155	34	83	83	NUM
njb-66	155	35	81.37	81.37	NUM
njb-66	155	36	19	19	NUM
njb-66	155	37	18.62	18.62	NUM
njb-66	155	38	penicillin	penicillin	NOUN
njb-66	155	39	35	35	NUM
njb-66	155	40	19.88	19.88	NUM
njb-66	155	41	141	141	NUM
njb-66	155	42	80.11	80.11	NUM
njb-66	155	43	9	9	NUM
njb-66	155	44	8.82	8.82	NUM
njb-66	155	45	93	93	NUM
njb-66	155	46	91.17	91.17	NUM
njb-66	155	47	ofloxacin	ofloxacin	NOUN
njb-66	155	48	88	88	NUM
njb-66	155	49	50.00	50.00	NUM
njb-66	155	50	88	88	NUM
njb-66	155	51	50.00	50.00	NUM
njb-66	155	52	26	26	NUM
njb-66	155	53	25.49	25.49	NUM
njb-66	155	54	76	76	NUM
njb-66	155	55	74.50	74.50	NUM
njb-66	155	56	chloramphenicol	chloramphenicol	NOUN
njb-66	155	57	165	165	NUM
njb-66	155	58	93.75	93.75	NUM
njb-66	155	59	11	11	NUM
njb-66	155	60	6.25	6.25	NUM
njb-66	155	61	76	76	NUM
njb-66	155	62	74.50	74.50	NUM
njb-66	155	63	26	26	NUM
njb-66	155	64	25.49	25.49	NUM
njb-66	155	65	gentamicin	gentamicin	NOUN
njb-66	155	66	167	167	NUM
njb-66	155	67	94.88	94.88	NUM
njb-66	155	68	9	9	NUM
njb-66	155	69	5.11	5.11	NUM
njb-66	155	70	81	81	NUM
njb-66	155	71	79.41	79.41	NUM
njb-66	155	72	21	21	NUM
njb-66	155	73	20.59	20.59	NUM
njb-66	155	74	nepal	nepal	ADJ
njb-66	155	75	journal	journal	NOUN
njb-66	155	76	of	of	ADP
njb-66	155	77	biotechnology	biotechnology	NOUN
njb-66	155	78	.	.	PUNCT
njb-66	156	1	d	d	X
njb-66	156	2	e	e	PROPN
njb-66	156	3	c	c	PROPN
njb-66	156	4	.	.	PUNCT
njb-66	157	1	2	2	NUM
njb-66	157	2	0	0	NUM
njb-66	157	3	1	1	NUM
njb-66	157	4	9	9	NUM
njb-66	157	5	vol	vol	NOUN
njb-66	157	6	.	.	PUNCT
njb-66	158	1	7	7	NUM
njb-66	158	2	,	,	PUNCT
njb-66	158	3	no	no	NOUN
njb-66	158	4	.	.	NOUN
njb-66	158	5	1	1	NUM
njb-66	158	6	:	:	SYM
njb-66	158	7	82	82	NUM
njb-66	158	8	-	-	SYM
njb-66	158	9	89	89	NUM
njb-66	158	10	bhandari	bhandari	PROPN
njb-66	158	11	et	et	PROPN
njb-66	158	12	al	al	PROPN
njb-66	158	13	.	.	PROPN
njb-66	158	14	2019	2019	NUM
njb-66	159	1	©	©	ADP
njb-66	159	2	njb	njb	PROPN
njb-66	159	3	,	,	PUNCT
njb-66	159	4	biotechnology	biotechnology	NOUN
njb-66	159	5	society	society	NOUN
njb-66	159	6	of	of	ADP
njb-66	159	7	nepal	nepal	ADJ
njb-66	159	8	88	88	NUM
njb-66	159	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-66	159	10	.	.	PUNCT
njb-66	160	1	group	group	NOUN
njb-66	160	2	patients	patient	NOUN
njb-66	160	3	.	.	PUNCT
njb-66	161	1	the	the	DET
njb-66	161	2	most	most	ADV
njb-66	161	3	effective	effective	ADJ
njb-66	161	4	antibiotic	antibiotic	NOUN
njb-66	161	5	against	against	ADP
njb-66	161	6	mrsa	mrsa	PROPN
njb-66	161	7	in	in	ADP
njb-66	161	8	pediatric	pediatric	ADJ
njb-66	161	9	patients	patient	NOUN
njb-66	161	10	was	be	AUX
njb-66	161	11	found	find	VERB
njb-66	161	12	to	to	PART
njb-66	161	13	be	be	AUX
njb-66	161	14	gentamicin	gentamicin	VERB
njb-66	161	15	.	.	PUNCT
njb-66	162	1	similarly	similarly	ADV
njb-66	162	2	,	,	PUNCT
njb-66	162	3	chloramphenicol	chloramphenicol	NOUN
njb-66	162	4	,	,	PUNCT
njb-66	162	5	cefotaxime	cefotaxime	NOUN
njb-66	162	6	were	be	AUX
njb-66	162	7	also	also	ADV
njb-66	162	8	found	find	VERB
njb-66	162	9	to	to	PART
njb-66	162	10	be	be	AUX
njb-66	162	11	effective	effective	ADJ
njb-66	162	12	against	against	ADP
njb-66	162	13	mrsa	mrsa	PROPN
njb-66	162	14	infections	infection	NOUN
njb-66	162	15	whereas	whereas	SCONJ
njb-66	162	16	penicillin	penicillin	PROPN
njb-66	162	17	was	be	AUX
njb-66	162	18	found	find	VERB
njb-66	162	19	to	to	PART
njb-66	162	20	be	be	AUX
njb-66	162	21	the	the	DET
njb-66	162	22	least	least	ADJ
njb-66	162	23	effective	effective	ADJ
njb-66	162	24	antibiotic	antibiotic	NOUN
njb-66	162	25	to	to	PART
njb-66	162	26	treat	treat	VERB
njb-66	162	27	mrsa	mrsa	PROPN
njb-66	162	28	infections	infection	NOUN
njb-66	162	29	where	where	SCONJ
njb-66	162	30	89.92	89.92	NUM
njb-66	162	31	%	%	NOUN
njb-66	162	32	of	of	ADP
njb-66	162	33	s.	s.	PROPN
njb-66	162	34	aureus	aureus	PROPN
njb-66	162	35	isolates	isolate	NOUN
njb-66	162	36	showed	show	VERB
njb-66	162	37	resistance	resistance	NOUN
njb-66	162	38	towards	towards	ADP
njb-66	162	39	this	this	DET
njb-66	162	40	antibiotic	antibiotic	NOUN
njb-66	162	41	.	.	PUNCT
njb-66	163	1	acknowledgements	acknowledgement	NOUN
njb-66	163	2	authors	author	NOUN
njb-66	163	3	would	would	AUX
njb-66	163	4	like	like	VERB
njb-66	163	5	to	to	PART
njb-66	163	6	thank	thank	VERB
njb-66	163	7	kanti	kanti	PROPN
njb-66	163	8	children	child	NOUN
njb-66	163	9	's	's	PART
njb-66	163	10	hospital	hospital	NOUN
njb-66	163	11	(	(	PUNCT
njb-66	163	12	kch	kch	PROPN
njb-66	163	13	)	)	PUNCT
njb-66	163	14	,	,	PUNCT
njb-66	163	15	maharajgunj	maharajgunj	PROPN
njb-66	163	16	,	,	PUNCT
njb-66	163	17	kathmandu	kathmandu	NOUN
njb-66	163	18	,	,	PUNCT
njb-66	163	19	nepal	nepal	ADJ
njb-66	163	20	for	for	ADP
njb-66	163	21	laboratory	laboratory	NOUN
njb-66	163	22	facilities	facility	NOUN
njb-66	163	23	.	.	PUNCT
njb-66	164	1	thanks	thank	NOUN
njb-66	164	2	also	also	ADV
njb-66	164	3	go	go	VERB
njb-66	164	4	to	to	ADP
njb-66	164	5	department	department	NOUN
njb-66	164	6	of	of	ADP
njb-66	164	7	microbiology	microbiology	NOUN
njb-66	164	8	and	and	CCONJ
njb-66	164	9	department	department	NOUN
njb-66	164	10	of	of	ADP
njb-66	164	11	chemistry	chemistry	NOUN
njb-66	164	12	,	,	PUNCT
njb-66	164	13	tri	tri	ADJ
njb-66	164	14	-	-	ADJ
njb-66	164	15	chandra	chandra	ADJ
njb-66	164	16	multiple	multiple	ADJ
njb-66	164	17	campus	campus	NOUN
njb-66	164	18	,	,	PUNCT
njb-66	164	19	tribhuvan	tribhuvan	PROPN
njb-66	164	20	university	university	PROPN
njb-66	164	21	,	,	PUNCT
njb-66	164	22	kathmandu	kathmandu	PROPN
njb-66	164	23	,	,	PUNCT
njb-66	164	24	nepal	nepal	ADJ
njb-66	164	25	for	for	ADP
njb-66	164	26	a	a	DET
njb-66	164	27	technical	technical	ADJ
njb-66	164	28	support	support	NOUN
njb-66	164	29	.	.	PUNCT
njb-66	165	1	references	reference	NOUN
njb-66	165	2	1	1	NUM
njb-66	165	3	.	.	PUNCT
njb-66	165	4	shittu	shittu	PROPN
njb-66	165	5	ao	ao	PROPN
njb-66	165	6	,	,	PUNCT
njb-66	165	7	jonson	jonson	PROPN
njb-66	165	8	l	l	PROPN
njb-66	165	9	:	:	PUNCT
njb-66	165	10	antimicrobial	antimicrobial	ADJ
njb-66	165	11	susceptibility	susceptibility	NOUN
njb-66	165	12	patterns	pattern	NOUN
njb-66	165	13	and	and	CCONJ
njb-66	165	14	characterization	characterization	NOUN
njb-66	165	15	of	of	ADP
njb-66	165	16	clinical	clinical	ADJ
njb-66	165	17	isolates	isolate	NOUN
njb-66	165	18	of	of	ADP
njb-66	165	19	staphylococcus	staphylococcus	NOUN
njb-66	165	20	aureus	aureus	NOUN
njb-66	165	21	.	.	PUNCT
njb-66	166	1	bmc	bmc	PROPN
njb-66	166	2	infect	infect	PROPN
njb-66	166	3	dis	dis	PROPN
njb-66	166	4	6	6	NUM
njb-66	166	5	.	.	SYM
njb-66	166	6	2006	2006	NUM
njb-66	166	7	,	,	PUNCT
njb-66	166	8	125	125	NUM
njb-66	166	9	:	:	PUNCT
njb-66	166	10	2334	2334	NUM
njb-66	166	11	-	-	SYM
njb-66	166	12	2336	2336	NUM
njb-66	166	13	.	.	PUNCT
njb-66	167	1	2	2	X
njb-66	167	2	.	.	X
njb-66	167	3	rehm	rehm	PROPN
njb-66	167	4	sj	sj	PROPN
njb-66	167	5	:	:	PUNCT
njb-66	167	6	staphylococcus	staphylococcus	NOUN
njb-66	167	7	aureus	aureus	NOUN
njb-66	167	8	:	:	PUNCT
njb-66	167	9	the	the	DET
njb-66	167	10	new	new	ADJ
njb-66	167	11	adventures	adventure	NOUN
njb-66	167	12	of	of	ADP
njb-66	167	13	a	a	DET
njb-66	167	14	legendary	legendary	ADJ
njb-66	167	15	pathogen	pathogen	PROPN
njb-66	167	16	.	.	PUNCT
njb-66	168	1	clev	clev	PROPN
njb-66	168	2	clin	clin	PROPN
njb-66	168	3	j	j	PROPN
njb-66	168	4	med	med	PROPN
njb-66	168	5	.	.	PROPN
njb-66	168	6	2008	2008	NUM
njb-66	168	7	75(3	75(3	NUM
njb-66	168	8	):	):	PUNCT
njb-66	168	9	177	177	NUM
njb-66	168	10	-	-	SYM
njb-66	168	11	180	180	NUM
njb-66	168	12	,	,	PUNCT
njb-66	168	13	183	183	NUM
njb-66	168	14	-	-	SYM
njb-66	168	15	186	186	NUM
njb-66	168	16	,	,	PUNCT
njb-66	168	17	190	190	NUM
njb-66	168	18	-	-	SYM
njb-66	168	19	192	192	NUM
njb-66	168	20	.	.	PUNCT
njb-66	169	1	3	3	X
njb-66	169	2	.	.	PROPN
njb-66	169	3	mallick	mallick	PROPN
njb-66	169	4	sk	sk	PROPN
njb-66	169	5	,	,	PUNCT
njb-66	169	6	basak	basak	PROPN
njb-66	169	7	s	s	PROPN
njb-66	169	8	:	:	PUNCT
njb-66	169	9	mrsa	mrsa	PROPN
njb-66	169	10	-	-	PUNCT
njb-66	169	11	too	too	ADV
njb-66	169	12	many	many	ADJ
njb-66	169	13	hurdle	hurdle	NOUN
njb-66	169	14	to	to	PART
njb-66	169	15	overcome	overcome	VERB
njb-66	169	16	:	:	PUNCT
njb-66	169	17	a	a	DET
njb-66	169	18	study	study	NOUN
njb-66	169	19	from	from	ADP
njb-66	169	20	central	central	PROPN
njb-66	169	21	india	india	PROPN
njb-66	169	22	.	.	PUNCT
njb-66	170	1	trop	trop	PROPN
njb-66	170	2	doct	doct	PROPN
njb-66	170	3	.	.	PROPN
njb-66	170	4	2010	2010	NUM
njb-66	170	5	40(2	40(2	NUM
njb-66	170	6	):	):	PUNCT
njb-66	170	7	108	108	NUM
njb-66	170	8	-	-	SYM
njb-66	170	9	110	110	NUM
njb-66	170	10	.	.	NUM
njb-66	170	11	4	4	NUM
njb-66	170	12	.	.	X
njb-66	170	13	foster	foster	PROPN
njb-66	170	14	tj	tj	PROPN
njb-66	170	15	:	:	PUNCT
njb-66	170	16	colonization	colonization	NOUN
njb-66	170	17	and	and	CCONJ
njb-66	170	18	infection	infection	NOUN
njb-66	170	19	of	of	ADP
njb-66	170	20	the	the	DET
njb-66	170	21	human	human	ADJ
njb-66	170	22	host	host	NOUN
njb-66	170	23	by	by	ADP
njb-66	170	24	staphylococci	staphylococci	PROPN
njb-66	170	25	:	:	PUNCT
njb-66	170	26	adhesion	adhesion	NOUN
njb-66	170	27	,	,	PUNCT
njb-66	170	28	survival	survival	NOUN
njb-66	170	29	and	and	CCONJ
njb-66	170	30	immune	immune	ADJ
njb-66	170	31	vasion	vasion	NOUN
njb-66	170	32	.	.	PUNCT
njb-66	171	1	vet	vet	NOUN
njb-66	171	2	dermatol	dermatol	NOUN
njb-66	171	3	.	.	PUNCT
njb-66	172	1	2009	2009	NUM
njb-66	172	2	20(4	20(4	NUM
njb-66	172	3	-	-	SYM
njb-66	172	4	5	5	NUM
njb-66	172	5	):	):	PUNCT
njb-66	172	6	456–470	456–470	NUM
njb-66	172	7	.	.	NOUN
njb-66	172	8	5	5	NUM
njb-66	172	9	.	.	PUNCT
njb-66	172	10	otto	otto	PROPN
njb-66	172	11	m	m	PROPN
njb-66	172	12	:	:	PUNCT
njb-66	172	13	mrsa	mrsa	PROPN
njb-66	172	14	virulence	virulence	PROPN
njb-66	172	15	and	and	CCONJ
njb-66	172	16	spread	spread	NOUN
njb-66	172	17	.	.	PUNCT
njb-66	173	1	cell	cell	NOUN
njb-66	173	2	microbiol	microbiol	PROPN
njb-66	173	3	.	.	PUNCT
njb-66	174	1	2012	2012	NUM
njb-66	174	2	,	,	PUNCT
njb-66	174	3	14(10	14(10	NUM
njb-66	174	4	):	):	PUNCT
njb-66	174	5	1513–1521	1513–1521	NUM
njb-66	174	6	.	.	PUNCT
njb-66	174	7	6	6	NUM
njb-66	174	8	.	.	PUNCT
njb-66	175	1	chambers	chambers	PROPN
njb-66	175	2	hf	hf	PROPN
njb-66	175	3	:	:	PUNCT
njb-66	175	4	the	the	DET
njb-66	175	5	changing	change	VERB
njb-66	175	6	epidemiology	epidemiology	NOUN
njb-66	175	7	of	of	ADP
njb-66	175	8	staphylococcus	staphylococcus	NOUN
njb-66	175	9	aureus	aureus	NOUN
njb-66	175	10	.	.	PUNCT
njb-66	176	1	emerg	emerg	VERB
njb-66	176	2	infect	infect	PROPN
njb-66	176	3	dis	dis	PROPN
njb-66	176	4	.	.	PROPN
njb-66	176	5	2001	2001	NUM
njb-66	176	6	7(2	7(2	NUM
njb-66	176	7	):	):	PUNCT
njb-66	176	8	178	178	NUM
njb-66	176	9	-	-	SYM
njb-66	176	10	182	182	NUM
njb-66	176	11	.	.	SYM
njb-66	176	12	7	7	NUM
njb-66	176	13	.	.	X
njb-66	176	14	ray	ray	PROPN
njb-66	176	15	p	p	PROPN
njb-66	176	16	,	,	PUNCT
njb-66	176	17	gautam	gautam	PROPN
njb-66	176	18	v	v	PROPN
njb-66	176	19	,	,	PUNCT
njb-66	176	20	singh	singh	PROPN
njb-66	176	21	r	r	PROPN
njb-66	176	22	:	:	PUNCT
njb-66	176	23	methicillin	methicillin	NOUN
njb-66	176	24	-	-	PUNCT
njb-66	176	25	resistant	resistant	ADJ
njb-66	176	26	staphylococcus	staphylococcus	NOUN
njb-66	176	27	aureus	aureus	NOUN
njb-66	176	28	(	(	PUNCT
njb-66	176	29	mrsa	mrsa	PROPN
njb-66	176	30	)	)	PUNCT
njb-66	176	31	in	in	ADP
njb-66	176	32	developing	develop	VERB
njb-66	176	33	and	and	CCONJ
njb-66	176	34	developed	developed	ADJ
njb-66	176	35	countries	country	NOUN
njb-66	176	36	:	:	PUNCT
njb-66	176	37	implications	implication	NOUN
njb-66	176	38	and	and	CCONJ
njb-66	176	39	solutions	solution	NOUN
njb-66	176	40	.	.	PUNCT
njb-66	177	1	world	world	NOUN
njb-66	177	2	health	health	NOUN
njb-66	177	3	organization	organization	NOUN
njb-66	177	4	(	(	PUNCT
njb-66	177	5	who	who	PRON
njb-66	177	6	)	)	PUNCT
njb-66	177	7	,	,	PUNCT
njb-66	177	8	special	special	ADJ
njb-66	177	9	issue	issue	NOUN
njb-66	177	10	on	on	ADP
njb-66	177	11	antimicrobial	antimicrobial	ADJ
njb-66	177	12	resistance	resistance	NOUN
njb-66	177	13	in	in	ADP
njb-66	177	14	southeast	southeast	PROPN
njb-66	177	15	asia	asia	PROPN
njb-66	177	16	.	.	PUNCT
njb-66	178	1	regional	regional	ADJ
njb-66	178	2	health	health	NOUN
njb-66	178	3	forum	forum	PROPN
njb-66	178	4	(	(	PUNCT
njb-66	178	5	who	who	PRON
njb-66	178	6	south	south	NOUN
njb-66	178	7	-	-	PUNCT
njb-66	178	8	east	east	PROPN
njb-66	178	9	asia	asia	PROPN
njb-66	178	10	region	region	PROPN
njb-66	178	11	)	)	PUNCT
njb-66	178	12	2011	2011	NUM
njb-66	178	13	15	15	NUM
njb-66	178	14	.	.	NUM
njb-66	178	15	8	8	NUM
njb-66	178	16	.	.	PUNCT
njb-66	179	1	sanford	sanford	PROPN
njb-66	179	2	md	md	PROPN
njb-66	179	3	,	,	PUNCT
njb-66	179	4	widmer	widmer	PROPN
njb-66	179	5	af	af	PROPN
njb-66	179	6	,	,	PUNCT
njb-66	179	7	bale	bale	PROPN
njb-66	179	8	mj	mj	PROPN
njb-66	179	9	,	,	PUNCT
njb-66	179	10	jones	jones	PROPN
njb-66	179	11	rn	rn	PROPN
njb-66	179	12	,	,	PUNCT
njb-66	179	13	wenzel	wenzel	PROPN
njb-66	179	14	rp	rp	PROPN
njb-66	179	15	:	:	PUNCT
njb-66	179	16	efficient	efficient	ADJ
njb-66	179	17	detection	detection	NOUN
njb-66	179	18	and	and	CCONJ
njb-66	179	19	long	long	ADJ
njb-66	179	20	-	-	PUNCT
njb-66	179	21	term	term	NOUN
njb-66	179	22	persistence	persistence	NOUN
njb-66	179	23	of	of	ADP
njb-66	179	24	the	the	DET
njb-66	179	25	carriage	carriage	NOUN
njb-66	179	26	of	of	ADP
njb-66	179	27	methicillinresistant	methicillinresistant	ADJ
njb-66	179	28	staphylococcus	staphylococcus	NOUN
njb-66	179	29	aureus	aureus	NOUN
njb-66	179	30	.	.	PUNCT
njb-66	180	1	clin	clin	PROPN
njb-66	180	2	infect	infect	PROPN
njb-66	180	3	dis	dis	PROPN
njb-66	180	4	.	.	PROPN
njb-66	180	5	1994	1994	NUM
njb-66	180	6	19	19	NUM
njb-66	180	7	:	:	PUNCT
njb-66	180	8	1123	1123	NUM
njb-66	180	9	-	-	SYM
njb-66	180	10	1128	1128	NUM
njb-66	180	11	.	.	PUNCT
njb-66	181	1	9	9	NUM
njb-66	181	2	.	.	PUNCT
njb-66	181	3	cesur	cesur	PROPN
njb-66	181	4	s	s	PROPN
njb-66	181	5	,	,	PUNCT
njb-66	181	6	cokca	cokca	PROPN
njb-66	181	7	f	f	PROPN
njb-66	181	8	:	:	PUNCT
njb-66	181	9	nasal	nasal	PROPN
njb-66	181	10	carriage	carriage	NOUN
njb-66	181	11	of	of	ADP
njb-66	181	12	methicillinresistant	methicillinresistant	ADJ
njb-66	181	13	staphylococcus	staphylococcus	NOUN
njb-66	181	14	aureus	aureus	NOUN
njb-66	181	15	among	among	ADP
njb-66	181	16	hospital	hospital	NOUN
njb-66	181	17	staff	staff	NOUN
njb-66	181	18	and	and	CCONJ
njb-66	181	19	outpatients	outpatient	NOUN
njb-66	181	20	.	.	PUNCT
njb-66	182	1	infect	infect	VERB
njb-66	182	2	control	control	PROPN
njb-66	182	3	hosp	hosp	PROPN
njb-66	182	4	epidemiol	epidemiol	PROPN
njb-66	182	5	.	.	PUNCT
njb-66	183	1	2004	2004	NUM
njb-66	183	2	25	25	NUM
njb-66	183	3	:	:	PUNCT
njb-66	183	4	169	169	NUM
njb-66	183	5	-	-	SYM
njb-66	183	6	171	171	NUM
njb-66	183	7	.	.	NUM
njb-66	183	8	10	10	NUM
njb-66	183	9	.	.	PUNCT
njb-66	183	10	creechs	creechs	PROPN
njb-66	183	11	cb	cb	PROPN
njb-66	183	12	,	,	PUNCT
njb-66	183	13	kernodle	kernodle	PROPN
njb-66	183	14	ds	ds	PROPN
njb-66	183	15	,	,	PUNCT
njb-66	183	16	alsentzer	alsentzer	PROPN
njb-66	183	17	a	a	PROPN
njb-66	183	18	,	,	PUNCT
njb-66	183	19	wilson	wilson	PROPN
njb-66	183	20	c	c	PROPN
njb-66	183	21	,	,	PUNCT
njb-66	183	22	edwards	edwards	PROPN
njb-66	183	23	km	km	PROPN
njb-66	183	24	:	:	PUNCT
njb-66	183	25	increasing	increase	VERB
njb-66	183	26	rates	rate	NOUN
njb-66	183	27	of	of	ADP
njb-66	183	28	nasal	nasal	ADJ
njb-66	183	29	carriage	carriage	NOUN
njb-66	183	30	of	of	ADP
njb-66	183	31	methicillin	methicillin	NOUN
njb-66	183	32	-	-	PUNCT
njb-66	183	33	resistant	resistant	ADJ
njb-66	183	34	staphylococcus	staphylococcus	NOUN
njb-66	183	35	aureus	aureus	NOUN
njb-66	183	36	in	in	ADP
njb-66	183	37	healthy	healthy	ADJ
njb-66	183	38	children	child	NOUN
njb-66	183	39	.	.	PUNCT
njb-66	184	1	pediatr	pediatr	PROPN
njb-66	184	2	infect	infect	VERB
njb-66	184	3	dis	dis	PROPN
njb-66	184	4	j.	j.	PROPN
njb-66	184	5	2005	2005	PROPN
njb-66	184	6	24	24	NUM
njb-66	184	7	(	(	PUNCT
njb-66	184	8	7	7	NUM
njb-66	184	9	):	):	PUNCT
njb-66	184	10	617	617	NUM
njb-66	184	11	-	-	SYM
njb-66	184	12	621	621	NUM
njb-66	184	13	.	.	PROPN
njb-66	184	14	11	11	NUM
njb-66	184	15	.	.	PUNCT
njb-66	185	1	eveillard	eveillard	PROPN
njb-66	185	2	m	m	PROPN
njb-66	185	3	,	,	PUNCT
njb-66	185	4	martin	martin	PROPN
njb-66	185	5	y	y	PROPN
njb-66	185	6	,	,	PUNCT
njb-66	185	7	hidri	hidri	PROPN
njb-66	185	8	n	n	NOUN
njb-66	185	9	,	,	PUNCT
njb-66	185	10	boussougant	boussougant	PROPN
njb-66	185	11	y	y	PROPN
njb-66	185	12	,	,	PUNCT
njb-66	185	13	joly	joly	PROPN
njb-66	185	14	gm	gm	PROPN
njb-66	185	15	:	:	PUNCT
njb-66	185	16	carriage	carriage	NOUN
njb-66	185	17	of	of	ADP
njb-66	185	18	methicillin	methicillin	NOUN
njb-66	185	19	-	-	PUNCT
njb-66	185	20	resistant	resistant	ADJ
njb-66	185	21	staphylococcus	staphylococcus	NOUN
njb-66	185	22	aureus	aureus	NOUN
njb-66	185	23	among	among	ADP
njb-66	185	24	hospital	hospital	NOUN
njb-66	185	25	employees	employee	NOUN
njb-66	185	26	:	:	PUNCT
njb-66	185	27	prevalence	prevalence	NOUN
njb-66	185	28	,	,	PUNCT
njb-66	185	29	duration	duration	NOUN
njb-66	185	30	,	,	PUNCT
njb-66	185	31	and	and	CCONJ
njb-66	185	32	transmission	transmission	NOUN
njb-66	185	33	to	to	ADP
njb-66	185	34	households	household	NOUN
njb-66	185	35	.	.	PUNCT
njb-66	186	1	infect	infect	ADJ
njb-66	186	2	control	control	PROPN
njb-66	186	3	hosp	hosp	PROPN
njb-66	186	4	epidemiol	epidemiol	PROPN
njb-66	186	5	.	.	PUNCT
njb-66	187	1	2004	2004	NUM
njb-66	187	2	25	25	NUM
njb-66	187	3	(	(	PUNCT
njb-66	187	4	2	2	NUM
njb-66	187	5	):	):	PUNCT
njb-66	187	6	114	114	NUM
njb-66	187	7	-	-	SYM
njb-66	187	8	120	120	NUM
njb-66	187	9	.	.	NOUN
njb-66	187	10	12	12	NUM
njb-66	187	11	.	.	PUNCT
njb-66	188	1	kenner	kenner	PROPN
njb-66	188	2	j	j	PROPN
njb-66	188	3	,	,	PUNCT
njb-66	188	4	connor	connor	PROPN
njb-66	188	5	ot	ot	PROPN
njb-66	188	6	,	,	PUNCT
njb-66	188	7	piantanida	piantanida	PROPN
njb-66	188	8	n	n	PROPN
njb-66	188	9	,	,	PUNCT
njb-66	188	10	fishbain	fishbain	PROPN
njb-66	188	11	j	j	PROPN
njb-66	188	12	,	,	PUNCT
njb-66	188	13	eberly	eberly	PROPN
njb-66	188	14	b	b	PROPN
njb-66	188	15	,	,	PUNCT
njb-66	188	16	viscount	viscount	PROPN
njb-66	188	17	h	h	PROPN
njb-66	188	18	,	,	PUNCT
njb-66	188	19	et	et	PROPN
njb-66	188	20	al	al	PROPN
njb-66	188	21	:	:	PUNCT
njb-66	188	22	rates	rate	NOUN
njb-66	188	23	of	of	ADP
njb-66	188	24	carriage	carriage	NOUN
njb-66	188	25	of	of	ADP
njb-66	188	26	methicillin	methicillin	NOUN
njb-66	188	27	-	-	PUNCT
njb-66	188	28	resistant	resistant	ADJ
njb-66	188	29	and	and	CCONJ
njb-66	188	30	methicillinsusceptible	methicillinsusceptible	ADJ
njb-66	188	31	staphylococcus	staphylococcus	NOUN
njb-66	188	32	aureus	aureus	PROPN
njb-66	188	33	in	in	ADP
njb-66	188	34	an	an	DET
njb-66	188	35	outpatient	outpatient	NOUN
njb-66	188	36	population	population	NOUN
njb-66	188	37	.	.	PUNCT
njb-66	189	1	infect	infect	VERB
njb-66	189	2	control	control	PROPN
njb-66	189	3	hosp	hosp	PROPN
njb-66	189	4	epidemiol	epidemiol	PROPN
njb-66	189	5	.	.	PUNCT
njb-66	190	1	2003	2003	NUM
njb-66	190	2	24	24	NUM
njb-66	190	3	(	(	PUNCT
njb-66	190	4	6	6	NUM
njb-66	190	5	):	):	SYM
njb-66	190	6	439–444	439–444	NUM
njb-66	190	7	.	.	PUNCT
njb-66	190	8	13	13	NUM
njb-66	190	9	.	.	PUNCT
njb-66	190	10	pokharel	pokharel	PROPN
njb-66	190	11	j	j	PROPN
njb-66	190	12	,	,	PUNCT
njb-66	190	13	rawal	rawal	PROPN
njb-66	190	14	k	k	X
njb-66	190	15	:	:	PUNCT
njb-66	190	16	bacteriological	bacteriological	ADJ
njb-66	190	17	study	study	NOUN
njb-66	190	18	at	at	ADP
njb-66	190	19	t.u	t.u	PROPN
njb-66	190	20	teaching	teaching	PROPN
njb-66	190	21	hospital	hospital	PROPN
njb-66	190	22	,	,	PUNCT
njb-66	190	23	kathmandu	kathmandu	PROPN
njb-66	190	24	.	.	PUNCT
njb-66	191	1	nepal	nepal	PROPN
njb-66	191	2	j	j	PROPN
njb-66	191	3	institute	institute	PROPN
njb-66	191	4	med	me	VERB
njb-66	191	5	.	.	PROPN
njb-66	191	6	1993	1993	NUM
njb-66	191	7	,	,	PUNCT
njb-66	191	8	15	15	NUM
njb-66	191	9	:	:	PUNCT
njb-66	191	10	217	217	NUM
njb-66	191	11	-	-	SYM
njb-66	191	12	221	221	NUM
njb-66	191	13	.	.	NOUN
njb-66	191	14	14	14	NUM
njb-66	191	15	.	.	PUNCT
njb-66	192	1	lamichhane	lamichhane	PROPN
njb-66	192	2	r	r	PROPN
njb-66	192	3	,	,	PUNCT
njb-66	192	4	adhikari	adhikari	PROPN
njb-66	192	5	rp	rp	PROPN
njb-66	192	6	,	,	PUNCT
njb-66	192	7	sherchand	sherchand	PROPN
njb-66	192	8	jb	jb	PROPN
njb-66	192	9	:	:	PUNCT
njb-66	192	10	study	study	NOUN
njb-66	192	11	of	of	ADP
njb-66	192	12	methicillin	methicillin	NOUN
njb-66	192	13	-	-	PUNCT
njb-66	192	14	resistance	resistance	NOUN
njb-66	192	15	staphylococcus	staphylococcus	NOUN
njb-66	192	16	aureus	aureus	PROPN
njb-66	192	17	(	(	PUNCT
njb-66	192	18	mrsa	mrsa	PROPN
njb-66	192	19	)	)	PUNCT
njb-66	192	20	isolated	isolate	VERB
njb-66	192	21	from	from	ADP
njb-66	192	22	different	different	ADJ
njb-66	192	23	clinical	clinical	ADJ
njb-66	192	24	samples	sample	NOUN
njb-66	192	25	.	.	PUNCT
njb-66	193	1	a	a	DET
njb-66	193	2	dissertation	dissertation	NOUN
njb-66	193	3	submitted	submit	VERB
njb-66	193	4	to	to	ADP
njb-66	193	5	the	the	DET
njb-66	193	6	central	central	ADJ
njb-66	193	7	department	department	NOUN
njb-66	193	8	of	of	ADP
njb-66	193	9	microbiology	microbiology	PROPN
njb-66	193	10	,	,	PUNCT
njb-66	193	11	tribhuvan	tribhuvan	PROPN
njb-66	193	12	university	university	PROPN
njb-66	193	13	,	,	PUNCT
njb-66	193	14	kirtipur	kirtipur	PROPN
njb-66	193	15	,	,	PUNCT
njb-66	193	16	nepal	nepal	ADJ
njb-66	193	17	1999	1999	NUM
njb-66	193	18	.	.	PUNCT
njb-66	194	1	15	15	NUM
njb-66	194	2	.	.	PUNCT
njb-66	195	1	bhandari	bhandari	PROPN
njb-66	195	2	rr	rr	PROPN
njb-66	195	3	:	:	PUNCT
njb-66	195	4	prevalence	prevalence	NOUN
njb-66	195	5	and	and	CCONJ
njb-66	195	6	antibiotic	antibiotic	ADJ
njb-66	195	7	sensitivity	sensitivity	NOUN
njb-66	195	8	pattern	pattern	NOUN
njb-66	195	9	of	of	ADP
njb-66	195	10	methicillin	methicillin	NOUN
njb-66	195	11	-	-	PUNCT
njb-66	195	12	resistance	resistance	NOUN
njb-66	195	13	staphylococcus	staphylococcus	NOUN
njb-66	195	14	aureus	aureus	PROPN
njb-66	195	15	(	(	PUNCT
njb-66	195	16	mrsa	mrsa	PROPN
njb-66	195	17	)	)	PUNCT
njb-66	195	18	in	in	ADP
njb-66	195	19	bir	bir	PROPN
njb-66	195	20	hospital	hospital	PROPN
njb-66	195	21	.	.	PUNCT
njb-66	196	1	a	a	DET
njb-66	196	2	dissertation	dissertation	NOUN
njb-66	196	3	submitted	submit	VERB
njb-66	196	4	to	to	ADP
njb-66	196	5	the	the	DET
njb-66	196	6	central	central	ADJ
njb-66	196	7	department	department	NOUN
njb-66	196	8	of	of	ADP
njb-66	196	9	microbiology	microbiology	PROPN
njb-66	196	10	,	,	PUNCT
njb-66	196	11	tribhuvan	tribhuvan	PROPN
njb-66	196	12	university	university	PROPN
njb-66	196	13	,	,	PUNCT
njb-66	196	14	kirtipur	kirtipur	PROPN
njb-66	196	15	,	,	PUNCT
njb-66	196	16	nepal	nepal	ADJ
njb-66	196	17	2002	2002	NUM
njb-66	196	18	.	.	PUNCT
njb-66	197	1	16	16	NUM
njb-66	197	2	.	.	PUNCT
njb-66	197	3	kumari	kumari	PROPN
njb-66	197	4	n	n	PROPN
njb-66	197	5	,	,	PUNCT
njb-66	197	6	mohapatra	mohapatra	PROPN
njb-66	197	7	tm	tm	PROPN
njb-66	197	8	,	,	PUNCT
njb-66	197	9	singh	singh	PROPN
njb-66	197	10	yi	yi	PROPN
njb-66	197	11	:	:	PUNCT
njb-66	197	12	prevalence	prevalence	NOUN
njb-66	197	13	of	of	ADP
njb-66	197	14	methicillin	methicillin	NOUN
njb-66	197	15	-	-	PUNCT
njb-66	197	16	resistant	resistant	ADJ
njb-66	197	17	staphylococcus	staphylococcus	NOUN
njb-66	197	18	aureus	aureus	NOUN
njb-66	197	19	(	(	PUNCT
njb-66	197	20	mrsa	mrsa	PROPN
njb-66	197	21	)	)	PUNCT
njb-66	197	22	in	in	ADP
njb-66	197	23	a	a	DET
njb-66	197	24	tertiary	tertiary	ADJ
njb-66	197	25	-	-	PUNCT
njb-66	197	26	care	care	NOUN
njb-66	197	27	hospital	hospital	NOUN
njb-66	197	28	in	in	ADP
njb-66	197	29	eastern	eastern	PROPN
njb-66	197	30	nepal	nepal	PROPN
njb-66	197	31	.	.	PUNCT
njb-66	198	1	j	j	PROPN
njb-66	198	2	nepal	nepal	PROPN
njb-66	198	3	med	me	VERB
njb-66	198	4	assoc	assoc	PROPN
njb-66	198	5	.	.	PUNCT
njb-66	199	1	2008	2008	NUM
njb-66	199	2	47	47	NUM
njb-66	199	3	(	(	PUNCT
njb-66	199	4	170	170	NUM
njb-66	199	5	):	):	PUNCT
njb-66	199	6	53	53	NUM
njb-66	199	7	-	-	SYM
njb-66	199	8	56	56	NUM
njb-66	199	9	.	.	NUM
njb-66	199	10	17	17	NUM
njb-66	199	11	.	.	PUNCT
njb-66	200	1	sanjana	sanjana	PROPN
njb-66	200	2	rk	rk	PROPN
njb-66	200	3	,	,	PUNCT
njb-66	200	4	shah	shah	PROPN
njb-66	200	5	r	r	PROPN
njb-66	200	6	,	,	PUNCT
njb-66	200	7	chaudhary	chaudhary	PROPN
njb-66	200	8	n	n	NOUN
njb-66	200	9	:	:	PUNCT
njb-66	200	10	prevalence	prevalence	NOUN
njb-66	200	11	and	and	CCONJ
njb-66	200	12	antimicrobial	antimicrobial	ADJ
njb-66	200	13	susceptibility	susceptibility	NOUN
njb-66	200	14	pattern	pattern	NOUN
njb-66	200	15	of	of	ADP
njb-66	200	16	methicillin	methicillin	NOUN
njb-66	200	17	-	-	PUNCT
njb-66	200	18	resistant	resistant	ADJ
njb-66	200	19	staphylococcus	staphylococcus	NOUN
njb-66	200	20	aureus	aureus	NOUN
njb-66	200	21	(	(	PUNCT
njb-66	200	22	mrsa	mrsa	PROPN
njb-66	200	23	)	)	PUNCT
njb-66	200	24	in	in	ADP
njb-66	200	25	cmsteaching	cmsteache	VERB
njb-66	200	26	hospital	hospital	NOUN
njb-66	200	27	:	:	PUNCT
njb-66	200	28	a	a	DET
njb-66	200	29	preliminary	preliminary	ADJ
njb-66	200	30	report	report	NOUN
njb-66	200	31	.	.	PUNCT
njb-66	201	1	jcms	jcms	PROPN
njb-66	201	2	-	-	PUNCT
njb-66	201	3	nepal	nepal	ADJ
njb-66	201	4	.	.	PUNCT
njb-66	201	5	2010	2010	NUM
njb-66	201	6	,	,	PUNCT
njb-66	201	7	6	6	NUM
njb-66	201	8	:	:	SYM
njb-66	201	9	1	1	NUM
njb-66	201	10	-	-	SYM
njb-66	201	11	6	6	NUM
njb-66	201	12	.	.	NUM
njb-66	201	13	18	18	NUM
njb-66	201	14	.	.	PUNCT
njb-66	202	1	tiwari	tiwari	PROPN
njb-66	202	2	hk	hk	PROPN
njb-66	202	3	,	,	PUNCT
njb-66	202	4	das	das	PROPN
njb-66	202	5	ak	ak	PROPN
njb-66	202	6	,	,	PUNCT
njb-66	202	7	sapkota	sapkota	PROPN
njb-66	202	8	d	d	PROPN
njb-66	202	9	,	,	PUNCT
njb-66	202	10	sivrajan	sivrajan	PROPN
njb-66	202	11	k	k	PROPN
njb-66	202	12	,	,	PUNCT
njb-66	202	13	pahwa	pahwa	PROPN
njb-66	202	14	vk	vk	PROPN
njb-66	202	15	:	:	PUNCT
njb-66	202	16	methicillin	methicillin	NOUN
njb-66	202	17	-	-	PUNCT
njb-66	202	18	resistant	resistant	ADJ
njb-66	202	19	staphylococcus	staphylococcus	NOUN
njb-66	202	20	aureus	aureus	NOUN
njb-66	202	21	:	:	PUNCT
njb-66	202	22	prevalence	prevalence	NOUN
njb-66	202	23	and	and	CCONJ
njb-66	202	24	antibiogram	antibiogram	PROPN
njb-66	202	25	in	in	ADP
njb-66	202	26	a	a	DET
njb-66	202	27	tertiary	tertiary	ADJ
njb-66	202	28	care	care	NOUN
njb-66	202	29	hospital	hospital	NOUN
njb-66	202	30	in	in	ADP
njb-66	202	31	western	western	ADJ
njb-66	202	32	nepal	nepal	NOUN
njb-66	202	33	.	.	PUNCT
njb-66	203	1	j	j	PROPN
njb-66	203	2	infect	infect	PROPN
njb-66	203	3	dev	dev	PROPN
njb-66	203	4	ctries	ctries	PROPN
njb-66	203	5	.	.	PUNCT
njb-66	204	1	2009	2009	NUM
njb-66	204	2	3	3	NUM
njb-66	204	3	:	:	PUNCT
njb-66	204	4	681684	681684	NUM
njb-66	204	5	.	.	PUNCT
njb-66	204	6	19	19	NUM
njb-66	204	7	.	.	PUNCT
njb-66	205	1	ansari	ansari	PROPN
njb-66	205	2	s	s	PROPN
njb-66	205	3	,	,	PUNCT
njb-66	205	4	nepal	nepal	ADJ
njb-66	205	5	hp	hp	PROPN
njb-66	205	6	,	,	PUNCT
njb-66	205	7	gautam	gautam	PROPN
njb-66	205	8	r	r	PROPN
njb-66	205	9	,	,	PUNCT
njb-66	205	10	rayamajhi	rayamajhi	PROPN
njb-66	205	11	n	n	PROPN
njb-66	205	12	,	,	PUNCT
njb-66	205	13	shrestha	shrestha	PROPN
njb-66	205	14	s	s	PROPN
njb-66	205	15	,	,	PUNCT
njb-66	205	16	upadhyay	upadhyay	PROPN
njb-66	205	17	g	g	PROPN
njb-66	205	18	,	,	PUNCT
njb-66	205	19	et	et	PROPN
njb-66	205	20	al	al	PROPN
njb-66	205	21	:	:	PUNCT
njb-66	205	22	threat	threat	NOUN
njb-66	205	23	of	of	ADP
njb-66	205	24	drug	drug	NOUN
njb-66	205	25	resistant	resistant	ADJ
njb-66	205	26	staphylococcus	staphylococcus	NOUN
njb-66	205	27	aureus	aureus	NOUN
njb-66	205	28	to	to	ADP
njb-66	205	29	health	health	NOUN
njb-66	205	30	in	in	ADP
njb-66	205	31	nepal	nepal	NOUN
njb-66	205	32	.	.	PUNCT
njb-66	206	1	bmc	bmc	PROPN
njb-66	206	2	infect	infect	PROPN
njb-66	206	3	dis	dis	PROPN
njb-66	206	4	.	.	PROPN
njb-66	206	5	2014	2014	NUM
njb-66	206	6	14	14	NUM
njb-66	206	7	:	:	PUNCT
njb-66	206	8	157	157	NUM
njb-66	206	9	-	-	SYM
njb-66	206	10	162	162	NUM
njb-66	206	11	.	.	SYM
njb-66	206	12	20	20	NUM
njb-66	206	13	.	.	PUNCT
njb-66	207	1	pant	pant	PROPN
njb-66	207	2	mr	mr	PROPN
njb-66	207	3	,	,	PUNCT
njb-66	207	4	shrestha	shrestha	PROPN
njb-66	207	5	d	d	PROPN
njb-66	207	6	,	,	PUNCT
njb-66	207	7	thapa	thapa	PROPN
njb-66	207	8	s	s	X
njb-66	207	9	:	:	PUNCT
njb-66	208	1	antibiogram	antibiogram	ADV
njb-66	208	2	of	of	ADP
njb-66	208	3	bacterial	bacterial	ADJ
njb-66	208	4	species	specie	NOUN
njb-66	208	5	causing	cause	VERB
njb-66	208	6	skin	skin	NOUN
njb-66	208	7	wound	wound	NOUN
njb-66	208	8	infections	infection	NOUN
njb-66	208	9	.	.	PUNCT
njb-66	209	1	nrmj	nrmj	PROPN
njb-66	209	2	.	.	PUNCT
njb-66	210	1	2018	2018	NUM
njb-66	210	2	2	2	NUM
njb-66	210	3	(	(	PUNCT
njb-66	210	4	3	3	NUM
njb-66	210	5	):	):	PUNCT
njb-66	210	6	53	53	NUM
njb-66	210	7	-	-	SYM
njb-66	210	8	60	60	NUM
njb-66	210	9	.	.	NUM
njb-66	210	10	21	21	NUM
njb-66	210	11	.	.	PUNCT
njb-66	211	1	isenberg	isenberg	PROPN
njb-66	211	2	h	h	PROPN
njb-66	211	3	:	:	PUNCT
njb-66	212	1	clinical	clinical	ADJ
njb-66	212	2	microbiology	microbiology	NOUN
njb-66	212	3	procedure	procedure	NOUN
njb-66	212	4	handbook	handbook	NOUN
njb-66	212	5	vol	vol	X
njb-66	212	6	i	i	PROPN
njb-66	212	7	and	and	CCONJ
njb-66	212	8	ii	ii	PROPN
njb-66	212	9	.	.	PROPN
njb-66	213	1	american	american	PROPN
njb-66	213	2	society	society	PROPN
njb-66	213	3	for	for	ADP
njb-66	213	4	microbiology	microbiology	NOUN
njb-66	213	5	(	(	PUNCT
njb-66	213	6	asm	asm	PROPN
njb-66	213	7	)	)	PUNCT
njb-66	213	8	press	press	NOUN
njb-66	213	9	,	,	PUNCT
njb-66	213	10	washington	washington	PROPN
njb-66	213	11	dc	dc	PROPN
njb-66	213	12	,	,	PUNCT
njb-66	213	13	new	new	PROPN
njb-66	213	14	york	york	PROPN
njb-66	213	15	usa	usa	PROPN
njb-66	213	16	,	,	PUNCT
njb-66	213	17	1992	1992	NUM
njb-66	213	18	.	.	PUNCT
njb-66	213	19	22	22	NUM
njb-66	213	20	.	.	PUNCT
njb-66	214	1	clsi	clsi	PROPN
njb-66	214	2	:	:	PUNCT
njb-66	214	3	performance	performance	NOUN
njb-66	214	4	standards	standard	NOUN
njb-66	214	5	for	for	ADP
njb-66	214	6	antimicrobial	antimicrobial	ADJ
njb-66	214	7	susceptibility	susceptibility	NOUN
njb-66	214	8	testing	testing	NOUN
njb-66	214	9	.	.	PUNCT
njb-66	215	1	25th	25th	ADJ
njb-66	215	2	informational	informational	ADJ
njb-66	215	3	supplement	supplement	NOUN
njb-66	215	4	,	,	PUNCT
njb-66	215	5	document	document	NOUN
njb-66	215	6	m100	m100	PROPN
njb-66	215	7	–	–	PUNCT
njb-66	215	8	s25	s25	PROPN
njb-66	215	9	.	.	PUNCT
njb-66	216	1	wayne	wayne	PROPN
njb-66	216	2	,	,	PUNCT
njb-66	216	3	usa	usa	PROPN
njb-66	216	4	2105	2105	NUM
njb-66	216	5	,	,	PUNCT
njb-66	216	6	35	35	NUM
njb-66	216	7	(	(	PUNCT
njb-66	216	8	3	3	NUM
njb-66	216	9	)	)	PUNCT
njb-66	216	10	.	.	PUNCT
njb-66	217	1	23	23	NUM
njb-66	217	2	.	.	PUNCT
njb-66	217	3	bergey	bergey	PROPN
njb-66	217	4	dh	dh	PROPN
njb-66	217	5	,	,	PUNCT
njb-66	217	6	buchanan	buchanan	PROPN
njb-66	217	7	re	re	PROPN
njb-66	217	8	,	,	PUNCT
njb-66	217	9	gibbons	gibbon	NOUN
njb-66	217	10	ne	ne	NOUN
njb-66	217	11	:	:	PUNCT
njb-66	217	12	bergey	bergey	PROPN
njb-66	217	13	’s	’s	PART
njb-66	217	14	manual	manual	NOUN
njb-66	217	15	of	of	ADP
njb-66	217	16	determinative	determinative	ADJ
njb-66	217	17	bacteriology	bacteriology	PROPN
njb-66	217	18	.	.	PUNCT
njb-66	218	1	williams	williams	PROPN
njb-66	218	2	and	and	CCONJ
njb-66	218	3	wilkins	wilkins	PROPN
njb-66	218	4	usa	usa	PROPN
njb-66	218	5	1974	1974	PROPN
njb-66	218	6	.	.	PUNCT
njb-66	219	1	nepal	nepal	ADJ
njb-66	219	2	journal	journal	PROPN
njb-66	219	3	of	of	ADP
njb-66	219	4	biotechnology	biotechnology	NOUN
njb-66	219	5	.	.	PUNCT
njb-66	220	1	d	d	X
njb-66	220	2	e	e	PROPN
njb-66	220	3	c	c	PROPN
njb-66	220	4	.	.	PUNCT
njb-66	221	1	2	2	NUM
njb-66	221	2	0	0	NUM
njb-66	221	3	1	1	NUM
njb-66	221	4	9	9	NUM
njb-66	221	5	vol	vol	NOUN
njb-66	221	6	.	.	PUNCT
njb-66	222	1	7	7	NUM
njb-66	222	2	,	,	PUNCT
njb-66	222	3	no	no	NOUN
njb-66	222	4	.	.	NOUN
njb-66	222	5	1	1	NUM
njb-66	222	6	:	:	SYM
njb-66	222	7	82	82	NUM
njb-66	222	8	-	-	SYM
njb-66	222	9	89	89	NUM
njb-66	222	10	bhandari	bhandari	PROPN
njb-66	222	11	et	et	PROPN
njb-66	222	12	al	al	PROPN
njb-66	222	13	.	.	PROPN
njb-66	222	14	2019	2019	NUM
njb-66	223	1	©	©	ADP
njb-66	223	2	njb	njb	PROPN
njb-66	223	3	,	,	PUNCT
njb-66	223	4	biotechnology	biotechnology	NOUN
njb-66	223	5	society	society	NOUN
njb-66	223	6	of	of	ADP
njb-66	223	7	nepal	nepal	ADJ
njb-66	223	8	89	89	NUM
njb-66	223	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-66	223	10	.	.	PROPN
njb-66	223	11	24	24	NUM
njb-66	223	12	.	.	PUNCT
njb-66	223	13	cheesbrough	cheesbrough	PROPN
njb-66	224	1	m	m	PROPN
njb-66	224	2	:	:	PUNCT
njb-66	224	3	microbiological	microbiological	ADJ
njb-66	224	4	tests	test	NOUN
njb-66	224	5	district	district	NOUN
njb-66	224	6	laboratory	laboratory	NOUN
njb-66	224	7	practice	practice	NOUN
njb-66	224	8	in	in	ADP
njb-66	224	9	tropical	tropical	ADJ
njb-66	224	10	countries	country	NOUN
njb-66	224	11	,	,	PUNCT
njb-66	224	12	part	part	NOUN
njb-66	224	13	-	-	PUNCT
njb-66	224	14	ii	ii	PROPN
njb-66	224	15	.	.	PUNCT
njb-66	225	1	low	low	ADJ
njb-66	225	2	price	price	NOUN
njb-66	225	3	edition	edition	PROPN
njb-66	225	4	,	,	PUNCT
njb-66	225	5	cambridge	cambridge	PROPN
njb-66	225	6	university	university	PROPN
njb-66	225	7	press	press	PROPN
njb-66	225	8	,	,	PUNCT
njb-66	225	9	india	india	PROPN
njb-66	225	10	2006	2006	NUM
njb-66	225	11	,	,	PUNCT
njb-66	225	12	01	01	NUM
njb-66	225	13	-	-	SYM
njb-66	225	14	267	267	NUM
njb-66	225	15	.	.	PROPN
njb-66	225	16	25	25	NUM
njb-66	225	17	.	.	PUNCT
njb-66	226	1	lencastre	lencastre	PROPN
njb-66	226	2	dh	dh	PROPN
njb-66	226	3	,	,	PUNCT
njb-66	226	4	oliveira	oliveira	PROPN
njb-66	226	5	d	d	PROPN
njb-66	226	6	,	,	PUNCT
njb-66	226	7	tomasz	tomasz	VERB
njb-66	226	8	a	a	DET
njb-66	226	9	:	:	PUNCT
njb-66	226	10	antibiotic	antibiotic	ADJ
njb-66	226	11	resistant	resistant	ADJ
njb-66	226	12	staphylococcus	staphylococcus	NOUN
njb-66	226	13	aureus	aureus	NOUN
njb-66	226	14	:	:	PUNCT
njb-66	226	15	a	a	DET
njb-66	226	16	paradigm	paradigm	NOUN
njb-66	226	17	of	of	ADP
njb-66	226	18	adaptive	adaptive	ADJ
njb-66	226	19	power	power	NOUN
njb-66	226	20	.	.	PUNCT
njb-66	227	1	curr	curr	PROPN
njb-66	227	2	opin	opin	PROPN
njb-66	227	3	microbiol	microbiol	PROPN
njb-66	227	4	.	.	PUNCT
njb-66	228	1	2007	2007	NUM
njb-66	228	2	10(5	10(5	NUM
njb-66	228	3	):	):	PUNCT
njb-66	228	4	428	428	NUM
njb-66	228	5	-	-	SYM
njb-66	228	6	435	435	NUM
njb-66	228	7	.	.	PROPN
njb-66	228	8	26	26	NUM
njb-66	228	9	.	.	PUNCT
njb-66	229	1	lelievre	lelievre	PROPN
njb-66	229	2	h	h	PROPN
njb-66	229	3	,	,	PUNCT
njb-66	229	4	lina	lina	PROPN
njb-66	229	5	g	g	PROPN
njb-66	229	6	,	,	PUNCT
njb-66	229	7	jones	jones	PROPN
njb-66	229	8	me	i	PRON
njb-66	229	9	:	:	PUNCT
njb-66	229	10	emergence	emergence	NOUN
njb-66	229	11	and	and	CCONJ
njb-66	229	12	spread	spread	VERB
njb-66	229	13	in	in	ADP
njb-66	229	14	french	french	ADJ
njb-66	229	15	hospitals	hospital	NOUN
njb-66	229	16	of	of	ADP
njb-66	229	17	methicillinresistant	methicillinresistant	ADJ
njb-66	229	18	staphylococcus	staphylococcus	NOUN
njb-66	229	19	aureus	aureus	NOUN
njb-66	229	20	with	with	ADP
njb-66	229	21	increasing	increase	VERB
njb-66	229	22	susceptibility	susceptibility	NOUN
njb-66	229	23	to	to	ADP
njb-66	229	24	gentamicin	gentamicin	NOUN
njb-66	229	25	and	and	CCONJ
njb-66	229	26	other	other	ADJ
njb-66	229	27	antibiotics	antibiotic	NOUN
njb-66	229	28	.	.	PUNCT
njb-66	230	1	j	j	PROPN
njb-66	230	2	clin	clin	PROPN
njb-66	230	3	microbiol	microbiol	PROPN
njb-66	230	4	.	.	PUNCT
njb-66	231	1	1999	1999	NUM
njb-66	231	2	37	37	NUM
njb-66	231	3	:	:	PUNCT
njb-66	231	4	34523457	34523457	NUM
njb-66	231	5	.	.	PUNCT
njb-66	232	1	27	27	NUM
njb-66	232	2	.	.	PUNCT
njb-66	233	1	pant	pant	PROPN
njb-66	233	2	j	j	PROPN
njb-66	233	3	,	,	PUNCT
njb-66	233	4	rai	rai	PROPN
njb-66	233	5	sk	sk	PROPN
njb-66	233	6	,	,	PUNCT
njb-66	233	7	singh	singh	PROPN
njb-66	233	8	a	a	PRON
njb-66	233	9	,	,	PUNCT
njb-66	233	10	lekhak	lekhak	PROPN
njb-66	233	11	b	b	PROPN
njb-66	233	12	,	,	PUNCT
njb-66	233	13	shakya	shakya	PROPN
njb-66	233	14	b	b	PROPN
njb-66	233	15	,	,	PUNCT
njb-66	233	16	ghimire	ghimire	PROPN
njb-66	233	17	g	g	PROPN
njb-66	233	18	:	:	PUNCT
njb-66	233	19	microbial	microbial	PROPN
njb-66	233	20	study	study	NOUN
njb-66	233	21	of	of	ADP
njb-66	233	22	hospital	hospital	NOUN
njb-66	233	23	environment	environment	NOUN
njb-66	233	24	and	and	CCONJ
njb-66	233	25	carrier	carrier	NOUN
njb-66	233	26	pattern	pattern	NOUN
njb-66	233	27	study	study	NOUN
njb-66	233	28	among	among	ADP
njb-66	233	29	staff	staff	NOUN
njb-66	233	30	in	in	ADP
njb-66	233	31	nepal	nepal	ADJ
njb-66	233	32	medical	medical	PROPN
njb-66	233	33	college	college	PROPN
njb-66	233	34	teaching	teaching	PROPN
njb-66	233	35	hospital	hospital	PROPN
njb-66	233	36	.	.	PUNCT
njb-66	234	1	nmcj	nmcj	PROPN
njb-66	234	2	.	.	PUNCT
njb-66	234	3	2006	2006	NUM
njb-66	234	4	8	8	NUM
njb-66	234	5	:	:	PUNCT
njb-66	234	6	194199	194199	NUM
njb-66	234	7	.	.	PUNCT